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HIV Among Drug Users in Poland:  Paradoxes of an Epidemic 
Kasia Malinowska-Sempruch 
Since 1988 when the first HIV positive drug user was identified in Poland, for close to two 
decades, the predominant route of HIV transmission has been through injecting drug use.  In mid 
2000s, Polish officials reported that injecting drug use no longer contributed to incrasing HIV 
incidence.  The consequences of such a statement are that many of the structural and personal 
risks associated with HIV infection go unaddressed,  that drug users are neglected by HIV 
prevention efforts, that HIV treatment is not made available to drug users and that the policy 
environment does not adequately support effective public health initiatives.   
This case study is based on documentation, archival records, interviews, participant observation, 
and physical artifacts shows that these assertions were made, and continue to be repeated, in a 
highly political context.  Poland is a post-socialist state with strong neoliberal leanings, and it is 
highly invested in successful integration with the European Union.   Powerful Catholic Church 
serves as an important backdrop.  While people considered “at risk” now have more freedom to 
conduct their lives, they also have a set of neoliberal expectations and religious pressures placed 
on them. Country’s geographic location adds to this complexity – situated between “Old Europe” 
where HIV problem has been successfully contained and the former Soviet Union, where the 
HIV incidence among drug users is the highest in the world, Poland attempts to align itself with 
the success of the West.  Furthermore, examination of the available data suggests that the 
assertions made by Polish officials omit numerous variables. 
My research shows that even though Polish leadership in the area of HIV and drug policy wishes 
to resemble Western Europe, Poland does not meet international standards for the prevention of 
HIV transmission.  The interviews I conducted, as well as the review of the literature on drug 
and HIV policies and programs suggest that these services are scattered, often unavailable, and 
that their number is stagnating, at best, and in some cases, even decreasing. This maybe a direct 
result of lack of engagement of drug users in their design.  Excluded from the discussion of risk, 
drug users are thus not the focus of prevention efforts.   
Based on gathered data, there are seven crucial issues that require immediate action if Poland is 
to manage HIV prevention and care for people who use drugs in a manner consistent with the 
international standards.   The areas requiring action are: a change in the drug policy from the 
current very punitive approach, expansion of needle and syringe programs and other harm 
reduction services,  improved data collection and an increase in the availability of HIV testing, 
scaled-up substitution treatment, improved quality of other forms of drug treatment, greater 
investment in civil society organizations, improved access to HIV treatment, and educational and 
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In 2006, at a meeting at the Polish Parliament, the director of the National AIDS Center reported 
that injecting drug use no longer contributed to the HIV and AIDS crisis in Poland. Two years 
later, the Director of Poland’s National Bureau for Drug Prevention reiterated this assertion. This 
assumption is highly significant to the epidemic as a whole because, since 1988 when the first 
HIV positive drug user was identified, the predominant route of HIV infection in Poland has 
been through injecting drug use. The consequences of such a statement by Poland’s drug and 
HIV policy leadership are that many of the structural and personal risks associated with HIV 
infection go unaddressed, that the focus is removed from injecting drug use as a factor leading to 
HIV infection, that drug users are subsequently neglected by HIV prevention efforts, that HIV 
treatment is not made available to drug users and that the policy environment does not 
adequately support effective public health initiatives.     
 
My research shows that these assertions were made, and continue to be repeated, in a highly 
political context.  Poland is a post-socialist state with strong neoliberal leanings, and it is highly 
invested in successful integration with the European Union.   Powerful Catholic Church serves as 
an important backdrop.  Furthermore, similarly to other parts of the world and regardless of 
political period, drug use and HIV have been viewed and responded to with a political agenda.  
Country’s geographic location adds to this complexity – situated between “Old Europe” where 
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HIV problem has been successfully contained and the former Soviet Union, where the HIV 
incidence among drug users is the highest in the world, Poland attempts to align itself with the 
success of the West.  
 
Figure 1. HIV Prevalence in Europe and former Soviet Union (UNAIDS, 2013)   
 
 
 Furthermore, my research shows that even though Polish leadership in the area of HIV and drug 
policy wishes to resemble Western Europe, Poland does not meet international standards for the 
prevention of HIV transmission. Availability of services and their quality are closely aligned 
with the political context – humiliation of patients as a tool of “treatment” in abstinence centers,  
as well as very high threshold opioid substitution serve as powerful examples. The interviews I 
conducted, as well as the review of the literature on drug and HIV policies and programs suggest 
that these services are scattered, often unavailable, and that their number is stagnating, at best, 
and in some cases, even decreasing. This maybe a direct result of lack of engagement of drug 
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users in their design even though elsewhere, the literature shows that involving persons who use 
illicit drugs in discussions about relevant interventions has been instrumental in controlling the  
HIV epidemic  (Friedman,  2007).    As Outlined by Parker (2000b) and Degenhardt (2010) the 
national and local politics and policies contribute to the structural risk, especially in area of drug 
policy.  Farmer suggests that the war on drugs is one of the newer ruses for managing inequality 
and criminalizing poverty (2005).   
 
Neither Poland’s drug nor HIV policies acknowledge that the resources that determine the extent 
to which people are able to avoid risk are, in fact, fundamental social cause of disease (Link, 
1995). Instead, the limited discourse that exists is focused on controlling risk factors at the level 
of the individual, and emphasizing personal responsibility.  With politics increasingly focusing 
on “law and order” paradigm, the few services that are still available are increasingly hostile 
towards public health goals.  As explained by one of my interviewees, “In the narrative of the 
Polish HIV epidemic, drug users are the voiceless actors.  They make every effort to disappear 
from public view. One has to make a conscious effort to want to see them. There are no active 
users in Poland complaining about the lack of services.”   Excluded from the discussion of risk, 





 on drug use related matters discuss the public heath 
interventions and policy context required for effective HIV prevention.  These guidelines suggest 
that the following components are necessary for successful national HIV prevention efforts 
among people who use drugs: needle and syringe distribution and/or exchange; outreach services 
such as condom and other paraphernalia distribution; provision of STI and other disease 
screening and treatment; referrals to or direct provision of housing, food and clothing; 
substitution treatment; other evidence-based drug treatment; HIV testing and treatment, and 
overdose prevention. All of these interventions must be multilayered and properly funded. They 
must also be delivered in a non-punitive policy environment that emphasizes public health rather 
than criminal justice since it is widely recognized that the fundamental social causes of a disease 
determine the extent to which people are able to avoid risk (Link, 1995). 
 
Data from numerous international studies demonstrates that the rate of HIV transmission has 
decreased as the result of concerted efforts (Parker, 2000b; EMCDDA, 2011), many of which 
aim to empower people at risk.  Global HIV prevention efforts frequently adopted strategies 
focused both on upstream factors, for example access to HIV medicines and targeted media 
                                                 
 
WHO/UNODC/UNAIDS position paper: Substitution maintenance therapy in the management of opioid 
dependence and HIV/AIDS prevention; Joint UNAIDS statement on HIV Prevention and Care Strategies for Drug 
Users; UNODC/WHO discussion paper – Principles of Drug Dependence Treatment; WHO, UNODC, UNAIDS, 






campaigns, and downstream factors such as needle exchange.  Addressing all of these influences 
maximizes a person’s chances of reaching his or her highest attainable standard of health (Koh, 
2010). Similarly, the international guidelines emphasize that countries that have piloted 
prevention services, but have not taken them to scale, have not been successful in containing 
HIV infection rates (Hunt, 2003; Rehm, 2003; Reference Group, 2010).  Since pilot programs 
have no effect on structural risks, the guidelines stipulate that services should be widely available 
to all drug users who may need them.  
 
Preliminary examination of the available data on HIV in Poland suggests that the assertions 
made by Polish officials in 2006 concerning the end of the drug-related HIV epidemic omit 
numerous variables. Furthermore, multiple and mutually reinforcing explanations were offered 
by a number of persons I interviewed, often citing politically conservative, law enforcement 
focused and catholic backdrop of the country as reasons for misinterpretation of data by the 
government.  It is interesting to notice that Poland’s struggle with HIV very much mimics the 
current international discourse and  pressure for success as evidenced by the global UNADS 
2011-2015 strategy of “Getting to Zero” ( 2010) as well as “Treatment 2015” (2012).  In both of 
these documents, drug users are for most part, unattended in global prevention and care efforts.  
As shared in correspondence with one of its members, UNAIDS Reference Group on HIV and 
Human Rights offered the  following analysis of “Treatment 2015” strategy:  “UNAIDS, and 
particularly the Secretariat, has to be much more balanced between achievements/”end of AIDS” 
messages and the very hard issues that need to be, and are not being, addressed as we move 
forward”.  The group goes on to talk about the  need to better address unjust application of 
criminal law and its consequences as a major barrier to testing and treatment access in many 
10 
 
parts of the world.   In similar spirit, a recent analysis as to what has been achieved in HIV 
prevention, treatment and care for people who inject drugs between 2010-2012 concludes: “As 
long as law enforcement responses counter public health responses, health-seeking behaviour 
and health service delivery will be limited’ (Degenhardt, 2013). 
 
In this context of multiple political interests, it is increasingly difficult analyze and understand 
HIV and drugs data.  From 1999 to 2004, out of 3,561 newly detected HIV infections reported 
through the routine surveillance system in Poland, injecting drug use was the most common 
transmission route, accounting for 78.6% of registered infections (Rosinska, 2006).  After 2004, 
and each year subsequently, the proportion of newly reported infections attributed to drug users 
decreased. At the same time, as reported by the Polish Public Health Institute, there is a notable 
trend in the increasing proportion of new infections identified as having an “Unknown” route of 
transmission (Figure 2). This trend in the use of “Unknown” has likely disguised the number of 






Figure 2. Routes of Transmission For New HIV Infections, as a Proportion of the Total 
 
Though the Directors of Poland's National AIDS Center and National Bureau for Drug 
Prevention have stated publicly that injecting drug use no longer contributes to the HIV and 
AIDS crisis in Poland, there is little evidence that this is accurate. In my dissertation I will 
endeavor to show why this assessment is flawed. I will also identify the consequences of 
structuring policy around unconfirmed assumptions and a lack of accurate data as to the true 
extent of the epidemic in Poland. Since its inception, the predominant route of HIV infection in 
Poland has been through injecting drug use. HIV is still transmitted through injecting drug use. 
The consequence of assuming otherwise is that many of the structural and personal risks 
associated with HIV infection are not addressed. To successfully prevent HIV transmission in 
Poland it is necessary to support effective and appropriately scaled public health initiatives. 
















































use with such initiatives as needle and syringe distribution and/or exchange and substitution 
treatment on a wide scale, it will fail to successfully prevent HIV transmission and will follow 
the trend recently observed in Europe, of countries such as Greece and Romania, with a 
significant increase of HIV incidence among drug users,  
  
In support of my hypothesis, my dissertation will review the history of drug and AIDS policies in 
Poland, drug and HIV prevention efforts, and the delivery of services to people who are living 
with HIV and who use drugs.  I will also analyze the social, historical, religious and political 
context that contributes to the structural risk. Finally, I will offer recommendations for 
improvements to current policy and service delivery that are consistent with international 
evidence and standards for effective drug and HIV policy and respond to structural 
vulnerabilities through approaches that modify social norms, institutions, and laws to reduce 
vulnerability and create environments in which individuals can protect themselves against HIV 
infection (Auerbach, 2009).   
 
The Historical, Political, and Social Context of the HIV Epidemic in Central and Eastern 
Europe  
The epidemic in Poland is best understood with a grasp of the regional context. Eastern Europe 
experienced the HIV epidemic later than most of the world. Its arrival in the region was 
concurrent with the dramatic political and economic changes that took place during the late 
1980s and early 1990s: the fall of the Berlin Wall, the shift from socialism to democracy and free 




All of these factors resulted in major changes to the political culture and the institutions 
responsible for addressing health and social services as well as to the way citizens related to 
these institutions and to each other. Throughout the region, strong states that held great control 
over their citizens in all spheres of life, including public health, were swiftly transforming. 
Poland’s former minister of economics identified the following symptoms of a newly emerged 
“soft” Polish state: legislative problems, deficits in the rule of law, increasing corruption, use of 
political power to serve special interests, inefficient public spending, poor performance of public 
servants, and delayed implementation of reforms that support social justice (Hausner, 2007).  
 
By the time sub-Saharan Africa, parts of Asia, North America and Western Europe had already 
detected sizable HIV epidemics in the late 1980s, Eastern Europe had reported only a few HIV 
cases. Seven Eastern and Central European countries - Albania, Bulgaria, Czechoslovakia, 
Hungary, Poland, Romania, and Yugoslavia - reported a total of 1,704 AIDS cases, out of a total 
of 48,144 reported for all 31 nations of Europe (WHO, 1991). 
 
Consistent with fundamental social causes theory, the risk of HIV transmission, similar to other 
infections facilitated by human behavior, is greatly shaped by the environment in which it occurs 
(Reid, 1992; Farmer, 1996; Rhodes, 2005). Although the World Health Organization (WHO) 
attempted to bring attention to the prevalence of risk associated with HIV transmission that was 
present in Eastern Europe, little notice was paid. During its fifth meeting in November 1989, the 
Management Committee of WHO’s Global Programme on AIDS expressed concern over the 
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factors that could lead to the spread of HIV in Eastern Europe; the opening of borders and 
liberalization of travel could expose previously secluded populations to contact with 
communities where HIV had been present for some time; an increase in unemployment and 
migration resulting from the political and economic alterations could lead to changes in attitudes 
and practices, resulting in further exposure to HIV; and an increase in sex work with the 
introduction of free market economies (WHO, 1990). The overall lack of social and economic 
stability and increased access to illicit substances increased rates of drug use across the region. 
Interestingly, drug use related risks were not identified by the WHO, nor anyone else, as a mode 
of transmission that could increase the risk of HIV transmission in Eastern Europe. 
 
With the political and economic reorientation from socialism to democracy and the arrival of a 
neoliberal philosophy with a newly established free market economy, the social services systems 
in the region came under severe financial pressure. The public health programs that were still in 
place, typically called “The Sanitation and Epidemiology Departments,” were based on the 
Soviet model of public control. As the countries in the region gradually moved away from 
socialism to democracy, the Soviet model was perceived with increasing mistrust. Consistent 
with Nathanson’s findings (2007), and even more so in this time of dramatic political change and 
scarce economic resources, public health held a low position within the ministerial hierarchy.  It 
was in this political context, and within these structures, that the National AIDS Center and the 




While governments and economies were restructuring, the Catholic Church was gaining 
authority throughout the region, especially in Poland, which considered Pope John Paul II, a 
fellow Pole, to be its most influential leader.   Mr. Kazimierz Kapera, Poland’s Vice-Minister of 
Health, declared that, “A morally sane life is a one hundred percent guarantee that one will not 
contract the fatal disease” (Hendriks, 1991).  According to a ministerial staff member holding a 
public health post at the time, the spirit of prevention efforts was consistent with the 
aforementioned philosophy.  She gave an example of outreach to college students at campuses in 
the North, in Szczecin.  Prevention efforts there consisted of persuading students to handwrite a 
pledge that they would not engage in sexual activity.  The collected statements were then 
provided to the Ministry.  Minister Kapera’s declaration was quickly followed by a statement 
from the Primate of Poland, Cardinal Glemp, who asserted that sin was the main means of HIV 
transmission. Many Eastern Europeans, indoctrinated to believe that the disease was a horror of 
capitalism and would pass them by, had a hard time accepting the realities of the problem.  “The 
roots of [HIV] transmission are the American and Western way of life, unrestrained and 
flourishing homosexuality, drugs and an obsession with sex,” explained one Soviet official 
(Eistein, 1990).  “The key to early and effective public health action by the state is that action be 
embraced by the holders of political power,” states Nathanson in her study of the harm reduction 
policies in four industrialized countries (2007).   In Central and Eastern Europe this did not occur 
in relation to HIV prevention, particularly among injecting drug users. This still holds true for 
most of the post-Soviet region, with a few exceptions of Slovenia and the Czech Republic 
(Csete, 2012).  In Czech Republic, a  government  made a remarkable decision to invest in a 
large-scale, rigorous research project to evaluate the impact of the drug law and based on its 
16 
 
outcomes --  that tough,  expensive  enforcement  did  not  decrease  use  prevalence,  produced 
the current progressive policies.   
 
Figure 3. Map of Europe 
 
 
In 1990, three counties in the region showed worrisome signs of increasing HIV incidence: 
Poland reported 1,178 HIV infections, Yugoslavia reported 2,023 HIV infections, and Romania 
reported 1,436 cases of AIDS (WHO, 1991). Note that the first HIV cases in these countries 
were detected in 1985 and 1986. Poland and Yugoslavia shared a common profile of new 
infections: drug users living in urban centers were at the epicenter of the epidemics.  The profile 
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of the epidemic in Romania was quite different where hundreds of children living in orphanages, 
a side effect of Romania’s anti-family planning and anti-abortion policies, were infected through 
medically questionable procedures.  Ill children in various institutions and hospitals were 
injected with blood to improve their health.  Also, needles and syringes were reused multiple 
times to immunize infants.   
 
Like the Americans who framed HIV as the disease of the dangerous “other” and legitimized 
exclusion (Nathanson, 2007), Eastern Europeans set off a process of severe social isolation of 
persons living with AIDS. Those living with AIDS were feared and discriminated against by the 
medical establishment, law enforcement agencies, employers, housing providers, and family 
members.  In Romania, gravediggers refused to bury the bodies of children who died of AIDS. In 
Bucharest’s mortuaries parents feared HIV and refused to claim the bodies of their children 
(Hendriks, 1991).  Poland and Hungary tested all prisoners and kept HIV-positive individuals 
isolated for the duration of their sentences (Hendriks, 1991) practice that was eliminated by the 
end of the 1990s.  In Poland, people with newly identified HIV were becoming homeless and to 
set up temporary shelters and halfway houses became a pressing issue.  According to one of my 
interviewees active in the area of HIV in the late 80s, many people were so terrified of their 
status being disclosed that they left their simply homes and moved across the country.  
Simultaneously, little, if any, medical care was available for those infected. As a result, most 
people avoided being tested. This, in turn, created a self-perpetuating problem: the threat of 
social ostracism and lack of care deterred people from getting tested, the low number of tested 
individuals resulted in low incidence data, which, in turn, allowed governments to ignore the 




Many countries continued the practice of the Soviet system, which was to designate sex work 
and homosexual activity as crimes punishable by imprisonment. Even though the new political 
establishments based on democratically elected governments claimed to protect the human rights 
of all individuals, some groups were clearly not included in the promise. Persons who identified 
themselves as gay and agreed to be tested for HIV became the target of bigotry and violence. 
Women in the sex industry were publicly ridiculed and mistreated.  At the same time, the sex 
trade was expanding with the rise in tourism and the arrival of Western businesses.  Sex work 
became a highly profitable industry and was, therefore, aggressively protected by those who 
profited from it.  These factors, in conjunction with high levels of stigma, made it difficult for 
prevention workers to access the people who were most at risk (Kreniske, 1991). 
 
During the Soviet domination of Eastern Europe, sexuality was not discussed openly and human 
rights were ignored. As the political systems evolved, attempts to begin a public discourse about 
sexuality came under assault by the increasingly powerful Catholic Church (Nowicka, 2008). 
The absence of psychological support or any counseling infrastructure, combined with the 
constant presence of powerful social controls, also made effective interventions difficult. As 
stated by Marcu, the designer and facilitator of a workshop on HIV and Human Rights held in 
The Hague in 1991: 
It is very difficult for people whose ideas have been deformed for such a long 
time to recover rapidly their capacity to discriminate, and to acquire a capacity to 
understand and evaluate the importance of the psyche, and of its care. In a way 
the minds and souls of these people will have to be reshaped in order to fit again 




During the waning years of Soviet-style medicine, when HIV was first spreading, there were no 
legislative means for ensuring confidentiality. Voluntary and confidential testing was not 
available. Instead, most governments invested in compulsory testing.  In Poland, for example, by 
1989 sex workers were required to test every six months, foreign residents tested twice a year 
(March and October), and prisoners were tested upon entry into the prison system (Stapinski, 
1989). At the same time, in the former Czechoslovakia, all foreign students had to present an 
HIV-negative test result to be admitted into the country. Czechoslovak nationals returning home 
after extended travel had to submit to an HIV test.  A number of HIV-positive foreigners were 
deported (Hendriks, 1991).  As recalled in an interview by a former staff of the Polish Ministry 
of Health, “When I began my job I opened a huge cabinet of WHO documents which no one 
paid attention to.  The more I read the more it became clear to me that what the WHO was 
recommending and what our Minister wanted to do was very different.  We often argued about it 
and, in the end, this was the reason I lost my job. Then he went to a meeting of Ministers in Paris 
and came back astonished.  I do not think he had any idea as to what needed to be done, but at 
least he understood that coercive and punitive actions would hurt Poland’s image at the 
international level.” 
 
The Alma Ata Declaration of 1978, to protect and promote the health of all the world’s people, 
was born in the former Soviet Union. It defined community participation as, “….a process by 
which individuals and families assume responsibility for their own health and welfare and that of 
the community, and develop a capacity to contribute to their own and the community’s 
development.” While the social determinants approach in other regions involved defining health 
needs and disparities in a way that engaged people to become advocates for change (Koh, 2010) 
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and despite the origins of the Alma Ata Declaration, individual action and community organizing 
were not supported and was often prohibited throughout the region. According to Cockerham 
who studied health outcomes in the communist and then post-communist Russia, health lifestyles 
are collective patterns of health-related behavior based on choices from options available to 
people.  Choices are a form of agency -- the process by which individuals critically evaluate and 
choose their course of action.  In communist societies, the choices of individuals were confined 
to a one social and political realm – socialism -- and expected to conform to the ideology it 
represented (Cockerham, 2002). 
 
This paradigm had a powerful impact on the scope and effectiveness of the groups that emerged 
to address the HIV and drug use crisis. It has been documented throughout Europe, North 
America that engaging persons who use illicit drugs in the development of interventions 
acknowledges their human rights and shows respect for their right to self-determination. When 
civil society finally began to organize around AIDS, drug users did not participate in the efforts. 
Consistent with trends in other regions, they have been the most stigmatized and least visible 
members of the HIV affected population.  If the existence of a “competent community” (Minker, 
1997) is a predictor of successful HIV prevention, drug users in Central Europe have a long 
struggle ahead of them. The region lacks groups resembling the articulate, visible, and well-
funded social action organization ACT UP, in which gay men in New York fought for access to 
prevention and care and advocated on behalf of other, less politically experienced and 
underfunded groups (Nathanson, 2007).  It is possible that the risk associated with advocacy for 
men who have sex with men (MSM) has been so great that absorbing the potentially even greater 
risk of demanding attention for drug user’s issues was not possible.  While much literature exists 
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about how governments can actively facilitate and support the role of civil society to address 
social determinants to improve health outcomes, today, well over two decades into the HIV 
epidemic among injecting drug users in Central Europe, there are still very few AIDS 
organizations and no strong national organizations representing the interests of people who inject 
drugs.  One of my interviewees, a journalist specializing in the issues of vulnerable groups, 
commented on the state of civil society in Poland, “There is no place here that teaches you how 
to organize effectively, how to form an NGO, how to collaborate and run an effective network.  
These are things that people on the other side of the Iron Curtain have been learning for decades.  
There are academic centers dedicated to this across the world - none of it exists here.”   Another, 
a retired academic, commented that on top of this lack of experience there are now 
“superstructures” such as the European Commission and others that are placing great 
bureaucratic expectations onto tiny groups and, in the process, are destroying their already 
limited capacity for advocacy.   
  
The Post-Socialist State and the Influence of the Catholic Church on HIV in Poland 
The first case of HIV was reported in Poland in 1985, following a period of intense political and 
social turmoil. To crush the political opposition, the government imposed martial law from 
December 1981 until July 1983. During martial law, close to 2,000 Poles were imprisoned and 
over 20,000 went underground. Though martial law was lifted in 1983, many prisoners were not 
released until 1986 during the general amnesty. As a result, the space for public discussion of 
social issues was virtually nonexistent. The collective memory of these events remains very 
present in Polish consciousness today.   This may offer one explanation as to why a country 
which was first to fight for democracy under the banner of Solidarity, almost a decade before the 
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fall of the Berlin Wall, no longer holds solidarity as an important social value. Instead, it opts to 
draw moral distinctions between “us”– perceived to be those who are free of HIV and drug use - 
and “them.” These artificial boundaries legitimize exclusion as a response to drug use and HIV.   
 
Ironically, in the early days of Poland’s democracy, it was General Jaruzelski, a communist 
general and a key person responsible for introducing martial law, who defended people living 
with HIV.  In 1990 a new democratically elected local government in a small town neighboring 
Warsaw had passed an ordinance banning HIV positive persons from entering the community.  
At the time Poland had yet to enact a new constitution that protected citizens from discrimination 
so the President was the only one with the authority to overrule such a law. As this event 
occurred during the transition of power, the country’s last Communist leader, General Jaruzelski, 
used his authority to waive the ordinance (Osiatynski, 2009).  The number of HIV cases has 
grown steadily since the political changes of 1989 and the relationship between Polish politics 
and the disease remains complicated.   
 
HIV and drug use reveal the processes and contours of post-socialist Poland where the 
“paternalistic” state has been replaced by one founded on neoliberal principles -- a union of 
classical liberal thought and a new set of ideals which are relevant to an increasingly 
individuated society based on autonomy, choice, and economic primacy (Barry,  1996). The 
collapse of socialism has had dramatic implications for the changing relationship between the 
state and its citizens, as well as for the way people have managed these changes, and for the 
different ways these changes have affected various segments of society.  In order to understand 
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the Polish response to HIV and drug use it is important to follow the process of post-socialist 
changes, including Poland’s entry into the European Union, and the Polish identity and notions 
of patriotism. It is also necessary to look at how various actors with frequently competing 
agendas defined the terms that now predict the rules of engagement between people living with 
HIV and drug users, the state, civil society, and others.   Membership in the European Union 
makes available a potential external referee when the state and the individual are in conflict and 
provides a framework for human rights.  This has been seen in practice in multiple court rulings 
that have been handed down to Poland by the European Court of Human Rights (ECtHR) in 
Strasbourg.   For example, the ECtHR ruled against Poland for not providing an abortion to a 14 
year old who suffered severe medical complications that resulted in her death though she had 
met all of the legal requirements for the procedure (European Court, 2012). In 2005 a decision 
against Poland was handed down in response to a local government’s ban of a gay pride march 
(European Court, 2005).  In addition, it became the philosophical basis on which to advocate for 
the extension of rights to diverse groups traditionally outside state-sanctioned support. European 
administrative channels fund networks of people living with HIV, advocates for lesbian, gay, 
bisexual, and transgender (LGBT) concerns, and, to a lesser extent, drug users.  New 
expectations and strategies for accessing rights and resources have emerged.   
 
Since the collapse of the Soviet Union and the socialist influence in Central Europe much 
analysis about moving from socialism to capitalism and democracy focused on economics and 
politics with less attention paid to how it affected state-citizens relations. This is a change that is 
complex and slow to emerge, as made evident by ongoing reports of difficulties with national 
and local administrations (Housner, 2007), as well with how individuals relate to each other.  
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Forms and sources of state power differ significantly in socialist and capitalist institutions and 
have direct implications for how the state and citizens interact.  In a capitalist system, goods are 
produced and sold to accumulate profit, whereas the socialist state worked to accumulate 
distributable resources and increase its citizens dependence by determining which resources were 
distributed to whom and when (Verdery, 1996).   
 
Neoliberal governance is based on the idea that the state should have a reduced role in both the 
economy – the invisible hand of the market -- and the provision of public services. The model 
that existed before 1989, in principle, guaranteed employment and intervened in the market to 
prevent economic depression.  Neoliberalism ended central planning and granted state funds to 
nongovernmental or private agencies that administer services; and directed expenditures towards 
unemployment programs and poverty assistance rather than subsidies for food, rent, education, 
childcare, and cultural services (Gal, 2000).  By enthusiastically embracing the economic 
reforms and integrating with the western markets, Poland began what has been termed, “shock 
therapy.”  Jane Hardy, in her assessment of the transformation described it as, “more shock and 
less therapy.”  The country was so eager for political and economic reform that little effort was 
made to assess whether any of the socialist policy would be useful to maintain.  Moreover, 
whatever was perceived as a legacy of the socialist system was almost automatically considered 
undesirable and was swiftly replaced or privatized. Consistent with neoliberal practices 
elsewhere, the role of the state was reduced to that of a manager of the process of privatization 
with an ever shrinking mandate to provide social security (Hardy, 2010).  Childcare centers were 
closed, work opportunities for women were reduced, medical clinics in rural areas were scaled 
down, as were other forms of social assistance.  All the while, the role of the church was 
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growing. Many Poles felt that they had lived through a failed Soviet experiment and thus rushed 
to replace it with what they perceived to be a well-tested success – a western democracy.  
People, who only months ago had participated in freedom strikes and supported the Solidarity 
movement, at great personal cost, were suddenly confronted with the new reality of 
unemployment, an ever shrinking social safety net, and disappearing social services.  Basic 
survival became a priority for the majority of citizens who found themselves in an economic free 
fall, a stark contrast to their recent experience of social solidarity.  This experience is different 
from one of Western Europe.  Since 1960’s economic circumstances have improved for most 
western Europeans. In the countries in Eastern Europe, material circumstances changed little 
between 1970 and the late 1980s and have deteriorated since 1990.  According to Babak (1998),  
perhaps as many as 50 per cent of citizens in the East, experienced a fall in their standard of 
living.  
 
As explained by a social scientist and think tank leader, “For many years the United States was 
our adopted homeland, it was our point of reference.  As soon as we had a chance, we began 
copying it by replicating its banking system. We wanted to have the best stock market in the 
region.  However, we were not copying the other side of the coin - the social activism, 
philanthropy, multiculturalism, and the political engagement of civil society.  A country that held 
such promise and the intellectual strength to stand up to the Soviet Union, when it finally 
succeeded, began behaving like a child, by simply copying the West.  We disappointed 
ourselves, but we also disappointed the West which was looking at us with amazement and hope 
that something inspiring and instructive for them would emerge from our process.”  For a time 
there was discussion of what was called the “Third Way,” a paradigm that introduced the values 
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of democracy and the free market while maintaining relevant socialist policy. However, this idea 
was drowned out by a Hungarian slogan that spread throughout the region, “The Third way leads 
to the Third World.”   
 
This idea of an individuated society sharply contrasts with the socialist notions experienced by 
citizens of Eastern Europe for the preceding half-century.  According to Cockerham (1999), 
health lifestyles in a society with high dependency on the state and discouraging individual 
initiative in daily life are not likely to feature a strong sense of personal responsibility for health. 
This sense of responsibility was unlikely to appear in the immediate aftermath of socialism’s fall, 
when alternative mechanisms of support were unavailable and established norms for health 
promotion were lacking.  Ericson (2000) argues that a belief in the notion of individual 
responsibility is one of the five basic characteristics of neoliberalism, alongside minimal 
government, market fundamentalism, risk management, and the inevitability of inequality due to 
choice. Elizabeth Dunn’s (2004) research on the privatization of a Polish baby food company 
shows that a very specific notion of personhood is required for the new capitalist institution.  She 
suggests that the introduction of capitalism requires a clear focus on the independent and self-
sufficient individual centered on work.  The “socialist” reliance on a generous safely net was 
peeled away and replaced with increasingly constrained conditions for various entitlements.  
This shift to neoliberalism meant that people were increasingly expected to be self-reliant and to 




This collision of neo-liberal thought, individual responsibility, and the individual’s right to 
choose, has resulted in a new understanding of health outcomes (Cheek, 2008).  Poland has been 
moving away from a social determinants approach, where the focus on social and economic 
factors, social support networks, physical and social environment, access to health services, and 
social and health policies are a part of an integrated multilayered effort (Koh, 2010).  It is not to 
say that the socialist government’s health policies were entirely informed by the notion of 
contextualizing risk factors or the theory of fundamental causes.  The socialist philosophy was, 
however, less focused on individualism in all spheres of life and was closer to the social 
determinants theory than the contemporary approach. Susan Santag described this in 1995,   
“What has followed in the wake of 1989 and the suicide of the Soviet empire is the final victory 
of capitalism and of the ideology of consumerism....  Individualism and the cultivation of the self 
and private well-being— featuring, above all, the ideal of `health.’” 
 
As described by Blaxter (1997), with emergence of neoliberal approaches, there is a noticeable 
rise in the rhetoric that blames the individual for health outcomes and attributes fault, “not 
simply through a carelessly unhealthy lifestyle, but also because of character failings or 
weakness of will.” People are blamed for  both  their  acts  and  their  omissions—what they  do  
wrong  and  what  they  fail  to  do  right  (Yoder, 2002).  The belief that we can freely select our 
ways of living is fundamental to the claim that illness results from behaviors associated with 
faulty lifestyle ‘choices.’  It is in this way that chronic illness becomes defined as an instance of 
personal moral failure in contemporary times, for if we can choose to be healthy by acting in 
accordance with the lessons given us by epidemiology and behavioral research, then surely we 
are culpable if we become ill (Galvin, 2002 ).   According to Link (1995), health policies built on 
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such premises, “can be lead astray if their purview is narrowly limited to a focus on individually 
based-risk factors.”  Without understanding the social conditions that expose people to 
individually based risk factors, interventions have an increased chance of failure.  Some social 
conditions are fundamental causes of disease and, as such, cannot be effectively addressed by 
individual interventions but rather, the intervention must address inequality in the resources that 
fundamental causes entail (Link, 1995). 
 
When economic and political transitions are taking place, institutions of the state tend to be 
consistently weak. There seems to be a general consensus that the process of democracy building 
was successful in some areas, while others require greater attention, most especially in the area 
of public administration.  Polish citizens perceive the sphere of public administration as the 
battlefield of party groupings and their relationship to the church. The turbulent history of public  
administration  after  1989 shows  that  the ambitions of politicians trying to appropriate public 
institutions for their own party interests continues to trouble the country. This is not the case in 
some other post-communist countries – for instance in the Czech Republic or Estonia the civil 
service has been functioning without any major disturbances (Burnetko, 2010).    In Poland, the 
two primary institutions responsible for HIV and drug use related matters are the National 
Bureau for Drug Prevention and the National AIDS Center.   While they are under the purview 
of the Ministry of Health, it was a Catholic priest, in a capacity of a ministerial advisor, that was 
charged with overseeing them. Though both institutions, since their inception, have presented 
themselves as innovations in Polish public policy, they fail when judged against Boise’s 
definition, which is that an organization can be "credited with an innovation if it accurately 
predicted the need for an idea which was new to the organization and implemented it in advance 
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of some irresistible external demand."   Rather, they serve as an illustration of Parker’s concept 
of “administering the epidemic” (Parker, 2000a) as, for the most part, they produce data and 
avoid any discussion of the structural drivers of HIV risk, drug use and drug dependence.  These 
institutions are clearly the children of the political and economic changes that have characterized 
Poland’s emergent democracy over the past 20 years.  At the same time, the state of civil society 
in Poland is not promising.  Before 1989, the socialist government did not allow instruments 
through which citizens could contribute to the common good.   Whatever did exist functioned as 
organizations formed by the government, for example Polish Scouts (Zwiazek Harcerstwa 
Polskiego), Societies of Rural Women (Kolo Gospodyn Wiejskich), etc.   At the same time, an 
illegal underground social movement, “Solidarity,” gathered those who were most active in their 
opposition to socialist government.  When the government fell, it was not only necessary to 
sustain this civic spirit, but also to allow for an institutional framework for civil society to be 
created.  After 20 years of democratic transformation, it has turned out that the institutionalized 
civil society is unable to perform the most basic functions, which the “illegal” civil society of the 
socialist times did so well.  Non-governmental organizations have become contractors of the 
neoliberal state (Markowski, 2010). 
 
The Catholic Church 
The idea that health and illness are matters of personal responsibility is embedded in traditional 
notions of illness and sin and it is strongly reinforced by the Polish interpretation of Catholic 
teachings and its practice.   As stated by Galvn (2002), those who function on the margins of 
neoliberal society because they are unable to maintain their health and fitness are not likely to 
feel any less damned than those whose illnesses were believed to be the result of sin. Chronic 
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illness, such as drug dependence or HIV is viewed as culpability in the face of known risks, an 
instance of moral failure.  The Church aligns with Beck’s view on “Risk Society” -- the idea that 
individuals are responsible for calculating risks and bearing costs and with John Knowles’ 
proposition that the individual has the power – indeed, the moral responsibility – to maintain his 
own health. “The cost of sloth, gluttony, alcoholic intemperance, reckless driving, sexual frenzy, 
and smoking is now a national, and not an individual, responsibility. This is justified as 
individual freedom – but one man’s freedom is another man’s shackle in taxes and insurance 
premiums. I believe the idea of a ‘right’ to health should be replaced by the idea of an individual 
moral obligation to preserve one’s own health – a public duty if you will. The individual then has 
the ‘right’ to expect help with information, accessible services of good quality, and minimal 
financial barriers” (Knowles, 1997).   This view is further reinforced by the Church’s historically 
strong opposition to the socialist government, making the polarized discourse, which exists 
elsewhere in Europe and the United States between the political left and right, even more stark in 
Poland.  Pope John Paul II spent much of his life arguing against the Soviet influences in Poland 
and the socialist philosophy. And while Knowles recognizes that illness and unhealthy habits 
often follow poverty and lack of knowledge, and argues that health depends on economic 
investment in poor communities, the availability of jobs, access to transportation and housing, 
and public safety, no such recognition appears in the church’s teachings.  Rather, one is expected 
to do the best they can and submit to the larger call of his or her destiny.  Risk society and 
individual risks mix with political Catholicism promoting populism and xenophobic nationalism.   
The political discourse, in which a “true Pole” is ethnically Polish and a practicing Catholic, 
aims to exclude ethnic or religious minorities, sexual minorities, drug users, and all “others.”  
The Church’s philosophy ignores literature documenting that changing the social conditions can 
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alter the determinants of disease.  Consistent with the idea of contextualizing risk factors, policy 
makers should require an identification and analysis of the factors put people at risk (Koh, 2010).   
 
The Catholic Church played a somewhat ambiguous role in the Polish transition to democracy. 
As one of the most trusted institutions it greatly contributed to the orderly and peaceful transition 
of power from socialism to democracy. During the first free elections in Poland in June 1989, the 
Church hierarchy sympathized with and often aided the Solidarity activists. In the run up to the 
accession referendum, Pope John Paul II helped to neutralize the “Eurosceptics,” who depicted 
Europe as morally decadent and atheistic and opposed Poland’s accession to the EU on both 
nationalistic and religious grounds.  At the same time, at the grass roots level, some within the 
Church sympathized with the nationalist and Catholic fundamentalists.   Tadeusz  Rydzyk, a  
Catholic  priest  and  Redemptorist  runs a media empire, which includes a radio station (Radio 
Maryja), television network, a  newspaper  and  a  college.  These outlets, operating under  the  
auspices  of the Church, reach millions of Poles daily with messages of xenophobia, anti-
Semitism as well as distrust of anything ‘non-Polish’ and ‘other,” providing  populists with 
institutional backing and ideological support (Kucharczyk, 2010).   The view of the Polish 
Catholic Church on drug use is consistent with that of Christians in the United States.  The anti-
drug fervor that has swept contemporary America has enjoyed acceptance from Christian 
churches.  For most, illicit drug use ranks high on lists of vices meriting disdain (LaHaye, 2000).  
Catholic and evangelical policy analysts, “support the enactment of strong and effective laws 
against all illegal drugs and their strict and impartial enforcement” (Ball, 1992).  What is missing 
in this discourse in the United States and in Poland is the recognition of the nineteenth-century 
discussion of the virtue of “temperance.” The Temperance  Era  began  by  urging  individuals  to 
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drink  with  moderation  and  prudence.  It ended  by  insisting  that  moderation  was  impossible  
and  that  government enforcement  of  total  abstinence  was  imperative (Bischke, 2003).   
 
In this context of disciplined citizens who comply with the demands of neoliberalism and a 
strong Catholic dogma and receive little support from existing, politically driven institutions of 
government administration or weak civil society groups, discussion of HIV prevention and drug 
use has left little room for considerations of the fundamental social factors and structural 
violence which determines social vulnerability of groups and individuals.  While people 
considered “at risk” now have more freedom to conduct their lives, they also have a set of 
neoliberal expectations and religious pressures placed on them – preferably to abstain entirely or 
take control over various aspects of their drug use and sexuality, to create conditions that will 
allow for safe choices and, as described in later chapters, cannot expect much support from the 




Chapter Two: Methodology 
 
 
My hypothesis is that the assertion by Poland’s senior drug policy and HIV officials, that 
injecting drug use is not a significant driver of HIV in Poland, was based on incomplete evidence 
and is likely to be inaccurate.  My intention is to assess the political foundations and implications 
of these statements with regard to the facts and their social uses. In addition to evaluating these 
claims, in and of themselves, I will also consider their ideological content.  The resulting analysis 
will provide an account of the relationship between the HIV epidemic, drugs, the systemic 
disempowerment of drug users, and how all of these factors result in policies and practices that 
are woefully inadequate for curbing the HIV epidemic and treating those in need of care.  
 
 According to Hunting (2012), assessment is the foundation of public health, “Before decisions 
can be made, before policies can be determined, before programs can be planned, public health 
professionals must assess the situation at hand . . .  Case-based learning may be an effective 
approach for developing competency in highly applied cross-cutting domains such as 
communication, informatics, diversity and culture, leadership, professionalism, program 
planning, public health biology, and systems thinking.”  My method is to fully explore the real 
world complexities of the phenomenon of HIV transmission among drug users in Poland as a 
single, holistic case study that encompasses the contextual conditions, as they are highly 
pertinent to the subject.  As defined by Robert Yin (2009), the case study focuses on the 
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contemporary and allows investigators to retain the holistic and meaningful characteristics of real 
life events – such as individual life cycle, small group behavior, organizational and decision 
making processes on multiple levels, and international relations, and it does not require control 
of behavioral events.  This case study is based on five of the six sources of evidence defined by 
Yin (2009): documentation, archival records, interviews, participant observation, and physical 
artifacts.   Direct observation was the only recommended method that was not engaged.  The use 
of multiple sources of evidence allowed for converging lines of inquiry – a process of 
triangulation and corroboration addresses the potential problems of construct validity.  
 
The findings of this dissertation draw on primary and secondary sources. The primary sources 
include transcripts of Polish Parliamentary debates and sub-committee hearings related to drugs 
and AIDS, newspaper and media reports covering current debates about the quality of drug 
treatment, and legislative amendments to the existing drug law. Accounts in Polish newspapers 
as well as magazines were valuable for documenting specific instances of conflict as well as 
portraying the broader social context and popular attitudes toward drugs and HIV.  In order to 
assure construct validity, I used multiple sources of evidence.  For example, I reviewed, in detail, 
drug policy and HIV articles of both Gazeta Wyborcza, considered a source for Poland’s liberals, 
and Rzeczpospolita, a source respected by conservatives. I also researched magazines that cater 
to audiences with varied demographics such as youth and Catholics and identified a number of 
drugs and HIV related articles in these sources.  Newspapers offered a more detailed analysis 
including various policy options while magazines were mostly descriptive and offered various 
forms of advice.  Many of these debates have taken place through electronic media, such as 
discussions generated by electronic campaigns. To track this, I followed engaged listserves and 
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portals.  My primary sources also include in-person, semi-structured interviews with 17 key 
actors involved in the events.  These interviewees include city and national officials currently 
responsible for drug and HIV policy, current and past legislators engaged in health-related 
issues, advocates in the area of drug policy and HIV, as well as drug treatment providers.  All of 
the interviews were carried out in the Polish language and were transcribed. The interviews took 
place in the cities of Warsaw, Krakow, and Bialystok.  I also spoke by phone and corresponded 
with a four sources from two additional cities in the West of Poland:  Szczecin and Wroclaw.  
The process of interviewing allowed me to assimilate information that was shared as the 
participants formulated their answers to the questions I posed, but also enabled me to capture the 
mood and affective components.  Each recorded interviewed lasted between one and a half and 
two hours. One interview was broken up into two hour and a half sessions. 
 
Secondary sources include extensive historical and contemporary documentation related to HIV 
and drug policies including scholarly literature, “gray” literature, international reports, and 
official documents of the National AIDS Center, the National Drug Prevention Program, and 
numerous NGOs. Reliance on secondary sources raises concerns about the reliability and validity 
of the data. I attempt to resolve this problem by identifying the points that are corroborated by 
multiple sources.   
 
The internal reports of the government entities responsible for drugs and HIV and their annual 
reports, and parliamentary records were essential to establishing how policies were developed 
and implemented. They demonstrate, for example, how various officials responded to public 
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concerns related to HIV transmission, the safety of health personnel, and perceptions of drug use 
as well as how they assessed their progress in the provision of services and their HIV and drug 
prevention efforts.  At the same time, I observed that some reports are highly political as can be 
seen when comparing the published accounts of meetings with the verbal reports of the 
participants.   In some instances the published reports were “cleaned up” of any controversy.  
The documents of international organizations such as the United Nations Office on Drugs and 
Crime (UNODC), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), as well as professional 
journals serve as important forums for the publication and discussion of standards for policy 
making in the areas of drugs and HIV and assessment of practice in the area of service provision.  
Alkoholizm and Narkomania is the only Polish journal where the practice of drug treatment is 
discussed.  HIV & AIDS Review is the only journal specific to HIV and it focuses on the 
medical aspects.   The extreme scarcity of peer-reviewed literature indigenous to Poland poses a 
threat to the reliability of this dissertation, as well as any work specific to drugs and HIV in 
Poland.   I relied on international publications for policy-related, peer-reviewed publications.   
 
The literature on methodology points out that adaptability and flexibility are important for a 
researcher conducting a case study (Yin, 2009;  Rowley, 2002 ).   A substantial amount of time 
was needed to collect the data for my research, during this period many relevant changes took 
place: the national legislation changed, a number of organizations ceased to exist, new people 
joined existing groups, and a new political party important to the debate emerged.  My attempts 
to avoid bias by engaging all sides of the debate were challenging.  Since I am professionally and 
publically engaged with advocacy for drug policy reform and harm reduction, a few persons who 
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were affiliated with the abstinence-only movement declined my requests for interviews.  I 
attempted to compensate for this by paying special attention to the publications and public 
statements of these individuals and the groups they represent.   
 
Collecting and analyzing publications, websites, listserves, records, and archives of non-
governmental organizations (NGOs) that engage in HIV and drugs policy debates allowed me to 
understand their priorities and also, the institutional relationships they had to each other and to 
various other actors. This also enabled me to see how the NGOs understood the social and 
political context surrounding them.  The NGOs include the Social AIDS Committee, the Polish 
Drug Policy Network, MONAR, and JUMP.   Modest archives consisting of a few rows of 
documentation shed light on the historical context in which drug use and also HIV emerged in 
Poland.  
 
Finally, as a means of direct participation, I took part in parliamentary hearings and several 
conferences and meetings on AIDS or drugs related matters organized by civil society and 
governmental actors. It was through these organizations that I established contact with the many 
of the people I interviewed.  As was the case with the interviews, I made every attempt to listen 
objectively and to understand the affect and non-verbal communication of each gathering’s 
participants. There were a number of instances in which the affect of the gathering was in direct 
conflict with an articulated message. In those cases I made efforts to understand the roles of the 
individuals involved in the discussion and to learn whether they spoke in a personal capacity or 
that of an official.   
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Analysis of case study evidence was an evolving process as new data became available.  In order 
to analyze all the transcribed interviews, I created an index with the following themes: drug 
policy, drug use, HIV policy, human rights, civil society, HIV activism, drugs activism, drug 
treatment, HIV treatment, HIV testing, governance, harm reduction, capacity building, 
international organizations, significant political events, peer reviewed publications, and political 
changes or events.  This helped me demonstrate how drug and AIDS themes relate to broader 
social and political events. For all of the other research, the observations, document analysis, 
listserves, and TV and radio programing, I created an informal database that was based on my 
electronic notes and applied the same “interview index” themes in order to analyze all of the 
material in a consistent manner.  The database allowed for patent matching and identification of 
meaningful frequencies of themes as well as explanation building and time series analysis.  
 
As an organizing framework, the dissertation focuses on three discrete time periods which are 
followed in chapters three through five.    
• The first period includes the years of socialist rule after World War II when the Soviet 
Union dominated Central Europe (1945), and the time of the Round Table Agreement (1998) 
when Soviet rule ended. This included the period of Martial law (from December 1981 to July, 
1983) when the government severely curtailed civil liberties in an attempt to crush political 
opposition represented by the Solidarity movement.  
• The second period, from 1990 through1999, was the decade when Poland first put into 
practice neoliberal principles and, at the same time, strengthened Catholic influence in public 
life.  It occurred under the leadership of the first freely elected president, Lech Walesa.  At the 
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time, tensions between the Catholic Church and the liberal authorities that emerged from the 
resistance Solidarity movement were high.  In 1993, access to abortion, became extremely 
restrictive while at the same time, in a sphere that was of less interest to the Church, a new 
progressive drug law was passed.  
• During the third period, between 2000 and 2011, the presence of a strong, well 
established Catholic Church was solidified  – religion was introduced into public schools, a cross 
appeared in the chamber of the parliament, political discourse became increasingly conservative, 
and the law and order theme dominated the discourse that led to a more punitive revision of the 
country’s drug law.  
 
My data is presented in a chronological account of how the problems emerged, were identified, 
and responded to.  In the introductory chapter I expanded my focus beyond Poland, and 
described the larger, regional context.  Poland was the first country in the region to shed Soviet 
authority, with others soon following.  In this chapter I discuss how the political, social and 
economic changes have impacted drugs and HIV policies in the countries of Eastern and Central 
Europe: the Czech and Slovak Republics, Hungary, Romania, Bulgaria, and the states of former 
Yugoslavia.  Chapter one also introduces the hypothesis and discusses relevant theory. Chapter 
three details the story of drug use and drug policy in Poland. Chapter four offers a history and 
current account of the state of drug treatment and harm reduction. And chapter five tracks the 
evolution of HIV policy in Poland.  In the final two chapters, I address the issues from a human 
rights perspective, summarize the lessons learned and recommend changes to policy and practice 
based on the international literature and guidelines in the area of drug use and HIV.  
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Chapter Three – Drug Use and Drug Policy in Poland 
 
 
During the first decade of the HIV epidemic in Poland, starting in late 1980’s, the relationship 
between injecting opiate use and HIV infection was clear. At the time, the majority of people 
infected with HIV were drug users. However, in subsequent years, it became increasingly 
difficult to understand this relationship as the HIV reporting system was modified, drug use 
patterns changed and diversified, and Poland underwent dramatic political and economic changes 
and became a member of the European Union.  Structural violence towards drug users intensified 
as a result of decades of shifting drug policies and the more recent process of political, social and 
economic transformation. This structural violence has had a detrimental effect on the HIV 
epidemic in Poland. 
 
The History of Drug Use in Poland 
Mentions of drug use in Poland between World Wars I and II are scarce and only reference three 
substances: morphine, coca, and codeine. Heroin is not mentioned in the documentation from 
this period. Historically, drug control has been strict in Poland, even in the 1930s, when only one 
pharmaceutical company was allowed to use imported opium and coca in its products.  When 
codeine production from locally grown poppy began, a second pharmaceutical producer was 
given permission to use it. At the time, one gram of morphine cost 20 Polish Zloty, the 
equivalent of a blue-collar worker’s weekly salary. Morphine use was almost exclusively an 
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experience of the middle class (Frieske, 1987).  To say that World War II, from 1939 to 1945, 
was violent and traumatic for Poland would be an understatement of vast proportions. The 
subsequent reconstruction of the devastated nation, followed by the establishment of a socialist 
regime, left almost no record of drug use.  It is not until the late 1950s and early ‘60s that there is 
increased mention of reliance on medications for relaxation and anxiety alleviation.  There is 
also some suggestion that physicians were quite liberal in prescribing tranquilizers, pain 
medicines, and benzodiazepines (Frieske, 1987). The late 1960s and early ‘70s brought 
noticeable shifts in the use of drugs.  Western social movements of the sixties found their way 
into Poland.  The use of illicit substances, for some people, became a ritual that bonded the 
young and freedom-seeking in an increasingly oppressive society.  Additionally, since alcohol 
use has historically been a serious problem associated with violence, and intellectual and 
emotional impairment, it has been suggested that the selection of illicit substances became, for 
the youth, a way to distinguish themselves from earlier generations (Fatyga, 2002).  
 
However, drug use was not exclusive to the hippie movements.  As documented throughout the 
world, drug use is motivated by a variety of environmental, developmental and social factors, as 
well as genetic vulnerabilities (Tatarsky, 2007; Reuter, 2010; Drucker, 2011a ).  In Poland there 
were several different social groups whose experimentation with illicit substances was not at all 
inspired by ideological motives.  The most common explanations for drug use have been 
difficulties in the family, school, and efforts to avoid mandatory military service (Frieske, 1987).   
In the absence of cannabis and LSD, at the time unattainable in the socialist block, the quest for 
psychoactive substances led users to pharmaceutical as well as chemical products.  It was 
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discovered that TRI, a stain-removing compound, caused euphoria and hallucinations when 
inhaled, as did various mixtures of pharmaceuticals.  As the 1970s progressed, locally grown 
poppy attracted the interest of those experimenting with psychoactive substances. 
Experimentation with various chemicals and pharmaceuticals was gradually replaced by products 
derived from the more widely available poppy.  Poppy-based products included: milk (mleczko) 
extracted from unripe poppy heads, soup (makiwara) produced by cooking poppy straw and, the 
most potent of all, kompot, also known as Polish heroin.   Competently prepared kompot could 
contain up to 80% morphine.  By the end of the 1970s, 90% of patients hospitalized for drug 
dependence were there because of their use of kompot. Law enforcement reports on drug use 
began to increase. In 1973, the police reported, for the first time, 528 cases of group drug 
consumption (an illicit activity under Polish law). In 1970, 8 people were reported to have 
distributed illicit substances, in 1973 this number went up to 539. In 1968, a total of 14 drug 
related offenses were reported in all of Poland, by 1973 this number rose to 819. In the first half 
of the 1970s, the media and professional publications expressed concern over growing drug use.   
 
There is almost no documentation from this time describing any prevention efforts, except for 
sporadic activities undertaken by catholic youth groups.  A Catholic University in Lublin, KUL, 
was the first institution to address drug dependence in its curricula for psychology, sociology, 
and re-socialization (Ciekiera, 1998).  For the most part, the KUL curriculum viewed drug use as 
an outcome of increasingly unstable families, escalating divorce rates, and eroding morals. As 
reported by one of my sources, a therapist specializing in drug treatment, Warsaw University 
offered an alternative perspective to that taught at KUL, “During the late 1970s, I became the 
student of an avant-garde department, the Institute for Reintegration and Prevention of Social 
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Problems. It was the first department that was truly interdisciplinary and included a basis for 
practice, but also for policy making, and activism. We created an informal group of 
psychologist-activists working in opposition to the prevalent practices of socialist control.   We 
were, for example, against viewing drug use only as a pathology.  Dr. Ewa Andrzejewska, one of 
our faculty and a child psychiatrist, espoused a more humanist view of drug use.”  While over 
time, some students did specialize in drug-related matters and are still active as practitioners; the 
group was not influential in defining new forms of dependence treatment outside of psychiatric 
institutions. Szkolny Osrodek Socjoterapii (SOS) in Warsaw, was another organization that took 
an alternative approach with its work assisting troubled youth.  SOS offered support and 
acceptance of young people who were in trouble for various reasons, often for drug use. Many of 
their clients were in great need of psychological assistance.  In a series of testimonies produced 
to celebrate the 30
th
 anniversary of SOS, a long-time graduate described the institution as a filter 
that helped those who would not have made it in a regular school, “We were a mixture of people 
who came from everywhere and for every reason; fear of mandatory military service, avoiding a 
life of crime, living with drug addiction, a part of the political opposition, coming from a hippy 
commune, an anarchist squat, a religious sect, or a psychiatric institution.”   One of the former 
staff of SOS recalled, “We had no ambition similar to Marek Kotanski’s, to replicate our 
approach or to look for facilities in other cities.  We wanted it to be the other side of drug 
treatment in Warsaw, the alternative to MONAR.   So we became a pilot that now, 30 years later, 
is still in existence.  Many popular musicians and writers were our students. Something good 
happened there, but we were unable to get our message out in order to mainstream our approach.   
Maybe because our message was not about being tough and punitive it did not fit well with the 
political climate of the time nor with the public’s perception of how to deal with drugs.” 
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Toward the end of communist rule, the level at which drug use and users were visible was 
contingent on explicit political goals.  When the political system was showcasing Poland as a 
successful, socialist state, drug users were hidden in psychiatric institutions and portrayed as 
anomalies of a “happy, successful society.”  Later, when the Western influence over Poland 
increased, images of drug users were brought out of the shadows as proof of the decadent and 
decaying Western way of life.  Because of the political agenda driving the level of visibility of 
drug use, the data from this period is inconsistent and questionable. 
 
In the mid 1970s, there was a sharp decrease in media coverage as well as in the public and 
professional interest in drugs.  Therefore it is difficult to understand how the next phase of the 
history of drug use unfolded in Poland. The only consistent reports are from the milicja (the 
national police force), which continued to reflect an increase in drug use. Half of the 2,300 
recorded drug crimes committed in 1977 were identified as “group drug use.”  The police 
increasingly harassed drug users, especially those who were visibly identified as part of the 
hippie culture.  Their views, often aligned with and inspired by the freedom movement from the 
West, were considered unpatriotic and a threat to the socialist state. Repression of the hippie 
movement escalated to the point where some were considered enemies of the socialist state. In 
response to the crackdown, larger drug using communities began to fracture into much smaller, 
harder to identify, groups. The process of kompot production, in individual apartments for small 
groups, facilitated this trend.  By the end of the 1970s, a problem that had been visible and 




It was not until the summer of 1980, which saw the biggest political protests in Poland since the 
war and the emergence of Solidarity, when a wave of media interest in drug use reemerged. The 
“solidarity festival,” as described by one of the advocates I interviewed, also had an impact on 
drug using behaviors, “I remember the summer of 1980 – people felt defiant, free.  They 
travelled to summer music festivals in groups and once you arrived, the smell of cooking kompot 
was overwhelming. The police did nothing.  Only later it became clear that their lack of action 
was intentional.  The government needed proof that things are going to hell and that a crackdown 
was justified.  We were just one small piece of a huge puzzle.”   In 1981 alone, the first year of 
martial law, 300 articles on drug use were published in the popular press (Frieske, 1987). While 
the scientific community estimated that approximately 20,000 people used kompot, a number of 
press reports speculated that there could be anywhere between 100,000 and 500,000 users 
(Ciekiera, 1998).  The divergent estimates in the media are now attributed to internal power 
struggles within the socialist party; the newly elected leadership depicted drug use as proof of the 
failure of their predecessors (ISP, 2009).   Growing moral panic about drugs occurred a few more 
times and always seemed to have a political motivation.  A few years later, for example, an 
influential Polish weekly, Wprost, as evidence against the socialist state, estimated the number of 
kompot users at 1 million, while the scientific community put the number closer to 50,000.  As 
recently as 2010, at a moment of political difficulty, Prime Minister Tusk employed militant, law 
and order language to rapidly shut down shops selling “smart-drugs” (various unregulated 
substances that had sprung-up around Poland), by using questionable estimates of users and 




As Poland gained independence and opened up to the West in 1989, so did its illicit drug market.  
Various imported substances slowly replaced the native kompot. In 1990, the cultivation of 
poppies became illegal without a government permit, and a new, morphine-free species was 
introduced to enable farmers to continue poppy cultivation (Curtis, 1992). Over a decade later, in 
2002, the first national survey was conducted to document the lifetime prevalence of drug use, as 
well as that in the previous year and in the 30 days prior to the survey. With 6,340 face to face 
surveys of randomly drawn sample aged 16 and older, the study documented several changes in 
the market for drugs.  Cannabis, a drug that was unavailable during the socialist regime, had 
become the substance of choice. Six and a half percent of the respondents had tried marijuana or 
hashish at least once in their lifetimes. Respondents who identified as currently using these drugs 
made up 2.4%, while 1.1% admitted having used cannabis in the previous 30 days. 
Amphetamine use was reported at 2% by experimental users, 0.6% for occasional users and 
0.2% for frequent users. The third most frequently used drug was LSD: 1.0% of respondents had 
experimented, 0.4% used it occasionally, and below 0.05% were frequent users. The lifetime 
prevalence of drug use was greatest within the age group of 16 to 24 year olds, of whom almost 
one-fifth had experienced cannabis. At the same time, only 1% of the oldest respondents 
admitted to its use in their lifetime (Sieroslawski, 2003).  While this national survey showed very 
little heroin use, a smaller and regionally concentrated study in 2002 by the Institute of Social 
Affairs carried out among 1,119 middle school “gimnasium”  students (13 to 15 year olds), 
reported the use of heroin at a lifetime prevalence of 3.1% (Fatyga, 2002).  While the study 
focused on rural communities with twice as many respondents residing in small towns and 
villages, the rates of self-reported heroin use was greater in urban areas.  The urban/rural 
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difference is especially significant among girls: 0.5% of 385 girls from rural areas and 4% of 198 
girls from urban areas reported having used heroin.  
 
The increasing trend of cannabis use where lifetime prevalence increased from 5 per cent in 1992  
to over 30 per cent in 2005 does not pose controversy and is consistent with average rates of use 
throughout the rest of Europe.  What is less clear, and requires further analysis, are the number of 
opiate users.  Kompot and heroin users were not included in the 2009 National Report due to the 
marginal prevalence of both substances. However, in the same year, 16% of people in residential 
treatment were documented to be opiate users.  The situation is further complicated by the fact 
that 63% of people in treatment fall into the “combined and unspecified” category and an 
unknown portion of them are opiate users as well.  The difficulty in understanding opiate use in 
Poland has been a problem for decades, and is often the result of various political tensions and 
interests that will be discussed in greater detail in Chapter Four.   
 
Drug Policy Setting Institutions 
The two most significant institutions responsible for national drug policy, treatment, and 
prevention are the National Bureau for Drug Prevention and the Council for Counteracting Drug 
Addiction. The National Bureau for Drug Prevention was created in 1993 and is an agency of the 
National Ministry of Health.  Its primary goals include maintaining regular contact with the 
organizations responsible for implementing the various tasks of the National Program for 
Counteracting Drug Addiction performed by ministries, central administration institutions, as 
well as the provincial, county and communal authorities. The Bureau’s responsibilities include: 
48 
 
drafting the National Program itself, organizing meetings and conferences that serve the 
monitoring activities, initiating new legislative solutions, co-financing supply reduction 
programs, preparing and launching anti-drug campaigns, cooperating with international 
organizations, coordination with the European Union priorities, and initiating new prevention, 
rehabilitation, and harm reduction activities (Jablonski, 2006). During the 1990s, the Bureau also 
funded various drug treatment efforts, but with the creation of the National Health Fund (NFZ), 
the responsibility of funding drug treatment shifted to this new entity while the Bureau provided 
guidance on treatment standards.  The Bureau is highly technical, coordinates national studies, 
and represents Poland on various international bodies, but is not visible in ongoing debates. An 
examination of 160 articles in the press over a four-month period during a debate on drug policy 
revealed no statements from this institution.   
 
The Council for Counteracting Drug Addiction was established on March 6, 2001. Its first 
meeting took place on July 10, 2002.  It is chaired by the Deputy Minister of Health and is 
composed of secretaries and undersecretaries of state from various ministries and representatives 
of local governments.  The Director of the National Bureau for Drug Prevention, Piotr Jablonski, 
carries out the role of Secretary.  The Council is to shape national anti-drug policy including 
substitution treatment, supervision over precursors and pharmaceuticals, poppy and hemp 
cultivation, the use of opiates in pain treatment and palliative care, and the efficacy of primary 
prevention (Drug Report, 2003). As with the National Bureau for Drug prevention, there were no 
Council statements in any of the media coverage of the turbulent public discussions of the 
current legislative process.   
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In order to democratize, introduce capitalism and join the well-established and bureaucratically 
developed European Union (EU), many of the Polish policies, tools, and institutions simply 
mimic those of Western Europe without having gone through the discussions, tensions, and 
debates that the West spent decades on to build consensus.  A prominent sociologist, Jadwiga 
Staniszkis, termed this phenomenon an “institutional mix” – a process through which various 
inspirations for institution-building are absorbed from external sources but without proper 
reflection and integration (Staniszkis, 2004).   Historically, this process of “adaptation” is natural 
for the Polish administration.  For forty-five years, during the socialist system, the Polish 
bureaucracy received instructions from the Soviet Union and integrated them into its political 
system, national policy and public life.   The current integration process with the European 
Union, with all its benefits, has left little room for Poland to discover its own way and no 
provisions were made to inspire these reflections.  The process of “adaptation” can also be 
misleading to the casual observer. Poland’s drug and HIV related institutions, on paper, are 
strikingly similar to those of our Western neighbors.  However, on the ground, one finds 
evidence of a weak state where ineffective governance results in insufficient delivery of services, 
superficial discourse, and limited engagement of potential partners.  This process of mimicking 
was strongly encouraged, through substantial financial and moral backing, by the United States 
and Europe (Hardy, 2010).  It was also important to Poland and its neighbors that it fit smoothly 
into the Western hemisphere and this goal often took precedence over domestic processes 
occurring at the national level.  
 
An additional problem identified by Jerzy Hausner, an economist and former Finance Minister, 
is the “non-responsibility of civil servants” who avoid accountability and are mostly invested in 
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protecting their own positions.  Because drug and HIV related policies and interventions are 
often controversial and can be hard to manage constructively in a public debate, these areas are 
easily relegated to a passive bureaucratic approach. This is especially the case in a deeply 
socially conservative country. As the following chapters explore, Poland lacks the individual and 
institutional leadership in the areas of HIV and drugs that drove progress in many other 
countries, for example Switzerland and Portugal (Csete 2010). 
 
The general perception of the Polish government is that it is excessively cautious, ineffective, 
and panders to the expectations of a demanding population. Such a reputation precludes 
constructive discussion of defining and meeting the needs of the citizens (Sadura, 2011).   It 
should come as no surprise that the two institutions mandated to prevent HIV and to support 
people living with HIV, drug dependents, and drug users, lack strong leadership and, as will be 
explored in the following chapters, are slow to respond to the needs of their constituents.  
 
National Drug – related Expenditures 
Each year, Poland submits a national report to the European Monitoring Center for Drugs and 
Drug Addiction and each report states that, in accordance with a 2002 regulation of the National 
Ministry of Education, each school is obliged to develop and implement a school-based universal 
prevention program (2004, 2005, 2006, 2007, 2008 National Report).  The same report breaks 
down expenditures for the implementation of the National Program for Counteracting Drug 
Addiction.  In 2003, three institutions-the police, the border guard, and the military police-
reported total expenditures related to the implementation of the National Program which came to 
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122,754,515 PLN.  The smallest of the three, the border guard, spent 410,188 PLN, which is four 
times the amount dedicated to drug prevention by the Ministry of Education (56,880 PLN).   The 
table below highlights the national expenditure’s emphasis on law enforcement.  
 
Figure 4.  Expenditures of National Program for Counteracting Drug Addiction (Euros) 
 Police Prison Services Ministry of Education 
2004 30,450,500 479, 500 14,220 
2005 31,503,155 89,760 22,360 
2006 35,139,949 2,791,657 45,148 
2007 41,131,105 2,471,582 134,099 
 
The minimal expenditure on prevention at the national level may help to contribute to 
understanding the results of a 2009 study that compared drug-related attitudes in six European 
counties. Among the surveyed nations, Poles had the least faith in prevention, only 16% of 
respondents thought that it is an important anti-drug initiative, this was in contrast with 54% of 
Hungarians and 53% of Danes (HCLU, 2009).   
 
A number of my interviewees had difficulty making sense of the expenditure figures.  Since 
much of the responsibility for implementing national drug prevention programs lies with local 
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governments, financing drug prevention, for example, is difficult to account for.  There have 
been many instances in which improvement to the roads and walkways leading to the soccer 
field was reported as drug prevention.   A similar example related to AIDS expenditures was also 
provided by one of my sources, “I read a report, from 2009, I think, listing institutions paying for 
drug-related efforts.  To my surprise, the largest funder was the National AIDS Center.  When I 
tried to understand what they paid for, it turned out that they include the cost of centrally 
purchased HIV medication of people who had been infected through drug use.  I found it 
somewhat absurd and dishonest.  It shows the focus on the need for success on paper, and has 
little to do with documenting what happens in reality.”   
 
The financing of various public health initiatives has undergone significant change.  Seventy 
percent of the funding for drug prevention efforts comes from local districts.  While this is often 
portrayed as a success of decentralization, and progress over the centralized Soviet system, many 
of my sources reported that prevention funding at the local level was part of a much more 
general pool that included resources allocated for building soccer fields, after-school programs, 
and soup kitchens.  While these are all worthy expenditures it is not clear that they contribute to 
the goal of HIV or drug prevention.  Such methods for managing public spending often allow for 
the more difficult issues, such as condom promotion or needle exchange, to go completely 




Polish Drug Legislation  
The first drug law in Poland was adopted on June 22, 1923, On the Subject of Psychoactive 
Substances and Items. The first paper on the subject was published in 1935 by Julian Fristenberg, 
a prosecutor, who described 95 cases of drug dependent persons in the Warsaw judicial districts 
between 1932 and 1934.  In the mid-1930s, physicians created the Polish Committee on 
Narcotics and Prevention of Narcotics Use and organized a multidisciplinary conference on the 
subject.  The second drug law came into effect in 1951, Control of Pharmacological, 
Psychoactive and Other Sanitary Items.  The content of this legislation was similar to that of the 
previous law, with one exception, it criminalized drug use in the presence of another person with 
a penalty of up to one year in prison.  This article of criminal law remained in effect for several 
decades.  
 
The first modern legislation fully dedicated to drug related matters was adopted on January 31, 
1985, a time when the country was negotiating various political freedoms. The legislation put 
Poland in the vanguard of progressive thinking about drugs in Europe, as it did not consider 
personal possession of illicit substances to be a criminal offense.   
 
As Poland changed its political and economic system in 1989, legislative changes followed.  It is 
difficult to understand how external political interests influenced this process.  The United States 
was the most significant and respected supporter of the Polish quest for democracy and the 
purging of socialism.  A 1992 United States-funded report criticized the Polish drug law as 
antiquated,  “Drug use is not a crime in Czechoslovakia, Poland, the Russian Federation…. In 
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Poland, penalties are not necessarily imposed for possession of large quantities of drugs.  
Incredibly, only about 30 full-time drug enforcement police patrol the entire country, 
….authorities themselves exhibit a relatively relaxed attitude toward illicit drugs. Prosecutors, 
judges and even police regard this crime in the same category as petty theft.” (Lee, 1992)  The 
author is clearly alarmed by increasing drug use in the region, but also by the laws and relaxed 
attitudes that are significantly different from the “War on Drugs” style rhetoric prevalent in the 
United States.  The report concludes, “Police and public health officials everywhere from 
Warsaw to Bishkek desperately crave large infusions of anti-drug assistance from Western 
nations, especially the United States … When the United States signs an aid agreement, such 
assistance should depend on the prospective recipient documenting legal and law enforcement 
reforms… The United States also could influence conditions on multilateral aid by using its 
leverage with institutions such as the International Monetary Fund and the World Bank.” (Lee, 
1992) 
 
The 1985 Legal Act put Poland on the map of countries with a liberal drug policy. As stated by 
one of my sources, the Polish socialist government had a somewhat hostile relationship with the 
United States at the time so it is likely that the Polish drug policy was the exact opposite of what 
was internationally promoted by the United States.  Personal possession of illicit substances was 
not penalized and addiction was considered to be an illness which required medical treatment. 
This legislative framework was in place until 1997 and was not questioned during the first years 
of democracy. If there was any difference in the Polish approach to drug policy, as compared to 
its liberal European neighbors, it would be the concept of drug users’ rights.  This discussion, 
while ongoing in Western Europe, was not a part of the Polish discourse.  Rather, the socialist 
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state viewed people who use drugs as infirm and requiring the care of the state apparatus. It may 
be this crucial difference that is responsible for the ease with which the drug policy shifted and 
drug use was criminalized only a few years later, without regard for any lessons learned from the 
previous practice.  Even though the legal penalties were not focused on users, in practice, many 
were absorbed by the criminal justice system.  Since production and distribution were considered 
a felony  and  most of opiate use was a homemade poppy brew called kompot, ongoing 
harassment by the police and the resulting criminal charges were a reality of drug users’ lives. 
Given this policy context, the level of discrimination against drug users, and those living with 
HIV specifically, is not surprising. 
 
In 1997, Poland began the process of negotiations for accession to the European Union with a 
referendum in which 72% of Poles voted in favor of joining (Stulik, 1998). In 1999, Poland 
joined the North Atlantic Treaty Organization (NATO).  Drug law came under scrutiny and in 
April 1997 new legislation was adopted bringing with it significant changes.  The 1985 law 
focused on production and sales, but did not comment on possession of illicit substances.  
Parliamentary debate of the new act took a moralistic tone as many were concerned that the law 
was too permissive. The vote was almost split in half, with a small margin in favor of continued 
decriminalization. Though the 1997 Drug Abuse Prevention Act made personal possession 
illegal, a compromise was reached by introducing Paragraph 48, Article 4 suspending criminal 
penalties for personal possession.  Since the amount considered “for personal possession” was 
left undefined, each case had to be assessed at the discretion of the courts. In practice, the police 
and the prosecutor’s office avoided prosecuting petty consumers, and the courts were reluctant to 
punish them.   
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With a noticeable shift toward the political right, only three years later, a new legislative 
proposal was tabled. In October of 2000 the non-punitive nature of the Polish drug law was 
rolled back with Article 62 introducing criminal charges for possession of any amount of illicit 
substance.  Three options for punishment were instated; the first and most favored was 
incarceration for up to three years; the second was incarceration for six months to eight years for 
cases involving considerable quantities of drugs; and the third was the “privileged” penalty that 
included a fine, the limitation of liberty, or incarceration for up to one year in cases of “lesser 
gravity.” (Kuzmicz, 2010)   
 
This change began the process of power reconfiguration and greatly increased the influence of 
law enforcement. Since then, Poland has had one of the most restrictive anti-drug laws in 
Europe, punishing possession of any amount of illegal substances with either a prison sentence 
of up to 3 years, financial penalties, or both.  The police were given unfettered power to conduct 
body searches, which occur for trivial reasons, and to raid homes when there is suspicion of a 
drug offense.   The number of drug users entering the criminal justice system and charged with 
personal possession has risen significantly with each year since 2000 and are presented in figure 
5.  The first study summarizing the impact of the amendment of 2000, that criminalized personal 
possession, was conducted by a professor of law at Jagiellonian University in Krakow, one of the 
most prestigious in Poland.   It has shown a substantive increase of arrests for drug possession.   
In 2000, less than 2000 people were arrested for drug possession.  By 2002 this number doubled. 
In 2004 it reached 25,000 and in 2006, over 30,000.  This trend continued thorough the decade.  
Besides showing a dramatic increase in the number of arrests for drug possession after the 
introduction of the 2000 law, the study pointed out that 56% of those possessing cannabis and 
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60% of those with amphetamines had less than 1 gram of the illicit substance.  It went on to say 
that less than 5% of the cases were in possession of more than 20 grams, an amount typically 
held by a dealer.  In addition, Krajewski’s research showed that 60% of drug arrests were the 
result of routine patrols in gathering places of young people whereas only 20% were the result of 
specialized police investigations targeting drug dealers.   
 
















In the limited public discussion that immediately followed, two reasons were given for 
toughening the law.  First, it was thought that criminalizing possession would help reduce drug 
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to discern drug dealers with small amounts of a substance from personal use possession. 
Furthermore, it was assumed that criminalizing personal possession would deter young people 
from using illicit substances and that the example set by severely punishing a few, would have 
the great social benefit of protecting many.  Nine years later, the Institute of Social Affairs tested 
both of these assumptions.  Almost half (48%) of surveyed police officers and 60% of 
prosecutors did not find criminalizing personal possession to be an effective tool in apprehending 
drug traffickers.  Similarly, as many as 66% of prosecutors, 58% of probation officers, 46% of 
judges, and 51% of police officers did not think that criminalizing personal possession deterred 
potential drugs users (Kuzmicz, 2010).  The Institute of Social Affairs also published an analysis 
of police data from 2008 showing that only 4% of drug offenses were due to possession of a 
significant amount of an illicit substance (ISP, 2009).  Krajewski’s data showed that 24% of 
defendants were assisted by a lawyer and that 76% “negotiated” with the prosecutor unassisted 
being told that pleading guilty on the spot will greatly improve chances for reduced sentence 
(2008).    This is a great concern to practitioners of criminal justice since such pressure 
undermines the principle assumption of the European Convention for the Protection of Human 
Rights and Fundamental Freedoms. Article 6: Right to a Fair Trial states, ”. . . everyone is 
entitled to a fair and public hearing within a reasonable time by an independent and impartial 
tribunal established by law.”  In 2008, Jagiellonian University’s analysis inspired the Minister of 
Justice, Zbigniew Cwiakalski, to establish a committee to suggest changes to the drug law.  
Krajewski was appointed to chair the committee.   
 
The legal changes of 2000 were initiated by the political opposition, a progressive Democratic 
Left Alliance, Sojusz Lewicy Demokratycznej (SLD), in response to demands from parents that 
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the government more actively control illicit drug use.  The person who inspired and led the 
legislative process that toughened the law in 2000 was Barbara Labuda, a Minister in the 
Presidential Chancellery, ironically, the most progressive minister in that government with a long 
history of feminist activism. Ms. Labuda’s explanation of her role in the policy change is 
consistent with Desveaux’s suggestion that a shock or galvanizing event, or a key interest group 
is needed to engage and inspire policy change. According to Ms Labuda: “I am not a doctor or a 
chemist.  I am a politician and a social activist. When parents and drug counselors visited my 
parliamentary office to tell me that they need assistance, that 7 year olds are using drugs, that 
15% of students take drugs, you expected me to do nothing?  Doing nothing would be 
comparable to offering kids poison in school shops.  Polish law had to take a stand and to speak 
against it.” (Staszewski, 2011) This emotional reflection, offered 10 years after the policy 
change, gives some insight into the politically charged parent supported anti-drug campaign that 
Minister Labuda led. The campaign’s motto, “Better in Prison Than in a Cemetery” was a 
reference to the high HIV infection rates among drug users.  
 
Interestingly, a few years earlier, neighboring Lithuania also experienced a surge in activism by 
parents who were concerned about their children’s drug use.  Their goal, however, was entirely 
different. “These moms gathering in Vilnius engaged in advocacy with the tools of democracy. 
They paid visits to public authorities, organized meetings with politicians, and liaised with the 
media about the need to offer treatment and other necessary services for drug users. It was due to 
the help of these moms that, in 1994, the rehabilitation center, Vilnius Centre for Dependency 
Diseases, opened its doors” (I can Live, 2009).  
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The legislative change in Poland occurred at a time when the political right was gaining strength 
and the future President Lech Kaczynski was emerging with his conservative Law and Order 
discourse. It appears that the left sacrificed on an issue that was less important to them to appease 
the increasingly powerful right.  It is also worth noting that President Kwasniewski enjoyed a 
strong relationship with the United States, which supported Poland’s entry into NATO. Drug use, 
previously considered a social and medical issue, was transformed into a problem of law and 
order in which drug users were now viewed as criminals, social outcasts, a threat to public 
safety, associates of the Russian Mafia, and perpetrators attacking law abiding citizens with HIV 
infected needles.  Popular culture perpetuated these stereotypes through such vehicles as 
Ekstradycja (Extradition), a cops versus Mafia crime drama mini-series that ranked at the top of 
Poland's favorite television shows.  
 
Ten years later, former President Aleksander Kwasniewski, who had signed the 2000 amendment 
into law, had a different perspective from that of Minister Labuda’s.  When confronted with data 
on how the 2000 law criminalized young people, he became one of the signatories of a letter 
from 44 Polish intellectuals advocating for changes to the repressive drug law (Krytyka 
Polityczna, 2010).  Since the law under discussion can be clearly traced to Kwasniewski’s 
presidency, many have advocated that the former President speak out on the issues.  The 
international debate, including the existence of the Global Commission on Drug Policy which is  
comprised of multiple former Presidents,  Kofi Annan and other high level politicians received 
much coverage in Poland assisted this process.  In 2012, former President Kwasniewski went so 
far as to publish an op-ed in the New York Times in which he admitted making a mistake by 
signing one of the most punitive drug laws in Europe:  
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In the year 2000, as the president of Poland, I signed one of Europe’s most conservative 
laws on drug possession. . .  We assumed that giving the criminal justice system the 
power to arrest, prosecute and jail people caught with even minuscule amounts of drugs, 
including marijuana, would improve police effectiveness in bringing to justice persons 
responsible for supplying illicit drugs. We also expected that the prospect of being put 
behind bars would deter people from abusing illegal drugs, and thus dampen demand. We 
were mistaken on both of our assumptions. Jail sentences for the possession of illicit 
drugs — in any amount and for any purpose — did not lead to the jailing of drug 
traffickers. Nor did it prove to be a deterrent to drug abuse. . .  It is my hope that political 
and community leaders in other countries, especially in Eastern Europe, will learn from 
Poland’s experience in criminalizing drug possession, a move that clearly fell short of its 
goals. Such a policy failure should not be repeated anywhere else in the world. 
(Kwasniewski, 2012)   
He joined the Global Commission on Drug Policy with a commitment not only to engage in 
efforts in Poland, but also in neighboring Ukraine where HIV is heavily driven by injecting drug 
use.  
 
It is worth noting that after 15 years with a relatively liberal law intended to be non-punitive for 
petty users and 11 years after the democratic changes had been in place in Poland, Minister 
Labuda’s amendment raised little opposition.  The trajectory she proposed was not consistent 
with the public’s understanding and views, at least in Warsaw.  A survey carried out in 2002 in 
Warsaw, Psychoactive Substances: Attitudes and Behavior, reported that 95% of people 
described a drug addict as someone who suffered from a physical illness and almost all 
respondents agreed with the medical definition of a drug addiction.  Only 10% of respondents 
defined drug addiction to be criminal.  When listing strategies for dealing with the problem of 
drug use, 12% favored punishment through the criminal justice system while the majority of 
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respondents favored treatment (Drug Report, 2003).  It is likely that, even though Poles had a 
basic understanding of addiction, they saw little to be gained from spending their political capital 
standing up for drug users, especially, as perceptions in Poland and other post-socialist countries, 
had begun shifting. Criminalization of the drug scene had been progressing not only in practical 
terms but also in the eyes of the public. Fear and exclusion replaced compassion and 
understanding (Moskalewicz, 2002).  It is also likely that the views of relatively cosmopolitan 
Warsaw residents did not represent the perceptions of all Polish citizens. Minister Labuda, an 
experienced politician, was well aware of this dynamic -- the neoliberal notion of self-reliance 
and individual responsibility were taking hold and the idea of contextualizing risk was losing 
acceptance.   Finally, as the AIDS literature points out, democratic institutions and norms have 
played a mixed role in prevention efforts in their response to the epidemic (Putzel, 2001).  
 
Though the drug policy discussions never used overtly religious language and the church did not 
visibly participate in the debate, the presence of the church was strongly felt. It greatly 
influenced perceptions of how illicit substances affect human dignity, and the conceptualization 
of the ideal post-socialist Polish citizen as an independent, morally strong actor, responsible for 
his or her own destiny.  In the first case, it was argued that human dignity is based on the ability 
to make a distinction between what is morally right and what is morally wrong. The use of drugs, 
at best, blurs this ability and, at worst, annihilates it completely.  “Blessed sobriety” is a phrase 
often used by church leaders when they publicly engage in discussions of substance use.  In the 
second instance, drug users were categorized into a larger group labeled “Homo-Sovieticus,” a 
term recognized by contemporary Russian psychology which was popularized in Poland by one 
of the most significant and progressive figures in the Polish Church, Professor Tishner.  “Homo-
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Sovieticus” is a person so stuck in the past and in the Soviet mentality that he is unable/unwilling 
to  assume any individual responsibility for his own existence and remains forever dependent on 
the paternalistic, Soviet apparatus and according to Cockerham (2002)  is of collectivist 
orientation and  supports the notion of socialist heritage.   Both of these church-promoted notions 
were present in public debates about drug policy.  As the politics in Poland shifted to the right 
and aligned more closely with the church, the discussion over who does and does not deserve 
state-funded care became more dominant as did a rhetoric of blaming individual for health 
outcomes.   Having a Polish citizenship was no longer sufficient to be considered worthy of 
state-funded public health measures or to health care.  In the new paradigm, one had to be 
morally deserving as well.  
 
It is important to note that there is one church representative, Arkadiusz Nowak, who played a 
critical role in repose to HIV and drug use in Poland.  He served as an AIDS and Drugs Advisor 
to three consecutive Ministers of Health beginning in 1994.  While he consistently stood up 
against discrimination of people living with HIV and supported substitution treatment on the 
grounds of providing medical service to the infirm, his statements were always carefully aligned 
with the views of the church and with the notions of risk society where individuals are 
responsible for calculating costs and bearing the costs.  During a recent discussion of 
amendments to the drug law he spoke against decriminalization because “it would send the 
wrong moral message.”  Recently, he spoke to the press about condom promotion in the context 
of a public health campaign for the Euro Cup 2012 taking place in Poland, “Only living a moral 




Beginning in the early 1980s, the process of political transformation in Poland can be divided 
into two periods. The early years were characterized as pro-democracy and liberal-leaning with a 
relatively transparent set of goals, and leaders with long political histories, and wide recognition, 
who were not always agreed with, but were generally respected.  Whereas in the second phase, it 
has been the populist appeals that largely drive public debate. Paradoxically, integration with the 
European Union opened a forum for a nationalistic discourse that reflected back on Poland’s 
difficult history under German and Soviet occupation (Fundacja Batorego, 2010).  It was in 
2005, at the initiative of the progressive Minister of Health, Marek Balicki, that the drug 
legislation was amended again.  Not surprisingly, taking into account the increasingly 
conservative climate, attempts to liberalize legislation related to personal possession of illicit 
substances met with significant resistance by both conservative and liberal parties, and ultimately 
failed. However, in mid-2011, due to a major mobilization of civil society, a much more modest 
attempt at changing the law to offer additional alternatives to the criminal justice system was 
successful. 
 
Anand Grover, upon appointment as the United Nation’s Special Rapporteur on Health and 
Human Rights, made his first country visit to Poland in 2010 where he engaged in a discussion 
and evaluation of the drug policy. The resulting report stated:  
“The Special Rapporteur wishes to underline that national criminal laws and regulations have 
a significant impact on the success of harm reduction measures implemented in countries.  
National criminal laws need to complement harm reduction strategies and programmes.  In 
this regard, criminal laws should not impede, but facilitate measures taken by States to reduce  
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the transmission of HIV and to  provide HIV-related  care and  treatment for people using 
drugs.  Research has shown that criminal laws proscribing syringe possession and promoting 
police practices targeting people using drugs increase the risk of HIV transmission and other 
health-related consequences, both directly and indirectly. Furthermore, such laws are likely to 
create a fear amongst people using drugs of seeking treatment and other health-related 
services, further fostering unsafe practices and risky behaviour………In the context of harm 
reduction policies the Special Rapporteur notes with concern that the Law on Counteracting 
Drug Addiction penalizes even the possession of very small amount of drugs, making it 
difficult for people to receive necessary substitution treatment (Grover, 2010). 
This observation was confirmed by an outreach worker from Warsaw, “Here people congregated 
in various groups and were always on the run, looking over their shoulders for dealers who 
wanted their money and the police who pushed them around.  At that time, about 20% of the 
drug users in Warsaw were from Russia, Belarus, and the Ukraine and all of them were afraid of 
the police. Providing services in that environment became harder and harder.”   
 
After the introduction of the punitive drug law in 2000, harm reduction programs, to be 
discussed in detail in Chapter Four, began reporting problems with uptake. Drug users became 
reluctant to access services concerned that participation would implicate them as partaking in an 
illegal activity.  This user behavior in Poland is consistent with the international literature that 
suggests that criminalizing personal drug use deters users from seeking health services out of 
fear of arrest (Beyrer, 2010; Jelsma, 2009; Sarang, 2012).  A long time outreach worker and drug 
counselor I interviewed observed that restrictions in the law might have had an entirely different 
effect.  In his view, the gathering places, called bajzel, where drug users could easily be found by 
outreach workers to share information and exchange injecting equipment, were the same spaces 
where, as he describes it: “Everything else was shared, including drugs and HIV. If you have a 
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large number of people that are coming and going and there is a constant rotation, this creates the 
possibility of rapidly spreading HIV.  This stopped with the change of the law because people 
stopped coming together.”  At the same time, he admits that over the last ten years, the fear of 
police intervention has tightened drug using networks making it harder to locate gathering points 
and more difficult for outreach workers to engage with these groups.   
 
In 2005, a year after Poland joined the European Union, Health Minister, Marek Balicki, 
attempted to undo the 2000 amendment, in part out of concern for the difficulties faced by the 
harm reduction programs. Minister Balicki’s effort failed in parliament.  Most of the drug 
treatment providers, including MONAR, did not support Balicki’s plea. It claimed that the 
changes to the drug law had no influence on access to harm reduction services and were purely 
reflecting a decreasing number of injecting drug users (MONAR, 2009).  The police argued that 
criminalizing possession improves police effectiveness in combating the illicit drug industry, but 
did not provide any hard data to support this assertion. Along with the production, trafficking, 
distribution, and transporting, the possession of illicit substances continued to be criminalized.  
The production, trafficking, purchase and possession of any equipment used for drug production 
was also illegal.  In addition, liabilities were imposed on the owners and managers of various 
establishments to report distribution or trafficking of forbidden substances. The police are 
unrestricted in their right to conduct body searches as well as searches of a person’s place of 
residence.  When formulating the charges for drug possession, the prosecutor often suggests that 
the accused admit guilt thus speeding the judicial process. Once the defendant pleads guilty there 
is little opportunity to recant their plea later.  For these reasons, the system weighs heavily on the 
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side of the police and judicial system, and results in thousands of young people entering 
adulthood with criminal records.  
 This legislative process, and all others related to illicit drugs since, illustrates what Wiktor 
Osiatynski, identified as “a superiority of moralistic culture over the rule of law.” A prominent 
scholar of Polish constitutional law, Professor Osiatynski was referring to the tendency in post-
communist societies to judge according to moral criteria rather than against a backdrop of legal 
norms.  In his view, this tendency is particularly strong in Poland where historically, traditional 
values and cultural norms had been subordinated to collective ones (Stulik, 1998).  This theory 
can be expanded to account for the limited consideration given to social science and public 
health research whenever data is in conflict with moral norms.  At the same time, the body of 
research addressing policy change is at its fledgling stage since policy making during socialist 
times was steered by the Soviet Union. 
 
The Two-Year Debate, June 2009 to June 2011 
It was clear that any shifts in drug policy would not be easy.  As proposed by James Desveaux, 
complex problems addressed by governments usually involve high political stakes (Desveaux, 
1994).  The multidisciplinary committee established by the Minster of Justice completed its work 
and presented its recommendations in mid-2009.  Recognizing the conservative political climate 
in the country at the time, it’s suggestions for change was cautious.  One suggestion was to 
replace Article 62.1, related to personal possession, with a measure that would prevent automatic 
sentencing and give prosecutors the option to suspend criminal proceedings when the amount of 
the illicit substance is small, in the case of first offenses, or if the defendant is drug dependent 
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and has a history of treatment. This proposed amendment was so minor that after it was accepted 
by parliament on April 1, 2001, Poland is still one of the most restrictive countries in Europe.  
In 2008, four years after Poland joined the European Union, a study of six European countries 
(Bulgaria, Sweden, Denmark, Holland, Czech Republic) carried out by the Hungarian Civil 
Liberties Union (HCLU), revealed Polish attitudes to be the most restrictive in the group, on 
occasion matched by Bulgaria. Regarding punishment for possession or cultivation of cannabis 
for personal use, 41.5% of Poles favored imprisonment, the most drastic criminal justice 
measure, as compared to only 11.1% of Czechs.  Fifty-nine percent of Poles, the highest of all 
surveyed populations, supported the “total war on cannabis” approach, while in the Czech 
Republic, the Netherlands, and Denmark the majority felt that cannabis users should not be 
punished.  In Poland, 18.7% of respondents answered that the best reason not to use drugs is that, 
“It is forbidden by law,” while in Denmark this rate was 3% (HCLU, 2009). This study reveals a 
significant departure in Polish public opinion from the beliefs identified a decade earlier, when 
the majority of Poles saw drug dependence as a medical problem requiring social and medical 
assistance.  Staniszkis describes this decade as having been ruled by “capitalist logic” where 
social services became marginalized, the “common good” was devalued, collaboration became 
unimportant unless it resulted in monetary savings, the multigenerational solidarity and contract 
was broken.  Poland’s neighbor, the Czech Republic, also endured decades under a totalitarian 
regime but took a different approach to drug policy, as shown in the HCLU study.  It is more 
aligned with the liberal trends in Denmark and Holland on almost all indicators. Vaclav Havel, 
first Czech President after the transformation, considered drug policies matters early in his 
presidency, as evidenced by publication of his personal writing.  He suggested that the approach 
to be taken by his country should be non-punitive and supportive of the young people (Hvisdala, 
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2007).  Following “Velvet Revolution” Czech political and economic transformation, with all its 
consequences, and the process of integration with the European Union were somewhat slower 
and less dramatic than the changes in Poland. Poland, with its Solidarity movement that inspired 
the other Socialist Block countries, went through the transformation at a much faster and 
dramatic pace.  It is also surely relevant that the Czech Republic is significantly more secular and 
that religious leaders, unlike in Poland, are not present in public debates about policy issues.   
 
Consistent with HCLU findings about Polish views on drugs, the two-year debate in the Polish 
media, political life, and among civil society about drug policy changes was complicated.  
Gazeta Wyborcza, a leading, liberal Polish daily, launched a campaign supporting the 
committee’s recommendations with the front-page headline, “My Narkopolacy.” The campaign 
sought to reshape Poland’s perception of drug addiction and to inspire change (Soltysiak, 2009).   
All other print media, including significant monthlies, professional journals, and local and 
national dailies representing a wide political spectrum also responded.  From the end of  June 
(the campaign began on June 6
th
, International anti-drug day) and July, 38 articles were 
published on the topic: 23 favored liberalization, 6 opposed it, and 10 were neutral.  August 
followed with 34 articles: 8 were in favor, 7 were opposed, and 19 were neutral.  In September, 
26 articles were published: 5 were positive, 1 was negative, and 19 were neutral. In October, 
there were 32 print media articles about drug policy: 13 favored liberalization, 2 opposed it, and 
17 offered no opinion. In November, 29 articles appeared: 11 favorably related to the proposed 
changes, 2 were against them, and 16 did not address the issue.  In the course of six months, a 
total of 160 articles on drug policy appeared in the mass media. Sixty of these articles favored 
drug policy liberalization, 18 were against it, and 81 offered no view on the proposed policy 
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changes, but did cover drug related issues in Poland and internationally. With just a few breaks 
for holidays and important national events, this rate of media engagement continued until the 
parliamentary vote.   
Figure 6.  Record of press coverage discussing drug liberalization (June – Nov. 2012) 
 Favor liberalization Oppose liberalization Neutral 
June-July 23 6 10 
August 8 7 19 
September 5 1 19 
October 13 2 17 
November 11 2 16 
Total 60 18 80 
 
 One of the views presented consistently was that the role of the law is to reflect the desires of 
society which, in this case, was total abstinence.  Proponents of this dissuasion argued that 
reduced penalties would inspire people’s interest in drug use, therefore penalties for drug 
possession should be steep.  Consistently with Kowles’ notion that individual has the power and 
responsibility to maintain his or her own health,  Rzeczpospolita, a Polish daily affiliated with 
the conservative party, in the early days of the debate, argued that hidden behind the appeal for a 
rational drug policy is an attempt at social engineering. The aim of this engineering is not a drug-
free society (which should be the ultimate goal), but a society that offers drug users a peaceful 
life. The authors opposed harm reduction, suggesting that it was a concept created by the left-
wing agenda without scientific evidence or value.  Rzeczpospolita concluded that since, “no one 
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dies of withdrawal,” there is nothing wrong with leaving drug users to deal with their addiction, 
in prison and on their own (Bazak, 2009).  Similarly, Catholic publications consistently came out 
against the proposed legislative changes.  Gosc Niedzielny, a conservative weekly promoted 
during, and sold after the Sunday mass in churches, argued that the proposed amendment sends 
the wrong signal about acceptance of drug use (Gruszka, 2009).  The Catholic Church opposed 
Poland’s European Union membership in 2004, arguing that integration threatens Christian 
values. It used the proposed change of legislation as an opportunity to prove that the European 
influence is undermining Polish morality.  The Catholic press presented an image of a model 
catholic citizen who opposed the communist government, had helped Poland survive years of 
foreign oppression, was forced into economic obedience towards the European Union, and 
whose children are now threatened by a liberalized drug policy.   
 
A year after the Commission made its recommendations and the debate began, Andrzej Czuma, 
was appointed as the new Minister of Justice.  Czuma is a lawyer who spent a significant part of 
his career in the United States and who was best known for his lobbying efforts to relax gun laws 
in Poland. While he maintained the view that the law needs to change, his public explanation was 
far from the original intent. In his interpretation, charges against the accused would only be lifted 
if the detainee disclosed information about his or her supplier.  This iteration caused significant 
discussion on both sides of the debate.  One of the leading progressive journalists in Poland 
expressed concern: “Current Polish drug law sends to prison young people caught with small 
amounts of drugs. It is absurd and it should be changed. The trouble with the current proposal is 
that it proposes to substitute one absurdity with another; he possibility of dropping the charges if 
a person who is caught reveals the source of the drug. Small dealers are usually part of larger 
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underground structures. Will the state be able to ensure the safety of the people who gave out the 
name of a dealer?” (Zakowski, 2009)  At the same time, a Catholic paper, Nasz Dziennik, 
warned the minister that he was opening the doors to police corruption, and appealed for criminal 
law that consistently prohibits citizens from possessing any amount of drugs, pointing to the 
Netherlands as a terrible country where “nothing is forbidden” (Czachrowski, 2009).  By the end 
of 2009, Deputy Minister Krzysztof Kwiatkowski was promoted and replaced Andrzej Czuma as 
the Minister of Justice. Minister Kwiatkowski, in his public statements, held the view that 
punitive drug laws violate civil liberties and that using criminal justice tools, especially prison 
sentences, are ineffective in deterring users and, in the long term, destroy young people’s lives.  
He disagreed with law enforcement’s claim that focusing on petty users leads to the 
apprehension of serious offenders, and argued that the 2000 law distracted the police from 
pursuing serious dealers. Minister Kwiatkowski used the following data, often referred to in 
public debates, to support his claims, “In the 10 years since the 2000 drug law was put into place, 
the number of arrests for personal possession increased by 1,500% while the successful 
prosecution of dealers decreased by 100%.” The debate was not limited to government experts. 
Chart topping Polish singer and a songwriter, Kazik Staszewski, spoke out in Machina, a popular 
music magazine.  He argued, in agreement with Minister Kwiatkowski, that Polish drug policy is 
ineffective because it criminalizes the users, distracting law enforcement from addressing the 
more detrimental crimes of dealing and drug production (Staszewski, 2009).   A letter to the 
Speaker of the House signed by 72 personalities from the news media and the art world pointed 
out that criminalizing personal possession marginalizes young people, and that having a criminal 




The print media was not the only space for public debate.  TokFM, the largest talk radio station 
in Poland, followed the issue closely. The Polish Drug Policy Network and Krytyka Polityczna 
created dynamic and engaging websites.  In a letter to the Speaker of the House, the Polish Drug 
Policy Network stated: “Ten years of the current drug law shows that this amendment has neither 
helped to decrease levels of drug use, nor reduce the amount of drug-related crime. In fact, it has 
done more harm than good… Research shows that it is mainly young people, with no links to 
organized crime, who are being punished for possessing small amounts of marijuana.” The letter 
was signed by 30 national and 76 international groups and activists (Polish Drug Policy 
Network, 2011b).  A blog about drug policy run by a lecturer of law, Mateusz Klinowski, was 
nominated for the prestigious Blog of the Year award (Klinowski, 2011). A Facebook campaign, 
Apelujemy, created by young professionals, collected over 60,000 signatures in support of the 
new law and used various new media tools to engage young people. Along with ongoing 
Facebook discussions, it also posted video statements made by international experts, one of them 
Ernest Drucker:   
 
"We can say from many, many years of experience in the U.S.--where we now have two 
and half million people in prison because of these laws--that they make everything more 
difficult to do, they use money on enforcement that should be used on prevention, 
education and treatment... and there is plenty of evidence from the United States, from 
Canada, from Australia, from Great Britain, that the more successful, effective way to 
deal with drug problems is to keep them away from the criminal justice system as much 
as possible.” (Apelujemy, 2011)    
In December of 2010, draft legislation made its way to the Parliamentary Committee on Human 
Rights and Justice where it was attacked by the conservative party Prawo i Sprawiedliwość or 
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PiS (Law and Justice) as well as the Chief Prosecutor whose office was integral to the long 
negotiating process. Gazeta Wyborcza suggested that the change in the prosecutor’s office may 
be the result of internal discussions pointing out the increased amount of time required of 
prosecutors on each case (Siedlecka, January 2011).  The majority party, Platforma 
Obywatelskam or PO (Civic Platform) was fully present at the next committee meeting and the 
draft proposal made its way out of the committee and onto the list of projects waiting for a 
parliamentary vote. The Polish Sejm voted to adopt the new drug legislation on April 1st, the 
Senate voted in favor on April 28th, and the President signed it into law at the end of May 2011 
(HRI, 2012).  The effort, while limited in scope, may have been successful for a few reasons.  
First, the data, which showed the unintended consequences of the 2000 law, was produced by a 
leading Polish University and was embraced by the Minister of Justice who had been appointed 
by the ruling party and who had a historical relationship with the Jagiellonian University and the 
study’s author.  Around the same time, international funding was made available to a few newly 
founded advocacy groups including the Polish Drug Policy Network which became important 
partners with the media, participated in parliamentary expert groups and was generally visible.  
The more liberal media, not only covered the Polish debate, but also increased coverage of the 
discussion in the international arena in support of the Polish argument for liberalization.  It is 
highly questionable as to whether a bolder amendment would have passed the legislature.  Since 
the proposal was originally initiated by the ruling party, Platforma Obywatelska, it stood by this 
very minor change during the parliamentary vote.   With relatively broad support from the liberal 





The history of illicit drugs in Poland, throughout these three years, shows that policy making and 
implementation has always occurred in a highly politicized context and is, as a result, somewhat 
unpredictable. The most recent policy change is consistent with the literature suggesting that 
evidence is used by policymakers when researchers engage them directly. It was the criminal 
justice study by Professor Krajewski that inspired the Ministry of Justice to take action.  Several 
sources in the literature also show that the likelihood of success is increased if evidence is 
explained through stories that resonate with key decision-makers, and if the evidence is used to 
influence the values and beliefs of decision-makers (Buse, 2011). Numerous letters, advocacy by 
civil society, and outreach to the popular and academic media were also helpful in prompting 
change.  Public health officials were not engaged, and possibly because of this, public health 




Chapter Four: Drug Treatment and Harm Reduction in Poland 
 
 
Treatment of drug dependence in Poland began in the early 1920s and was administered in 
psychiatric facilities. The first patient to be admitted for treatment of drug dependence was 
recorded in 1921 at the Dziekanka psychiatric facility. Seven years later, there are 85 such 
records from psychiatric institutions around the country, increasing to 295 admitted in 1933 
(Bielewicz, 1988).  There are also a few records of sanatorium stays, but these were expensive 
and rather rare.  A heated discussion about the need for mandatory treatment occurred in late 
1920s. It was instituted for those who broke the law while intoxicated as a compromise between 
what was perceived as a lenient judiciary and those who advocated for a more severe punishment 
(Bielewicz,1988). In 1964, 165 persons were admitted to psychiatric institutions for drug 
dependence.  The number of those treated remained steady throughout 1960s (Frieske, 1987).    
 
Abstinence-Based Drug Treatment 
Psychiatric institutions were the only option for drug treatment in Poland until the end of the 
1970s.  Numerous attempts were made to include drug dependent patients in alcohol treatment 
facilities, but these were, for the most part, considered unsuccessful.   As described by a drug 
treatment provider, “You have to understand that psychiatric units were not popular places in the 
seventies.  We were all watching One Flew Over the Cuckoo’s Nest and thinking of our patients, 
young people locked up in psychiatric institutions, sedated and sometimes tied to beds. Often, 
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these young people, young drug users, were there because they were perceived by the 
government as a nuisance.  They were there for no other reason, really.”   The first psychiatric 
unit to specialize in drug treatment was run by Ewa Andrzejewska in Garwolin.  She is often 
described as a being maternal figure to patients and staff alike.  A number of professionals 
concerned with the increase in drug use and dissatisfied with the standard treatment methods, 
started flocking to Andrzejewska’s department (Jump’93, 2011).  Among them was Marek 
Kotanski, a charismatic psychologist who founded the first therapeutic community in 
collaboration with the Garwolin psychiatric hospital in 1978.  A rundown estate with many acres 
of farmland was transformed into Poland’s first therapeutic community in Gloskow near 
Garwolin. This was the beginning of MONAR. The Polish socialist government had a number of 
mansions that it had confiscated from the owners after World War II.  They were used for 
various purposes, but with time, lacking the resources to maintain them, they became severely 
run down.  A second therapeutic community, Majdan, was organized under very difficult 
circumstances on another dilapidated estate with no running water, sanitary facilities, or central 
heating.  The facility’s patients did all of the renovations necessary to make the space habitable 
(Cekiera, 2010).  As Kotanski’s approach to drug treatment grew in recognition and popularity, 
the government handed over other such destroyed buildings to MONAR and young drug users, 
predominantly male, provided the free labor needed to rehabilitate what became a network of 
facilities across Poland.  With the confidence of the socialist government, Kotanski managed to 
assemble the physical and political infrastructure that made MONAR the influential institution it 
is today; Poland’s largest drug treatment provider with 32 long-term rehabilitation centers 
making up 40% of all rehabilitation beds in the country (Poradnia, 2011).  Currently, there are a 
number of regions in Poland where MONAR’s rich resources and infrastructure make it 
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impossible for other organizations interested in providing drug treatment to compete.   All of the 
people I interviewed, when asked to list drug treatment organizations in Poland, listed MONAR 
as the first and the most significant one. All of MONAR’s centers, along with six Catholic 
Therapeutic Communities, KARAN, receive half of Poland’s national health budget dedicated to 
drug treatment (Jump’93, 2011). A study by the Institute of Neurology and Psychiatry illustrates 
the imbalance: 15% of all those in need of treatment and using the therapeutic community model 
use up to 60% of the national treatment budget, while half of all those in treatment and using the 
ambulatory method are allocated only 10% (Moskalewicz, 2010). 
 
While the organization has evolved over time, MONAR’s overall objective is to provide drug-
free residential treatment and all of the services offered by the network support this goal. 
Consequently, the aim of MONAR’s outreach is to entice users into detoxification programs that 
are then followed by residential treatment.  The homeless shelters for drug users run by MONAR 
also aim to bring clients into the fold of drug-free residential treatment.  The treatment 
philosophy of MONAR is based on the premise that while addiction is a disease, it is a disease of 
the soul (Kotanski, 2003).  To provide an effective cure, patients require clear structures, a daily 
routine filled with physical labor, and a nonnegotiable set of rules. Those who do not comply are 
punished in various ways and those who break their abstinence are immediately expelled.   
 
A set of rules and guiding principles established by Kotanski thirty years ago continues to be 
applied in MONAR’s therapeutic communities today.  They were also adopted by a number of 
other implementers of this approach, such as KARAN. In short, as described by one of the drug 
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treatment experts associated with the drug treatment establishment for over two decades “The 
assumption was that treatment had to hurt.  So even people who tell you that they favor treatment 
over prison, believe that treatment will be appropriately punitive.”  Drug dependence was 
perceived as a fatal infectious disease and expulsion from treatment was seen as the only option 
for someone who was breaking the rules -- the health and safety of an entire group could not be 
sacrificed for the comfort of one, failing patient. “To increase the likelihood of therapeutic 
success, the ‘cancerous’ cells must be removed brutally, without concern for the pain the process 
will cause for the young person,” wrote Kotanski in 2003 when explaining the requirement for 
absolute abstinence and his nonnegotiable, “ treatment intervention” of immediate dismissal of 
patients who broke abstinence.  Treatment centers established internal “mini police squads,” 
made up of more experienced patients, whose job it was to check their fellow patients every 
three hours for pupil dilation and injection marks (Osipczuk, 2010).  Such a view of drug 
dependence justified a number of punitive interventions including head shaving, prison-like 
uniforms, humiliating signs worn on a patient’s chest or back, and an extreme institutional 
culture where the majority reigned over the interests of the individual.  This approach was 
consistent with the values of the ruling political party at the time when MONAR was established 
– individualism was undesirable under the socialist regime. A discourse of sacrificing individual 
needs for the good of the group was not unusual and may be one of the reasons why MONAR’s 
philosophy was widely publicized and quickly recognized as the only successful treatment 
option, even without any data. MONAR organized public spectacles with patients, dressed in 
prison-like uniforms, cleaning public toilets.  This fit the common perception of drug use and 
drug users – drawing clear moral boundaries.  It may be that MONAR received support from the 
government at the time, exactly because of its approach to treatment, rather than the 
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government’s concern for increasing drug use.  At the same time, heavily addicted young people 
found a sense of community there. According to one former client and currently an outreach 
worker, “While being at a sort of work camp was not meant to be fun, during the communist 80s, 
this was the only place welcoming to someone who was an addict and we appreciated that.”  The 
medical establishment, pleased to have rid itself of these complicated cases of drug dependence, 
kept silent thus allowing for MONAR’s approach to remain unchallenged for decades. In most 
Polish cities today, if a person presents himself or herself to a psychiatrist and reports drug use, 
they will often be sent to a therapeutic community. As reported by a drug treatment provider, “I 
cannot tell you how many young people were sent to me with serious anxiety problems and 
depression, but only incidental use of cannabis. Having any drug experience made them 
ineligible for psychiatric care. This is changing slowly, but we have a very long way to go.”   
Another source stated, “While I have a number of issues with Kotanski’s megalomania, I always 
felt that he was truly committed to the cause and in the face of evidence, could be flexible. If you 
sat and had a real conversation with him, a change in his thinking slowly became visible.  When 
he died in a car crash it was a great tragedy for the drug treatment world in Poland.  The people 
who took over for Kotanski are much more rigid in their approach.  It’s as though, in Kotanski’s 
memory, they are more committed to his early goals than he ever was.  Poles always try to be 
holier than our Polish Pope.  Today MONAR is more Kotanski-like than Kotanski was himself.” 
It was only in 2008 that an article critical of MONAR titled, “With Face in Manure,” was 
published in the popular press. The article began, “To rehabilitate junkies, 30 years after its 
establishment, MONAR still uses extreme methods. Haven’t cleaned the pigsty? Spend the night 
with the pigs. Didn't wake up on time? Cold water over your head.” (Olszewski, 2008)  After 
visiting one of the centers, the author described the system:  
81 
 
The daily routine at a MONAR rehab center near Opole, in Western Poland, hasn’t 
changed since 1982. Starting their day with a two-kilometer run at 6:30 a.m., patients 
work hard all day on the farm. They meet twice a week in the evening to discuss plans for 
the center and decide on punishments for colleagues who have not followed the routine. 
Methods to break-in the newcomers these include wearing signs around their neck. There 
is a long list of rules; sexual abstinence (couples are not allowed to meet after 11p.m.), no 
television, three coffees a day maximum, no swearing, etc. Life here is similar to other 
rehab centers where patients are taught that a proper way of life includes hard work, 
meals, sport, sleep, and sometimes a holiday. For several years, a sign hung in the 
common room stating, ‘Love the grayness of life.’ An example of ‘provocative therapy’ 
was witnessed when a therapist screamed at a female patient, ‘You are fat, ugly, you have 
cellulite, everyone laughs at you behind your back.’ The girl, with tears in her eyes asked 
‘Why are you telling me this?’ The therapist replied, ‘Because that’s the truth. Do 
something with yourself.’ The therapist explained that these methods are used in 
MONAR, ‘because otherwise we wouldn’t manage.’ (Olszewski, 2008) 
A former client recorded a similar experience in a book,  
At the community meeting therapists assigned work for everyone. It was important to 
follow the rules because any violation had serious consequences. If someone broke a rule, 
he or she had to admit it during the community meeting and was assigned a punishment, 
called dociazenie. If you fell asleep with the lights on, you had to wear a light bulb 
around your neck for 24 hours. These penalties were important because they taught you 
to take responsibility for your behavior. Junkies are very imaginative when it comes to 
inventing punishments for others.  After breakfast it was time for work, with a break for 
lunch. Care was taken so that junkies were not bored. Novices were forbidden to stay 
alone in the room, because it usually causes destructive thoughts.  Therapeutic 
Community is a session where all members gather. This is a time when being offensive 
and judging others is not forbidden.  There was usually an avalanche of hurtful words.  
You could really be humiliated, but it served a positive purpose – as a junkie, we can 
really stick to our denial. (Osipczuk, 2010) 
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Such treatment is in stark opposition to Article 7 of the International Covenant on Civil and 
Political Rights (1966),“No one shall be subjected to torture or to cruel, inhuman or degrading 
treatment or punishment.”   
 
In the Polish facilities using the model of therapeutic communities little actual drug treatment 
takes place.  Instead, every activity, from peeling potatoes to working the land and morning 
exercises is considered therapy.  It should also be noted that not all therapeutic communities are 
alike, “The oldest communities, where directors of the organization had themselves been through 
this sort of treatment in the 1980s, tended to be the most problematic, usually had a bad 
reputation and many empty beds.” (Osipczuk, 2010)   
 
Until the political changes in 1989, having established a network of therapeutic communities, 
Poland considered itself a leader in drug treatment, among the Soviet Block countries. It’s this 
self-perception of Poland’s advancement in comparison to its neighbors that might have worked 
to Poland’s detriment. As the political changes took hold and the national borders opened, the 
neighboring countries, recognizing their own limited experience, looked to the West for 
examples of effective treatment.  Over time, various approaches were introduced in the Czech 
and Slovak Republics and Hungary while Poland persisted with its widely practiced abstinence-
only method.  Much more pragmatic, and secular Czech Republic was especially welcoming to 
the harm reduction approach which continues to be a strong pillar of its drug policy.  It is also the 
first country in Central Europe to legislate access to cannabis for medical purposes.  In Poland, 
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the introduction and expansion of other approaches, such as drug replacement therapy and harm 
reduction, has been very difficult, met with strong opposition, and has not flourished.   
Methadone availability has been low and the number of needle exchange outlets and exchanged 
equipment has seriously decreased over the last decade, after peaking in 2004.  The report of the 
United Nations Special Rapporteur on Health and Human Rights, following his visit to Poland 
stated: 
Trends indicate that, while  substitution  treatment  is  available,  a  drug-free treatment  
regime  is  still  prevalent  within  the  country.   This  is  of  particular  concern,  as  
studies demonstrate  that  substitution  therapy  is  a  more  efficient  and  less  costly  
way  to  treat  drug dependence. Studies have indicated that patients under methadone 
maintenance treatment and buprenorphine substitution therapy are more likely to 
discontinue or considerably decrease their use of illegal psychoactive  substances.  
Furthermore, harm reduction interventions are well supported and promoted by   
UNAIDS, WHO and UNODC in their best practice guidelines. (Grover, 2010) 
 
The Current State of Drug Treatment in Poland 
Poland has two different systems for treating addiction; one for alcohol dependence and the other 
for drug dependence.  Treatment for dependence on alcohol is supervised by the State Agency 
for the Prevention of Alcohol Related Problems and the National Bureau for Drug Prevention 
oversees the treatment of drug dependence.  The network for alcohol treatment consists of 400 
outpatient centers and 111 inpatient facilities.  All facilities are part of the public health care 
system and the National Health Insurance (NFZ) or the Ministry of Health covers the cost of 
treatment for alcohol and drug dependence when a person is not eligible for NFZ coverage.  
Drug dependence is treated by fewer than 100 outpatient centers, 20 inpatient detoxification 
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programs and 60 inpatient facilities, most of which are run by non-governmental organizations 
(IATPAD, 2009).  During the process of political transformation, the number of people seeking 
psychiatric care, including drug and alcohol dependence, increased significantly.  An increase of 
70 percent was recorded between 1990 and 2003.  The number of people admitted for drug 
dependence is smaller, but the rate of increase is greater (IATPAD, 2009). Drug treatment in 
Poland is voluntary, with only two exceptions; when a patient is under 18 his or her guardians 
can make the decision or when the patient is an inmate and then admission is done on the 
directive of a prison physician.  
 
A multi-country study in Europe that interviewed clients of alcohol and drug services in Poland 
concludes that drug treatment patients were much less positive about their experience than the 
patients treated for alcohol.  Waiting lists, cumbersome bureaucracies where a patient must 
spend days retrieving information about previous treatment from various cities throughout the 
country, descriptions of random admission procedures, the sense that personnel are unfettered, 
the stress from feeling that the constant requests and instructions are senseless, a two hour 
commute to the “closest” treatment center, and poor facilities described as resembling a movie 
set, were some of the problems identified (IATPAD, 2009).  Most of these comments refer to 
therapeutic communities as they are the predominant service.  
 
In 2009, the Helsinki Foundation for Human Rights monitored 18 therapeutic communities (over 
20% of the total in Poland) located in 6 voivodships.  In addition, in-depth interviews were held 
with seven former patients currently in the care of outpatient clinics. Among the monitored 
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centers, 7 were run by MONAR (39%), 5 by other non-governmental organizations (28%), 4 by 
the local government (22%), 1 by a Church organization and 1 by a private enterprise. Four 
centers admitted minors and 3 housed mothers with children. Most conducted long-term therapy 
of 12 months or more (70%), and a few promoted a stay of up to 24 months. Short-term therapy, 
for up to 6 months, was offered by three centers, including one for a period of 8 to 9 weeks.   
 
The Helsinki Foundation’s report noted no concerns in the observance of fundamental human 
rights; the right to information, protection from degrading treatment, privacy, contact with 
relatives and loved ones, the right to lodge a complaint, and to access education. It did however, 
observe the following problems: lack of clarity about the need for stripping and body searches at 
admission, unjustified restrictions regarding contact with relatives and others, lack of clarity 
about penalties imposed by the community and staff.  Access to stationary treatment was deemed 
satisfactory but a concern was noted that patients often treat their stay at the center as an 
opportunity to improve their physical condition, survive the winter, wait out a difficult time in 
their life, and not necessarily as an opportunity to treat their dependence.  Terms such as 
“treatment tourism,” or a need to “get a grip on oneself” were not unusual. Data regarding 
patients who fail to complete the course of treatment (approximately 70 to 75%) and then return 
to another facility were not unusual and were troubling, both in terms of the effectiveness of the 
treatment and the costs incurred by the Polish National Health Fund (NFZ). The maximum 
number of long-term treatment stays by one person was 12 (Helsinska Fundacja, 2010).  The 
Central Bureau of MONAR objected to monitoring by the Helsinki Foundation.  The centers that 
accepted the monitors did so on their own volition, which puts into question the generalizability 




The shorter-term treatment centers have more therapeutic activities in the strict sense, while the 
long-term therapy programs involve various types of work, often referred to as ergo therapy.  
There was no evidence that those who stay at the facilities for 1.5 to 2 years undertaking various 
types of community work are better prepared for independent life after release. No standards and 
mechanisms for evaluating the effectiveness of drug treatment for individuals were identified.   
 
Even though MONAR has been in existence for over 30 years and it uses large amounts of 
public funding, there has been no formal institutional evaluation.  There are a few masters 
degree-level papers that assessed individual treatment centers cited during the celebration of 
MONAR’s 25th anniversary at the Catholic University in Lublin.  Evaluation of the effectiveness 
of treatment was assessed by interviewing 30 former residents who completed the program and 
had maintained abstinence from drugs for at least one year. They were asked questions about 
their current and retrospective self-image. The author concluded that those who successfully 
completed treatment could be characterized as needing permanence and stability, and possessed 
a desire to help others, a strong need to understand others, diligence, high energy, initiative, 
tolerance, and forbearance in interpersonal relations.  Another attempt at evaluation concluded 
that the community home creates a unique atmosphere of sincerity, security and responsibility. 
Friendships that developed during treatment are of paramount importance for people treated for 
drug addiction.  The feeling of community and responsibility for one another and striving for the 
same purpose is critical to the effectiveness of rehabilitation in MONAR.  A third evaluation 
effort summarized the following outcomes of a study without explaining how the study was 
87 
 
done; 27% of the residents state that the center is nice, 20% positively evaluated education 
efforts, 13% felt that MONAR is effective, 50% believed that they can live a sober life, 20% felt 
that they are learning honesty, and 17% felt that MONAR gave them hope for a drug free life.  
Seventy-seven percent stated that the treatment system at the center is helpful (Cekiera, 2010).  It 
is clear from these small evaluation efforts that a number of drug dependent individuals 
appreciate the service they receive, they value the opportunity to be a part of a community and 
that this is where they find acceptance and friendship.  With no long term follow up of patients 
initiated into treatment; its efficacy is impossible to measure. The first evaluation, for example, 
mentioned only those who completed treatment and said nothing of people who entered but 
dropped out.  According to Helsinki Foundation 75% never complete the course of treatment.  
This is consistent with data from the US where outcome studies of abstinence-based treatment 
showed 15%-35% retention at 12 weeks (Kellogg, 2007; Marlatt 1998).   
 
Substitution Treatment 
A pilot substitution treatment program established in 1991 at the Institute of Psychiatry and 
Neurology in Warsaw was one of the first of its kind in the entire Communist Block.  It created 
much debate, and, as in many countries (Ambekar, 2012; Drucker, 2012; Newman, 1983), when 
it began it mobilized substantive opposition. Professor Zielinska, for example, a well-respected 
AIDS physician, in an interview with the press stated, “Providing methadone turns a blind eye to 
the fact that someone is a drug addict.  In fact, it sentences this person to a slow death. It is 
clearly unethical because by prescribing it, physicians show the patient that no further effort will 
be made to rescue him or her.”  Arkadiusz Nowak’s view was that methadone may offer an 
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alternative, but only for a few: “We cannot allow it to be available to anyone who wants it.  
Humanitarian reasons allow for methadone to be provided to drug addicts with AIDS and those 
with a very long history of use and many failed attempts at treatment. When very little life 
remains.”  And finally, Marek Kontanski said, “The doctor’s job is to treat drug addicts.  Instead, 
they tell them that they can live, thanks to methadone.   They give them the drug and create a 
philosophy to go along with it.  They basically condemn them to a life of addiction. But people 
who take methadone do not live a full life.  That is fiction. It is a fiction promoted by medical 
professionals.” (Montgomery, 1998)   As recalled by a harm reduction provider and a former 
drug user, the greatest opposition to substitution treatment comes from the providers of 
abstinence oriented drug treatment, “ I too was very suspicious of this model.  What changed my 
mind, really, was a friend who, out of frustration, after another failed attempt at treatment, tried 
to commit suicide by jumping in front of a train.  I can list people who are no longer with us who 
could have been helped if treatment providers were more open to this possibility.”  The first 
program outside of Warsaw, also as a pilot, was inspired by an infectious disease physician in 
Chorzow who identified the need for substitution treatment in support of drug users’ adherence 
to HIV treatment.   This model was supported by Arkadiusz Nowak as it aligned with his view 
that people with AIDS should have access to this modality, as a palliative intervention. When the 
pilot phase ended and methadone was approved for treatment of opioid addiction, for reasons 
that continue to be unclear, the most expensive form of it, produced by an Italian pharmaceutical, 
Molteni, was registered in Poland.  This has had long term implication to availability of 
methadone treatment since high price of the medicine is often quoted as an obstacle in expansion 




Though MONAR has adopted a harm reduction philosophy, one major difficulty remains. It 
amended its constitution to state that none of its centers can be associated with substitution 
treatment because it goes against the organization’s drug-free philosophy.  This is a 
disappointing development since, with its extensive network of programs throughout the country 
and decades of experience, MONAR is perfectly placed to advocate for and deliver much needed 
substitution treatment services.  A number of European countries, including Switzerland and 
Italy, have managed to open their therapeutic communities to welcome methadone patients.  
This, however, is not currently possible in Poland. Interestingly, a MONAR drop-in clinic in 
Krakow, under the direction of a long-time harm reduction advocate, is providing buprenorphine 
to clients who are unable to abstain from opiates.  This is a pilot program that has been 
functioning quietly and does not seek attention. 
 
Despite rich literature on effectiveness of substitution treatment (MacArthur, 2012) and an 
increasingly favorable policy environment for this form of treatment, the number of drug users 
receiving substitution treatment has remained low. Slightly over 2,000, or 8% of the estimated 
number of dependent opiate users, are receiving substitution treatment.  In comparison, there are 
70,000 methadone patients in neighboring Germany (Golz, 2006), which represents roughly 40% 
of Germany’s illicit opiate users. In Switzerland, 18,000 out of a population equal in size to 
Poland’s 25,000 opiate dependents are receiving methadone treatment (Csete, 2010).  In 
neighboring Lithuania, which began substitution treatment at a similar time and under similar 
conditions as in Poland, approximately 15% of people dependent on opiates receive substitution 






Figure 7.  Funds allocated by NFZ, in PLN, to methadone & drug-free treatment in 
2006/2007   
 
 
For active drug users, adherence to the HIV treatment regimen is a challenge documented 
throughout the world (Oppenheimer, 2003; Carrieri, 2006).  To enroll and keep drug users in 
care, substitution treatment, such a methadone or buprenorphine, is used as an adherence support 
(Villalbi, 2004; Altice, 2006).  Since antiretroviral medicines often interact with methadone, it is 
important that HIV clinics and methadone programs develop collaborative relationships 
(Cholewinska, 2004).  With this idea in mind, infectious disease clinics in Chorzow, Wroclaw, 
and Warsaw introduced onsite methadone substitution treatment.  This initiative has been 
successful and warrants expansion. 
 
Though Poland has made substitution treatment more widely available, the programs are not 
necessarily based on the principles of harm reduction or the desire to empower people who are 
drug dependent. In fact, treatment is most often delivered by way of authoritarian medical 
institutions.  Methadone patients have reported frequent urine tests, threats of expulsion, under-
dosing, and strip searches for evidence of ongoing injection (NGOs: Wyzwolenie and Jump’93).  
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One of the foremost authorities on HIV treatment for drug users published the following 
observation, “Specialists in the treatment of addiction must objectively differentiate between 
actual withdrawal symptoms and manipulation typical of drug addicts seeking to obtain higher 
methadone doses.” (Cholewinska, 2004)   The suspicion that patients are abusing the “privilege” 
of therapy pervades Polish drug treatment and HIV services.  
 
As methadone programs mature, patients are becoming more aware of their needs and 
empowered to express them.  Wyzwolenie, an organization of methadone patients in Krakow, 
was formed in response to an announcement by program staff that the methadone dose for each 
patient will be reduced with a goal of complete detoxification within days.  As stated by the 
organization’s representative, “We felt that no one cares about our needs and that we were being 
pushed back to the place we struggled to get out of – back into uncontrolled addiction.” 
(Wodowski, 2006)  One of the goals of Wyzwolenie is to help methadone patients reintegrate 
into society by completing high school, obtaining employment, and reconnecting with family.  It 
also advocates on behalf of patients who are in trouble with the treatment program and are at risk 
of expulsion. Jump’93 (National Polish Association of Drug Users and Substitution Patients), 
based in Warsaw, is another organized group of methadone patients.  In addition to supporting 
patients in the capital, they also do advocacy work in cities where methadone is unavailable.  
Even though drug user movements are present across Europe (Curtis 2004, Michels 2012), 




Various national frameworks regulating and encouraging the expansion of substitution treatment 
are firmly in place; the National Health Program from 2007 to 2015, the National Psychiatric 
Care Program, and the National Program for Drug Prevention from 2011 to 2016 are all 
approved by the Polish parliament.  One of the objectives of the National Health Program is to 
increase the number of ambulatory clinics for drug treatment, including substitution treatment 
programs.  The National Psychiatric Care Program, even more specifically, is mandated to create 
substitution programs throughout the country wherever there are a minimum of 30 potentially 
opiate dependent persons. Finally, the National Program for Drug Prevention, has to provide at 
least 25% coverage of all substitution treatment given to opiate dependent persons in all regions 
of Poland.   
 
Since the introduction of substitution was controversial in Poland and required a number of clear 
and restrictive legislative measures that stipulated the basis and conditions under which opiate 
dependent persons may be treated with methadone, a number of amendments were enacted.  The 
2005 Act stated that methadone may be provided within the framework of a therapeutic program 
by a healthcare facility licensed by the provincial governor and on the recommendation of the 
Head of the National Bureau for Drug Prevention.  Following are the admissions criteria: the 
patient has been addicted to opioids for at least three years, is 18 years of age or older, 
abstinence-based treatment attempts have failed, the patient commits to abstain from narcotic 
and psychotropic substances, and expresses written consent to enter into such treatment.  
Methadone is the basic substitute drug used and enrolled patients must participate in counseling 
for at least two hours per week (Rozporzadzenie, 2007).  A more recent amendment removes 
most of these restrictions.  Under strict conditions, it even makes it possible to enroll a person 
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that is below the age of 18.  The criteria to show multiple failed attempts of abstinence-based 
treatments was also removed as heavily addicted patients were traveling the country in order to 
enter a residential program only to discharge themselves a few days later.  It is noteworthy that 
while the Drug Prevention Bureau can be credited with successful efforts in relaxing criteria for 
methadone treatment, it is somewhat slow in its efforts to expand the number of medicines 
available for substitution, yet another manifestation of neoliberal practice of Polish institutions, 
as described by Hausner (2007).  MONAR opposed the amendments relaxing the treatment 
criteria. Its center in Gdansk went on the record stating their concern that young, drug dependent 
persons will maintain their addiction by taking methadone financed by public funding, rather 
than strive for abstinence.   In their view, such treatment should only be available to pregnant 
women and people with serious medical conditions.  A similar statement was issued in 2008 by 
the entire organization suggesting that the current criteria was too lenient and advocated for an 
increase in the number of years of opiate use and the number of failed attempts at other forms of 
treatment.   
 
While most European countries use multiple pharmaceutical products for this purpose, for 
example, Germany has 18, Poland only uses methadone.   Buprenorphine, the second most 
administered substitution medicine in Europe is currently only registered in Poland as a pain 
medication, with a very few exceptions where it is prescribed, somewhat illegally, as 
replacement therapy the cost of which patients must cover in full.   Slightly more than 2,000 
people, or 8% of those who are estimated to be opiate dependent, have access to substitution 
treatment. Despite its early adoption of this form of treatment, Poland now has the second lowest 




While formal restrictions on substitution treatment have been relaxed since the first programs 
came into existence, many program directors continue to enforce some of the outdated rules 
making most of Poland’s substitution high-threshold.  In addition, funding calculated by the NFZ 
is such that it is more profitable for the program to have a client show up for his or her medicine 
every day, clients have to make an extra effort to be allowed to take their treatments home.  
Generally, the spirit of most of the methadone programs resembles the overall drug treatment 
culture in Poland. A six month wait is required to re-enter a methadone program if someone left 
of their own will or was expelled.  No other form of treatment exists in Poland, where it would 
be legal to require a patient to wait half a year to receive medically necessary medication.  
“Methadone is not considered medicine by the very medical staff who provide it,” states one of 
my interviewees. “If it were, all these practices would have no justification.  They think of their 
patients as bums and losers.  How else could you justify withholding medical treatment from 
someone who needs it?”    One of my interviewees, a drug treatment provider, when speaking of 
substitution programs said: “It is as though we are running a relay race.  Methadone programs 
continue what started in the therapeutic communities. We no longer cut off people’s hair, now 
we cut off their balls.”  A former methadone patient and now an active advocate for substitution 
treatment has a similar observation:  “Only a few days ago, 14 people were drug tested and 
crossed off the list in one day.  None of them were provided reduced doses to get them off 
methadone.  In the last year, we had a few of those ‘black Tuesdays.’ Rotation at the programs is 
high.  On an annual basis, roughly one third of patients get thrown out and immediately replaced 




Throughout the 2000s there have been various forms of advocacy for the expansion of 
substitution availability.  The objective has primarily been to guarantee access to substitution in 
all the large Polish cities.  Gdansk, the home of MONAR’s current leader, Jolanta Koczurowska, 
has been especially resistant.  In mid-2011, local authorities finally made 650,000 PLN available 
for the renovation of a facility (Katarzynska, 2011). However, by the end of the year, the 
program was still not in operation.  The public debate is visible as evidenced by a number of 
press articles in the last three years, the most recent of which quotes several local officials and 
specialists opposing the availability of substitution. Mr. Dubiel, a deputy chair of the regional 
National Health Office states: “I do not understand why methadone therapy should be covered by 
the national health insurance.  Especially at a time when we lack funding for a children’s 
hospital.”  Another, Ms. Dominiczak from the voivodship social service bureau states, “If this 
program begins, we will do all we can to make sure that only the most infirm have access to it.”  
Finally, Mr. Kowalczyk, the local treatment specialist and an advisor to the Wojewoda 
(governor) states, “If methadone cured addiction, whoever invented it would have received a 
Nobel Prize.” (Gromadzka-Anzelewicz, 2011)  A physician from the neighboring city, 
Bydgoszcz, inspired by the pleas of patients, activists, and ongoing media reports, set up a 
temporary satellite facility out of his own clinic and now provides treatment to 30 individuals 
from Gdansk.    
 
During his mission to Poland, the United Nation’s Special Rapporteur visited Gdansk, where he 
met with representatives from local Government and civil society. His summary of these 
discussions follow:   
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Despite  the  fact  that  the  2005  Act  on  Counteracting  Drug  Addiction  provides  for  
the establishment  of  substitution  programmes,  drug-free  treatment  -  the  therapeutic  
community model based on total abstinence theory -  is the norm in the tri-city region of 
Gdansk, Sopot, and Gdynia.  There are nearly 310 places in the region for those in need, 
including both inpatient and outpatient treatment centres, and the regional government 
has allocated up to 7 million PLN (approximately 2.5 million US$) to such drug free 
centres.  As the therapeutic community model remains  the  standard  in  Gdansk,  it  is  
difficult  for  people  requiring  methadone  treatment  to receive the care they need in the 
area, and they must travel to Warsaw or Krakow to receive it.  The  Special  Rapporteur  
commends  the  decision  of  the  local  Government  to  start  a methadone maintenance 
programme in Gdansk by September 2009, but regrets that, as of March 2010, the 
programme has not yet been established.   
 
Tensions between the advocates of the drug free, substitution, and harm reduction treatments are 
high in Poland. These are illustrated by the outcomes of a round table discussion that took place 
in April 2011 organized by the Polish Drug Policy Network, an association of methadone 
patients called JUMP and the the Ombuds for People Who Use Drugs (a position created by an 
NGO).  The purpose of the meeting was to discuss the availability and quality of drug treatment 
services among 23 participants representing 12 institutions.  The group produced a letter to the 
Council for Drug Prevention identifying the following concerns:  
· The preference for abstinence-only treatment undermines the availability of substitution 
treatment.  
· While more than half of those seeking treatment are in outpatient care, the intervention is 
severely underfunded and receives less than 10% of national treatment funding. 
·  Poland has more therapeutic communities than any other country in Europe. Seventy-
five percent of total funding for drug treatment from the National Health Fund is 
dedicated to this modality leaving few resources for other options. 
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· In many regions large monopolistic organizations refuse to expand the scope of services 
provided and exclude substitution treatment and harm reduction.  
· Post-treatment must be undertaken in settings where people can also access jobs, 
education, and other opportunities.  Isolating those who have completed treatment in 
remote and inaccessible locations is counterproductive.  
· The deficit of physicians willing to administer substitution treatment is a problem that 
needs urgent attention -- only 25 such physicians could be identified in all of Poland. 
· The only comprehensive, city-wide  program that has been responding to drug users 
needs for two decades in Krakow was dismantled with little intervention from national 
bodies.   
The following recommendations were issued:  
· The availability of substitution treatment must be expanded. 
· Capitalizing on the amendments to the criminal law that strive to reduce 
imprisonment, cooperation needs to be established between the judiciary and drug 
treatment providers. 
· Physicians must have access to in substitution treatment training. 
· Local governments must pay more attention to homeless drug users who receive little 
support and are vulnerable to HIV infection. 
· Antimonopoly actions should be initiated against treatment providers who 
intentionally block others from expanding their range of services. 
· Case management should be introduced as a method for controlling public 
expenditures and understanding use of services. The only successful holistic model of 
treatment in Krakow should be reinstated. 
 
Harm Reduction 
In 1988, when the first drug user infected with HIV was identified in Poland, there were no 
syringe exchange programs in place. A legal regulatory framework allowing for methadone 
maintenance therapy was not to be adopted until almost 10 years later, in 1997. By then, the 
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average HIV prevalence among communities of injecting drug users in Poland was at twenty 
percent, and in some voievodships (states) the rate was as high as forty percent.  Hepatitis B and 
C are common among drug users: in a study of 133 HIV positive patients treated in the 
Department of Infectious Diseases in Krakow, eighty-four percent of drug users had HIV, 
Hepatitis B and C concurrently, as compared to eight percent of non-drug using HIV patients 
(Kalinowska-Nowak, 2004).  A town near Poland’s eastern boarder, Bialystok, reported HCV 
rates of 90% among drug users (Cook, 2008). 
 
It was in the context of the drug-free treatment environment that, in 1989, after the first drug user 
who happened to also be a MONAR client, was diagnosed with HIV, that MONAR began 
intermittently making needles and syringes available.  The initiative was inspired by the 
availability of syringes through donations from Sanitation and Epidemiology Stations and the 
Red Cross.  This was the most significant effort ever undertaken to make syringes available to 
drug users in Poland.  Rarely, however, did the syringes satisfy the needs of users who 
complained that they were of poor quality and the wrong size. It has been estimated that from 
1989 until 1995, approximately 1 million needles and syringes were distributed throughout 
Poland, roughly 125,000 per year (Wodowski, 2005).  By comparison, a Chicago-based NGO, 
exchanged 2.6 million syringes in 2006 alone for a population of drug users that was less than 




Currently MONAR, though formally engaged in harm reduction efforts, has only two needle 
exchange programs, one in Krakow and the other in Warsaw.  In other cities, needles and 
syringes are available sporadically, but are not distributed with a strategic focus.   
 
Needle and Syringe Programs 
Like most of Europe, Poland’s National Program of HIV Prevention introduced needle and 
syringe exchange programs in the late 1980s (Drucker, 2011a).  However, coverage has been 
negligible since a budget was not allocated to support the program. This is still the case today.  
When the first discussions about implementation took place, medical personnel rejected the idea 
of making needles and syringes available to drug users claiming that such services would 
encourage drug use.  It is worth noting that at that time, hospitals and medical clinics were 
struggling with a shortage of medical equipment.  In the beginning, given the lack of proper 
budgeting, shortages in conventional medical settings and the novelty of harm reduction, none of 
the government’s medical providers were persuaded to offer needle exchange (Kulka, 1998).  
However, a year later, a small number of sexually transmitted infection (STI) clinics and public 
health offices began to offer needle distribution. Many rejected the provision of free condoms, 
consistent with the Ethical Commission of the Chamber of Physicians, which publicly declared 
that the promotion of condoms is “shameful” (Hendriks, 1991). As happened in France, where 
physicians united in opposition to some forms of treatment (Nathanson, 2007), Polish doctors 
played a counterproductive role by stating views that were at odds with conventional HIV 
prevention and evidence-based drug treatment. The Ministry of Health offered financial 
incentives to medical staff working with HIV positive drug users, including salary increases of 
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up to 200% (Johns, 1991).  By 1993, 75% of voivodships in Poland reported having at least on 
needle distribution site, many of them implemented by MONAR (Kulka,1998).  The Open 
Society Institute
2
 made external funding for harm reduction services in Poland available in 1997 
(OSI).   
 
The only national study of needle exchange and distribution in Poland was carried out in 1996. 
Of the 254 questionnaires that were sent out to MONAR, STI clinics, psychiatry clinics and 
ambulatory health services, 65 were returned.  The study concluded that no matter how limited 
or unprofessional the syringe distribution or exchange was, it enabled initial contact with active 
drug users and thus a way for workers to distribute HIV educational materials.  For drug users 
not interested in pursuing drug treatment, the distribution point for free needles and syringes 
became the only opportunity to engage with a health care or social assistance setting.  For many 
providers, distribution of injecting equipment became their first opportunity to offer a service 
that was not coercive, was assessed as helpful, and did not place clients in a disempowered 
position.  The following problems were reported by the respondents in the study: the lack of 
funding hindered the distribution of syringes and often resulted in breaks in service; the poor 
quality of injecting equipment donated by various institutions; difficulties with police who 
                                                 
 
2
 The author is currently an employee of the Open Society Foundations, previously, Open Society Institute   
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confiscated needles and syringes from outreach workers or clients; the recycling of returned 
equipment; the lack of drug-user-friendly medical services often requested by clients.  A study of 
the relationship between HIV rates and the number of needles and syringes distributed between 
1992 and 1995 indicated a significant inverse correlation between the rate of distributed injection 
kits per drug user and the number of new infections (Kulka, 1998).   
 
At the end of 2011, the European Monitoring Center for Drugs and Drug Addiction, in 
cooperation with the European Center for Disease Prevention and Control jointly released a set 
of guidelines for European Union member states, Seven Ways to Reduce Infections Among 
People Who Inject Drugs.  The recommendations are: 
• Provide free access to clean drug injection equipment, including sterile needles and 
syringes, as part of combined multi-component prevention, harm-reduction, counseling and 
treatment programmes. 
• Offer vaccinations for infections for which effective vaccines exist, such as hepatitis A, 
B, tetanus and influenza. For HIV-infected individuals, the pneumococcal vaccine is also 
recommended. 
• Provide access to treatment, in particular substitution treatment, for opioid users. 
• Grant access to testing for HIV, hepatitis C and hepatitis B and other infections, including 
tuberculosis; ensure the link to treatment. 
• Provide antiviral treatment as clinically indicated for HIV, hepatitis B or hepatitis C-
infected. Tuberculosis treatment is recommended for active cases, while prophylactic therapy 
should be considered for latent cases. 
•  Provide health promotion focused on safer drug use and sexual behaviour to enable 
people to increase their ability to control and improve their health. 
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• Offer a range of services, delivered according to user needs and local conditions, such as 
drug treatment, harm reduction, counseling, testing and referrals to other medical services. 
 
There is no city in Poland that meets all of these guidelines.  Warsaw comes the closest, but it 
lacks the vaccinations recommended for people who inject drugs.  In all of Poland’s existing 
harm reduction programs, four vaccinate staff against hepatitis A or B (2010 National Report).  
None of the programs offer vaccinations to their clients.  
 
As presented in Figure 8 below, there has been a significant decline in the number of needle 
exchange outlets in the country and the number of needles and syringes exchanged.  There are 




The greatest number of needles (731,832) and syringes (545,738) were distributed in 2004. The 
greatest decline, 259,220 needles and 196,960 syringes, was in 2009. The number of needles 
distributed per user fell to 80 pieces a year while in 2008 it had been approximately 140 (2010 
Raport). 
The UN Special Rapporteur on Health and Human Rights commented on this decline: 
There is a need for improved harm reduction measures to treat drug dependence in 
Poland… It has been indicated that there has been a decline in the number of available 
needle and syringe programs over recent years. For example, while there were 21 needle 
and syringe programs available throughout the country in 2002, only 13 such programs 
existed in 2008.  The total number of people being treated by these programs has 
significantly decreased and as of 2008, only 432,720 needles and 318,054 syringes were 
distributed in the country (Grover, 2010).    
The shift from national to local planning and implementation of drug related services had a 
detrimental effect on harm reduction. The effect was compounded by the fact that this shift took 
place when Poland became a member of the European Union and international funding 
assistance for Poland began to decline.  As municipalities and other local authorities became the 
primary funders of harm reduction, the programs began to wither.  Today, Warsaw, with a 
functioning needle exchange and multiple methadone programs, is the only exception. While 
expansion of substitution treatment is complicated and has met with severe opposition, various 
national strategies for health, psychiatric health, and drug prevention clearly state the objectives 
that localities should attempt to adhere to and provide important advocacy tools.  This is not the 
case with needle exchange as national documents do not provide concise implementation 




The harm reduction professionals I interviewed had divergent views on the dramatically 
decreasing number of needles and syringes exchanged.  On the one hand, there is agreement that 
foreign funding was instrumental in getting programs started as well as for scaling up and 
professionalizing those services already in existence.  It also increased much needed flexibility.  
The programs have always been locally based with little opportunity for sharing information or 
collaboration between cities. Staff are reporting an increased difficulty now that local funding 
does not allow for collaboration and limits the possibilities for outreach.  As explained by one 
source: “Since we are funded by the municipality, we can only work in the area of the 
administrative city.  If we learn of groups of drug users situated immediately outside of the 
boarders of the city, we would not be allowed to assist them.”  Attempts were made to create a 
Polish Harm Reduction Network to facilitate collaboration and advocacy across the country, but 
the project failed to secure funding.  With the end of international support, many programs either 
scaled down or closed.   Other sources report that in mid-2000, even with foreign money in 
place, programs were not reaching many drug users because the numbers of injectors were 
decreasing.  Yet another explanation offered was that increasing arrests due to the 
implementation of the punitive drug law atomized the drug user communities, forced the 
disappearance of gathering places, and inspired people to use mobile phones to arrange for as-
needed exchange.  While structural interventions were never strong in Poland, the new law 
shifted the burden of HIV prevention entirely on drug users themselves without any recognition 
of social conditions as fundamental causes for illness.   Newer drug users, who began drug use 
after the introduction of the 2000 law, never tapped into the support network that was available 
before and are now, for the most part, functioning underground out of the reach of harm 
reduction programs.  A harm reduction worker from Warsaw reported meeting 40 “newer users” 
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in 2011, each had begun by smoking heroin and then progressed to injection.  In the absence of a 
public health campaign, they learned about the needle exchange program from their dealer.   
 
An alternative view was offered by a harm reduction worker from the south of Poland. They 
believed that the decline in the number of harm reduction programs was due to the decreasing 
number of opiate users.  As the drug dealing industry became more established, tensions between 
users and dealers became so significant that they inspired people to detox.  In the past, many 
drug users were part of a network in which drugs were produced by a group of friends and then 
distributed to others.  The violence associated with buying from a dealer was new to many older 
users in Poland.  The first case of a person whose arms were broken because of a debt they could 
not pay off caused serious commotion in this community.  Others I interviewed disagreed with 
the notion of a communal and friendly drug production network.  They stated that while such 
situations occurred, there were always dealers who produced drugs for commercial gain and the 
possibility of getting in trouble with them was always a possibility.  While they agreed that small 
drug using networks might have been somewhat affected by the drug market issues, they doubted 
that they served as inspiration for a significant reduction in opiate use and doubted that such 
reduction occurred on a national level.  Consistent with this view, Poland’s drug markets have 
always been uneven and vary from city to city.  There is some evidence, for example, that 
smokable heroin, also known as brown sugar, was most popular in Olsztyn, Zielona Góra, 
Warsaw, and Wrocław while kompot is the most prevalent opiate in  Głogów and Zgorzelec  
(Osipczuk, 2010).  During my discussions in the south of Poland, it was confirmed that kompot 
continues to be the drug of choice among opiate users in Krakow and Katowice.  Consistent with 
my findings in Warsaw, a harm reduction staff member in Krakow reported that they were 
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reaching fewer  injecting clients than they had 10 years ago and that the bajzels, where drug 
users gathered, exchanged, bought, sold, and used illicit substances, are no longer in existence. 
As in Warsaw, outreach has, for the most part, stopped in Krakow.   Clients who do access the 
services are usually older, have a long history of heroin use, have multiple medical conditions 
and legal problems, and they access services not only to exchange needles and syringes but also 
for comprehensive case management now available in Krakow.  The decline of needle exchange 
in Krakow is also attributed to the decline in the number of opiate users and the punitive law that 
puts self-identified drug users at risk of arrest.  Service providers are concerned, however, that 
there may be groups of injectors in Krakow that are not visible to them.  A few times a year they 
do hear of small, insular groups, that are unknown to any of the staff or the older clients.  The 
most recent report from the National Drug Prevention Bureau states that there is no clear 
evidence that the number of injecting drug users is falling and that the classification used in 
medical statistics makes it impossible to determine the actual number of injecting users (2010 
National Report).   Varied views were expressed about the impact that the increasing numbers of 
methadone patients had on the use of needle exchange.  Some felt that clients of methadone 
programs are indeed abstinent from other substances and no longer needed needle exchange, 
hence they contributed to the decreasing need for such services.  Others saw the situation as  
more complex – methadone patients indeed are cautious to admit to drug user since this may 
cause them to be discharged from the program. Some methadone clients are themselves outreach 
workers for needle exchange programs; some clients of the needle exchanges are wait-listed to 
enter a methadone program and are feared to report on others, etc.  All of this complicates the 
degree to which people on methadone have access to needle exchange programs.  While 
methadone clients are tested for the use of opiates and limit their opiate use, there are other 
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injectable substances that are undetectable by the drug tests in the clinics.  For example, as 
reported by the staff of harm reduction programs, legal pharmaceuticals that contain ephedrine 
can be altered and injected for an amphetamine-like effect.    
 
The staff of harm reduction programs consistently state that while their programs were created to 
provide services to clients functioning in a relatively open drug scene, that reality has changed 
dramatically.  As stated by one of my interviewees: “No one had the knowledge and the 
experience to redesign their programming and to respond to the changing environment. Many of 
us felt that our case was an exception rather than a symptom of what was occurring nationally.  
Left to our own means, with the constant struggle to fundraise for existing programs, we find our 
own service inadequate and those at the national level do not provide any tactical support.  Yes, 
we do participate in meetings sometimes, but these meetings are not really for strategic thinking.  
They are more for the National Drug Prevention Bureau to gather information from us for their 
publications.”  The regions of Poland that never had harm reduction services for people who 
inject drugs, persist in their lack of action, justifying their course by declining number of 
exchanged needles and services elsewhere.   
 
Needle and syringe distribution began in Poland in 1986 in Jelenia Gora at the MONAR 
counseling center and was replicated by other MONAR offices throughout Poland.  HIV among 
drug users had been identified and the number of new infections was increasing.   Marek 
Kotanski was the first person in the country to speak against the discrimination of HIV positive 
persons while holding an HIV positive child in his arms on national television.  The scale of this 
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needle and syringe distribution and the attention paid to these public health efforts were not 
significant -- counseling centers were not set up to accommodate recurring client visits. Their 
primary purpose was to refer those who needed long-term treatment to appropriate MONAR 
facilities. As one of the harm reduction providers explained:  “This was all about ‘fishing.’  You 
would go into the street and see what you could ‘catch,’ always with an aim to enroll people in 
treatment. It really took us a long time to learn that being so invasive and prescriptive does not 
help us develop relationships with drug users on the streets.”  Outreach was limited and the 
quality of equipment did not meet with the client’s expectations.  The size of the needles and 
syringes were, for example, often different from those used by clients and there was limited 
outreach work, if any (Wodowski, 2005). Despite these shortcomings, the idea of making clean 
equipment available to active drug users became a part of the landscape.  As the number of HIV 
infections among drug users grew, needle and syringe exchange became a higher priority for a 
few of the programs. MONAR Krakow and MONAR Warsaw become the largest providers of 
this service.  At both sites, it was the initiative of individual staff members that led to the 
expansion of harm reduction services.  In Krakow it was Marek Zygadlo, followed by Grzegorz 
Wodowski and in Warsaw, Jacek Charmast followed by Pawel Nasilowski.  In 1996, at the 
urging of representatives from these two cities, the harm reduction philosophy was formally 
adopted by MONAR (Charmast, 2006).   As recalled by an outreach worker who set up one of 
the early programs: “We were worried that being out there with needles and syringes, somewhat 
publicly, would result in an outcry and accusations of permissiveness.  I expected, for example, 
that senior citizens would be yelling at us in the park, but none of that happened.”  More robust 
needle exchange programs followed as the concern over HIV and hepatitis increased.  The 
human rights of drug users became a subject of discussion. This was an important contribution as 
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it fit well with the political changes taking place in Poland during the 90’s.   In a few of 
MONAR’s centers, clients became partners rather than being subject to coercion or humiliation 
into sobriety.  The role of outreach workers became more precise, with goals that were clearer 
and more client-friendly.   The interactions between drug users and outreach workers were 
increasingly supportive, and the push for abstinence became less of a priority (Charmast, 2006).   
Over time, however, MONAR Krakow and Warsaw came under tremendous pressure from 
management and the board of director. By 2011, Zygadlo and Charmast, catalysts for the 
expansion of harm reduction services, had been removed from MONAR.   Since financial 
irregularities were given as reason for departure in one case, and working against the interest of 
the organization in the other, it was difficult for others intent on pursuing harm reduction at 
MONAR to speak out in support of the two men.  
 
Drug Use and Treatment in the Prisons 
The 2000 drug law that criminalized possession of any illicit substance affected Polish prisons.  
Among four studied Eastern European countries (Estonia, Hungary, Lithuania, and Poland), 
Poland has experienced the most significant increase in rates of incarceration. Almost half of the 
inmates (49% ) reported lifetime drug use before entering prison. By comparison, federal studies 
in the US estimate that 60 to 83 percent of prisoners have used drugs at some point, twice the 
estimate for a general population (Drucker, 2011b).   This ratio is similar in Poland.  20% 
reported drug use during their prison stay, 3% reported injecting while in prison.  As outside of 
prisons, abstinence-only treatment predominates with a few, scattered methadone programs in 
jails for select individuals.  In a survey, 20% of respondents evaluated drug treatment as good 
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and 80% qualified it as bad.  Reported needle sharing in prison was higher in Poland than in the 
four other countries (Thane, 2011).   While discussion about access to methadone treatment in 
prison is ongoing, its availability is limited and sporadic.   
 
The European Committee for the Prevention of Torture and Inhuman or Degrading Treatment 
(CPT) visited Poland in December 2009 and issued a report that states:  
Practically no progress had been made as regards the care of inmates with drug-related 
problems, the services offered to them, or the development of a prevention policy. 
Methadone substitution programmes were not available in the establishments visited, 
with the exception of Poznań Prison Hospital where a few prisoners were being treated 
with methadone. Further, none of the establishments visited had in place harm-prevention 
measures (such as, for instance, the provision of bleach and information on how to 
sterilise needles, needle-exchange programmes or the supply of condoms). 
The CPT wishes to stress that the management of drug-addicted prisoners must be varied 
– combining detoxification, psychological support, socio-educational programmes, 
rehabilitation and substitution programmes – and linked to a real prevention policy. It 
goes without saying that health-care staff must play a key role in drawing up, 
implementing and monitoring the programmes concerned and co-operate closely with the 
other (psycho-socio-educational) staff involved. 
The CPT reiterates the recommendation made in its 2004 visit report that the Polish 
authorities develop and implement a comprehensive policy for the provision of care to 





NGOs in the Drug Field 
For the most part, the people I interviewed did not agree with the director of the National Bureau 
for Drug Prevention, Piotr Jablonski, that the objectives of the national program implemented 
almost entirely by NGOs are a measure of Poland’s success. As reported by the Helsinki 
Foundation, directors and therapists from the monitored drug treatment facilities presented a 
troubling lack of cooperation and there was often competition between inpatient and outpatient 
treatment facilities.  All of my sources, many affiliated with NGOs, concurred with this 
assessment and reported that the civil society environment in Poland is such that the lack of 
cooperation and sense of competition is a serious problem for most of the NGOs.  One offered 
the following analysis: “Poland is somewhere between the West and a post-Soviet East: while 
organizations are allowed to exist, they exist to provide a clearly defined function, a service.  
People rely on their own financial survival providing these services so they do not see a need for 
cooperation with the competition.  For example, why would they let others know that a new 
grant competition is taking place? They are also not able to be critical of local or national 
institutions because these are the funding sources that sustain their organizations.”  Much was 
said about MONAR as a monopolist and its total isolation from others, “Their structures and 
internal relationships are so old and interdependent that they would not want outsiders to see 
their internal systems.” As an example, a number of years ago a meeting was organized by 
Marek Kotanski to create a joint platform for drug treatment organizations.  This was a welcome 
idea since a number of staff at MONAR were concerned with the organization’s isolation and 
those newer to the field welcomed an opportunity to collaborate.   After the meeting took place, 
Kotanski’s interest in collaboration declined.  The meeting clearly established that MONAR was 
the largest and most powerful organization and collaboration with others was perceived as 
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unwelcome power-sharing. It was recognized that: “The role taken on by many NGOs in the 
West, that of advocate and government watchdog, is totally utopian for Poland.  Our government 
partners are not interested in progress.  They are interested in self-preservation: keeping their 
own jobs and keeping the peace.  This is how their relationship with the NGOs is determined.” 
 
NGOs find it impossible to be critical of the local and national government, since they all receive 
funding from one or all of the responsible government entities. As one source stated, “It is 
inaccurate to call us NGOs – we are at the service of the government.”  Another pointed out that, 
though the 2005 legislative changes of the drug law allowed NGOs to operate substitution 
programs: “Not much has happened since then – two, maybe three programs were opened.  This 
expectation by the government, that the non-profit sector will solve the problem and deliver 
services is not realistic.  This is especially so, if the funding they are willing to provide is so 
insignificant and does not take into account our real needs.”   Two of the persons I spoke with, 
from two different cities, described a situation where the municipal councils significantly 
reduced funding to NGOs working with vulnerable groups.  They shared their disappointment 
and held a small meeting with colleagues from other programs to discuss a response, but they did 
not follow through.  In one of the cases, the group could not reach consensus. In another, many 
felt so overwhelmed by what would be required of them to keep the programs afloat, and were 
concerned that the effort required will not bring about substantive enough outcomes.  When 
discussing the power that civil society has to force government into action, the only positive 
example offered was that of international funding for newly emerging harm reduction programs 
in mid 1990s.  “Since some local co-funding was required, and we really wanted to make these 
programs available, it forced us, and we in turn successfully lobbied local governments to 
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contribute.  We made it happen.  Then all the programs lobbied the National Drug Prevention 
Bureau to make money available for needle exchange.  Before then, no local or national 
government had given money for needle exchange.” 
 
While Poland has the longest history of responding to drug use in Central Europe, much of this 
response is based on a single approach.  As the relationship between the state and its citizens 
changes and drug use diversifies, so should the interventions offered to people who use drugs. 
The process of diversification has been complicated and often undermined by the very 
organizations and individuals who were pioneers of drug treatment advocacy years ago.  Public 
health implications are most visible in the spread of HIV and HCV and will be discussed in 
chapter five. It is worth noting that debates and tensions over the balance between harm 
reduction and abstinence treatment is not something that is exclusive to Poland.  Neighboring 
Germany, for example, also struggled to establish an effective equilibrium for years. “Only 
abstinence-oriented services were regarded as the magic bullet and the 'gold standard’ of 
treatment.” (Michels, 2012)  Similarly, strong opposition to substitution treatment in France was 
overcome only when a sharp increase in the HIV infection rate among drug users was observed 
(Nathanson, 2007).  The Polish evolution has taken much longer, and matters that seem to have 
been resolved by other countries continue to be a constant source of debate which, in turn, affects 








Jonathan Mann, former head of the World Health Organization’s Global AIDS Program, often 
said that the way we conceptualize and frame the question will determine the answer.  The 
problem of HIV transmission among injecting drug users in Poland, and how it is interpreted and 
portrayed exemplifies this thinking.  In a 2010 interview, on the 25th anniversary of HIV in 
Poland, Dr. Anna Marzec-Boguslawska, the Director of the National AIDS Center stated, “It 
should be emphasized that preventive actions are targeted and respond to the current needs of 
specific populations at varied degrees of risk, i.e. women, youth, heterosexual couples, men who 
have sex with men, prison inmates, and immigrants.” (Kontra, 2010)  It is remarkable that while 
drug users constituted close to 50% of all those infected with HIV at the time, Dr. Marzec-
Boguslawska did not mention them nor talk about interventions appropriate for injecting drug 
users.  The same is true of the National AIDS Center’s most recent report, which describes the 
implementation of government activities (Work Plan, 2010).  Though the language of harm 
reduction is used, it pertains to the prevention of HIV through sexual transmission in the context 
of a generalized epidemic.  Referring to a “generalized” epidemic might be effective for rallying 
concern, but it distracts from those mechanisms that are most likely to be helpful (Des Jarlais, 




Drug users, excluded from the discussion of risk, are not identified as targets for prevention and 
HIV treatment efforts in Poland.  An outreach worker from Warsaw observed, “The HIV 
education materials for drug users that I have seen are almost 10 years old.  That is probably also 
when we last received funding from the National AIDS Center.  From the perspective of our 
officials, this is when the problem was solved.  It’s as though they do not know that each day I 
see a few new people who inject, as though they do not know that our country has changed, our 
laws have changed, people use drugs differently, and use different drugs.” 
 
HIV in Poland 
At the end of September 2012, Polish authorities reported 16,053 HIV cases, placing Poland in 
the category of low prevalence countries. Of these, at least 5,930 persons were infected through 
injecting drug use.  Injecting drug user has been strongly established throughout the world as a 
risk factor for HIV infection (Rhodes, 1999; UNAIDS, 2005; Mathers, 2008).  It has been 
documented that because of the unique way in which kompot  is prepared, shared and sold,  that 
this risk is potentially even greater.  Limited evidence exists that HIV was identified in the 
substance itself, after a number of users drew it in from a common receptacle (Kala, 1997).   
Today, many older users know about the risk posed by this method and often take the precaution 
of re-heating their dose before injecting in order to reduce the risk of viral infection but smaller, 
isolated groups may not be fully aware.   
 
With the first HIV infection identified in 1985, the number of HIV cases peaked in 1990 with 
809 registered new cases, declined to 384 in 1993, and has increased slowly since then, reaching 
a new peak in 2011 when the highest ever incidence was recorded.  Since data comes in with 
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some delay, it is expected that the actual number of new infections during 2011 will be between 
1,210 and 1,290  (Rosinska, 2012).  In 2009, 939 HIV cases were diagnosed in Poland 
constituting a 10% increase over the rate of infection in 2008 and a 33% increase over the 
median rate recorded between 2003 and 2007 (Werbinska-Sienkiewicz, 2011). There is some 
discussion over the 30% increase in HIV infection in 2011, as compared to the year before.  A 
psychologist implementing voluntary and confidential HIV testing (VCT), questions whether this 
30% increase does not fall within the range of estimated infections in Poland (25,000 – 35,000). 
“Since we test so little and the number of tests slowly increases, maybe we are just discovering 
old infections.  We have to know when these people got infected to draw any conclusions.”  
According to a drug counselor, also engaged in HIV prevention: “Sitting between Ukraine and 
Western Europe puts Poland in an interesting position.  There are now hundreds of thousands of 
drug users infected with HIV in Ukraine and Russia.  Poland’s numbers are encouraging in 
comparison, but not so positive when you compare our infection rates to those in Western 
Europe.” 
 
Data on HIV and Testing Among People Who Inject Drugs 
Surveillance of HIV and AIDS is carried out by the National Institute of Hygiene which is 
currently transforming into the National Institute of Public Health (NIPH-NIH). Its mission is, 
“To protect the health of the population through actions taken in the field of public health, 
including research and training. NIPH-NIH offers its expertise to the government, NGOs, and 
civil society in the fields of public health, risk assessment, and avoidance.”  All national HIV 
prevention and treatment activities in Poland are outlined in the National Program for Combating 
AIDS and Preventing HIV which is approved by the Prime Minister and coordinated by the 
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National AIDS Center.  The ministries of Education, National Defense, Health, Internal Affairs, 
and Justice, as well as several non-governmental organizations, and scientific associations are 
responsible for the National Program.  Compliance with the National AIDS Program, even 
though it is approved by the Council of Ministers, seems to be a low priority for most of the 
ministries since expenditures for specific components consistently fall short of the plans 
contained in the approved document.  Medical care for HIV-infected individuals in Poland is 
provided by 14 specialized reference centers often based at University Hospitals. This helps with 
the quality control of HIV treatment, but it concentrates HIV knowledge in a few, select 
locations, leaving the majority of physicians in Poland uneducated about symptoms and 
treatment (Jablonowska, 2007).  A physician I interviewed suggested that the level of knowledge 
about HIV among general practitioners is declining.  During her academic interactions with 
family physicians she often hears that they are not motivated to expand their knowledge of HIV 
because relatively few cases present in their practices. 
 
Though Poland held the 2012 Chair of the UNAIDS Program Committee Board, the UNAIDS 
slogan ‘know your epidemic, know your response,’ an appeal to put evidence at the center of 
national AIDS planning, is far from being implemented in Poland.  It is important to note that 
since relatively few HIV tests are performed each year in Poland one can expect that the actual 
number of Poles living with HIV is higher than the government reports.  From 2003 to 2004, 3.2 
HIV tests were performed per 1,000 inhabitants. At the time, in the majority of European Union 
countries, the rate of testing was greater than 20 per 1,000 inhabitants (Rosinska, 2007).   In 
2006, EuroHIV reported that Poland, together with Albania and Georgia, had the lowest testing 
rates in the WHO European region, conducting fewer than 5 tests per thousand inhabitants 
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(ECDC, 2006).  In 2009, with 5.6 tests per 1,000 inhabitants, Poland remained one of the three 
countries with the lowest test rates (ECDC, 2009). By 2010 the trend persisted with only 4.9 tests 
per 1,000 - significantly lower than its European Union neighbors. The rate in Slovakia is 20.1, 
in Czech Republic it is 33.6, and in Latvia it is 26.2. European countries with the highest HIV 
testing rates are: France at 76.9, and Belgium at 60.1. It is estimated that 70% of Poles who are 
HIV positive do not know they are infected (Sytuacja, 2010).   
 
Some of my interviewees have speculated that the low rate of testing for HIV in Poland reflects a 
conscious policy decision.  It was suggested that, because of the budgetary difficulties, many 
policy makers would prefer not to know the actual prevalence rates because Poland could not 
afford comprehensive treatment for all who need it.  These observations are consistent with the 
overall trend by the international AIDS establishment to show success, as evidenced by “Getting 
to Zero” and “Treatment 2015” strategy papers (2010, 2012). As critiqued by the UNAIDS 
Reference group -- statements about the world being “on the brink of ending one of the worst 
pandemics of our time” falsely raise expectations to believe that the HIV epidemic may soon be 
over. Such statements take away from the hard messages that should be at the center of UNAIDS 
advocacy. A senior policy maker in Poland offered similar comments on the country situation, 
“At the government level, difficult issues are not seen as something to be discussed and solved.  
They are always the cause of conflict and as such as hidden in burocratic, unhelpful language.  If 
you are a governmental institution, your primary strategy is to avoid conflicts.  So any activity 
that threatens the status quo is to be avoided, at all costs.  If there is no public debate about this 




This same policy maker also expressed concern for the overall passivity of Polish society 
towards taking responsibility for their own health, including high smoking rates and alcohol 
consumption.  He suggested that blame for low HIV testing rates should be shared among those 
institutions responsible for making tests available and Poles themselves, who are generally 
inactive and disinterested in preventive efforts.  He also referred to the persistent effects of a now 
defunct socialist law, on the Polish consciousness. All employed individuals (meaning all Poles, 
since employment was mandatory), had to present a health certificate to their employer and 
update it regularly, depending on their profession.  In a situation where people were legally 
required to comply with certain medical procedures, many perceived as absurd, there may have 
developed a distrust of any government supported health “propaganda,” and, alternately, planted 
the expectation that a signal will come from above, if there is a true public health concern.  When 
the law changed, no policy efforts were made to encourage greater personal responsibility.   
 
This observation of a senior Polish health official is concurrent with date on mortality rates in 
Europe.  While mortality has improved in the West over half a century, it is in stark contrast with 
the decline in the East.  As argued by Bobak (1998), social and economic conditions play a 
significant role in the speed how rapidly the society can leave the unfavorable phase of 
transition.   Life style, behaviors and diet seem to have the most substantial impact on these 
health outcomes, with smoking and alcohol having the largest impact,  According to Peto (1992), 
about a half of the East-West gap was caused by smoking and  Leon’s data  (1997) shows that 
much of Russian mortality is due to alcohol.  Several studies identify negative health lifestyles as 
the primary social determinant of the decline in life expectancy in the former socialist nations,  
with Russian male life expectancy as the most dramatic illustration.  In 1965 it was at 64.0 years 
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and decreased to 61.7 by 1980.  Gorbachev’s three year anti-alcohol campaign inspired some 
improvement, reaching 64.9 years in 1987.  Since then however, there has been an accelerated 
decline showing male life expectancy in Russia to be  58.9 in 2000 (Cockerham, 2002).  
 
In Poland, among those who do test for HIV, the routes of transmission are mostly unknown.  In 
their 2011 reports, the European Center for Disease Control (ECDC) and the World Health 
Organization (WHO) excluded two European Union countries, Poland and Estonia, from their 
analysis of European trends.  More than 50% of the data on transmission modes was missing in 
both cases (ECDC, 2011).  As noted by the National Institute of Hygiene, since 2000, there has 
been a consistent increase in reports of new HIV cases identified as having an unknown route of 
transmission.  All the people I spoke with were convinced that this high rate of “unknowns” is a 
serious problem since it does not allow for the planning of strategic and targeted interventions 
(Walichowska, 2010).  Their views as to the reasons for the current state of affairs were 
divergent.  Some felt that the National Institute of Hygiene is not doing its job in more actively 
soliciting information.  Others, that it is the job of the National AIDS Centers to provide 
technical guidance to the laboratories, to train them, to explain the importance of gathering 
information in order to design targeted prevention efforts. Still others felt that maintaining the 
status quo is simply comfortable for all involved.   
 
According to an epidemiologist monitoring HIV data in Poland, there seems to be a confluence 
of factors that are responsible for incomplete reporting.  First, the new Infectious Disease Law 
passed in 2001 significantly relaxed the expectations placed on medical providers and 
laboratories to gather information about routes of infection.  Names could be replaced with 
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identifier codes, if patients wished to remain anonymous.  I was able to confirm this by locating 
reporting forms (separate for HIV infection and AIDS diagnosis) attached to the 2001 Infectious 
Disease Law. Only the form reporting an AIDS case asks about possible routes of transmission, 
no such form exists for HIV reporting.  One of the HIV physicians I corresponded with views 
this as an oversight: “When the parliament was approving the legislation, it all happened very 
quickly. The omission of this form was a mistake and it appears that it was never corrected.”  
Second, as the Polish health care system changes, and with the increasing availability of private 
laboratories aiming to maximize profits, there is little interest in gathering additional 
information.  The reporting to the National Institute of Hygiene relies heavily on the good will of 
various institutions, laboratories, and individuals.  Some reports are submitted with a delay of six 
months or more. Finally, as health care system reforms began in early 2000, and severe pressure 
was exerted to cut costs, various “additional” services, such as HIV testing at detox units and 
other treatment centers, were removed.  This assumption was confirmed by people I spoke with 
who work at the VCT centers.  Many are referred for a test by a methadone clinic or detox 
program, or pregnant women undergo a test at the request of their obstetricians.   These patients, 
in principle, are under the care of medical facilities that are saving scare resources by referring 
their patients to VCT clinics instead of providing the testing service themselves.   
 
It is important to stress that, since the first HIV diagnosis during the socialist period and up until 
2000, all reporting was meticulous and included names, addresses and other personal 
information.  This raised serious confidentiality issues and was opposed by many individuals and 
organizations.   The system was considered outdated and potentially abusive.  I referred to my 
notes from a 1998 meeting about the need to change data collection.   People who favored this 
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level of information gathering argued that if names and addresses were not requested, it would 
send a message to people trained in the socialist system where detailed reporting was a norm, 
that reporting itself was not important and that information flow would break down.  As it turns 
out, their concerns were largely ignored; no trainings or specialized communications were put 
into place to prevent incomplete reporting when the law changed in 2001.  Recognizing 
problems related to incomplete data, the law was amended again in 2008, but it still awaits 
instructions on implementation.  Until these are created and adopted, the 2001 instructions still 
apply.  
 
Even though the data has been incomplete since 2001, reports of the National AIDS Center and 
comments from its director continue to state that injecting drug use no longer contributes to HIV 
infections in Poland (Redlinska, 2010; Kontra, 2010; Glazewska, 2011).  While acknowledging 
that injecting drug users were most affected in the first 10 years of the epidemic, after 2001 all 
subsequent publications and statements suggest that the trend was successfully reversed. 
 
However, a different picture from the one portrayed by the National AIDS Center emerges when 
analyzing HIV incidence rates among those who identified injecting drug use as the route of 
infection (Malinowska, 2013). As figure 9 shows, although the number of tests performed among 
injecting drug users between 2000 and 2009 (18,783) was less than one-third of the number of 
tests performed between 1988 and 1999 (72,832), HIV incidence was still higher in the years 




Figure 9. HIV among Drug Users  
Years Number of HIV tests HIV incidence 
1988 – 1990 13, 401 6.17 % 
1991 – 1993 22,582 4.1 % 
1994 – 1996    20,620 4.6 % 
1997-1999       16,229  5.93 % 
2000-2002 8,684  8.75 % 
2003 – 2005   5,988  11.0 % 
2006 – 2008 2,935 9,3 % 
2009-2011 2,717 5,7% 
 
All data is based on reports from the Polish Institute of Hygiene. 
 
The European Center for Disease Control (ECDC) was less convinced by the 2006 Polish data 
than were the Polish government representatives.  In its report it states:  
The apparently injection-driven epidemic in northeast Poland near the Kaliningrad border 
suggests possible links with the Russian outbreak. However, because the transmission 
route was not reported for many of these cases, this data must be interpreted with caution. 
The gender distribution of cases with an unknown transmission route (72.4% males, 
27.6% females) parallels that in IDUs (74.2% males, 25.8% females), indicating that 
injecting drugs could play an important role in the group with an unreported transmission 
route.  Among the cases with a reported transmission route, the proportion of IDU 
transmissions was the highest in the two northeastern regions – 89.3% in Warminsko-
Mazurskie and 88.1% in Podlaskie. (ECDC, 2006)  
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The report of the Polish Minister of Health makes a similar observation: “In the last five years, 
there was a significant increase in new infections in the region of Poland that neighbors the 
Kaliningrad region of Russia which has the highest HIV rates in Europe.” (Minister of Health, 
2011)  There was no attempt, however, by Polish officials, to offer an analysis of how the 
situation in Kaliningrad might affect Poland with regard to HIV transmission among injecting 
drug users. The ECDC also listed Poland, along with Estonia, Latvia, Lithuania, and Spain, as 
countries with ongoing HIV transmission among young IDUs (under 25) with prevalence levels 
above 5% between 2005 and 2010 (ECDC, 2011). 
 
I asked a number of my interviewees about the assumption that HIV among drug users is no 
longer a problem and most did not agree.  Some felt that the incompleteness of the data does not 
allow for such statements.  A counselor at a testing center in Warsaw, for example, suggested 
that the number of diagnosed HIV infections among drug users in her center is low, but so is the 
number of drug users who come in for testing.  She could not explain why their center 
predominantly attracts people who are concerned about potential sexual transmission. Even 
though she finds data from the VCT sites reliable, she does not consider them particularly useful 
for understanding HIV infection among people who inject drugs.   In 2010, 333 persons tested 
for HIV at the VCT centers identified injecting drug use as a probable route of transmission.  
That number represents 2% of all clients at the 29 VCT centers in Poland. Among these, 8.1% 
were HIV positive.  Each year, injecting drug users constitute a diminishing group of people 
tested at the anonymous testing sites.  In 2004, they made up 4.7% of the VCT centers’ clients, in 
2007 they were down to 3%, and in 2010 still further decreased to 2%. Two drug treatment 
providers from two different cities in Poland offered somewhat similar explanations for the low 
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interest among drug users in accessing HIV testing.  One provider felt that drug users have little 
faith in institutions they are not familiar with and that they are unlikely to walk through the door 
of an unknown, formal and intimidating building.  Similarly, the second provider pointed out that 
drug users have long lists of grievances towards the medical establishment so unless something 
really hurts, they will avoid any contact.   There was agreement that IDU clients only come in for 
an HIV test when it is requested by an outpatient drug treatment facility. Since these facilities are 
scarce and not always appealing, so is HIV testing of drug users. 
 
Anonymous and voluntary testing sites began operating in Poland in 2001.  In 2010, 26,118 
persons were tested. The most comprehensive report, based on 2005 data, was published in 2006 
and showed that less than 4% of people who came for testing have a history of injecting drug use 
(ARC, 2006).   Somewhat surprising, in a report from 2010, is that 8% of clients tested were 
pregnant women (Minister of Health).  This may be because in that year a ministerial instruction 
was adopted mandating provision of HIV testing to pregnant women. As explained by one of my 
interviewees, since cost cutting is a top priority for nationally funded health care clinics, 
obstetricians are suggesting that their patients get tested at the free VCT clinics rather than 
deplete the scarce resources of their healthcare provider.   
 
The HIV epidemic among IDUs was first observed around 1990, when this population 
represented more than 80% of all HIV infections in Poland.   It was a group more frequently 
tested than any others (Szadkowska, 2003).  As described by one of my interviewees: “When I 
think about it now, I am horrified.  All drug users were told they had to test.  There was no 
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treatment, no one asked if they wanted to know, and no one gave them the choice to opt out.”  As 
Figure 10 shows, until 2000, the number of tests of this population were consistently high.  What 
is not clear is whether the number of tests among drug users after 2000 declined significantly or 
if testing continued, but the results were absorbed into the growing group of tested individuals 
classified as having an “unknown” transmission route. In 2009 76.5% of all infections, and in 
2010 80.9% were attributed to an “unknown” route of transmission.  In 1992 8,000 tests among 
injecting drug users were recorded, ten years later, in 2002, that number dropped to 2,500.  It is 
also unclear what effect the criminalization of the personal possession of drugs had on HIV 
testing.  What we do know is that former gathering places of drug users, where information was 
exchanged, and outreach workers were able to offer information and assistance, disappeared. It is 
possible that, just as men who have sex with men who do not identify as gay maybe difficult to 
reach, dispersed drug users are now no longer a part of a network that supports information and 
advice about testing. 





HIV Prevention and Drug Users  
Studies from 2004 and 2009 of five locations show infection rates consistent with the trends 
noted in Figure 10.   The 2004 study had 426 participants from three different sites in Poland and 
recruited subjects from various modalities of intervention (detox, drug treatment, and needle 
exchange). Among the participants in this study, the overall HIV prevalence was 11% (Rosinska, 
2004).   A smaller study, carried out in 2009 with 193 participants recruited from low threshold 
programs, reported that 8.1% of their clients were infected with HIV in Gdansk and 11.9% in 
Krakow (Rosinska, 2009).  
 
Poland is one of the European Union countries that spends the least on prevention, – 0.05 Euros 
per person. From 2005 to 2010 there has been a continuous decrease in spending (Minister of 
Health, 2011).  As a senior policy maker explained: “It seems that during the socialist times 
public health was more of a priority. One might question whether the tools were effective, but 
the will was certainly there.  It is not the case now.  It is enough just to look at the very low 
mammography screening rates in Poland as compared to those in the rest of Europe.”  Currently, 
96% of all government resources for HIV related efforts are spent on HIV treatment, only 4% is 
allocated to prevention (Minister of Health, 2011).  The UN Rapporteur on Health commented 
on this imbalance after his visit to Poland: “Although HIV was not a focus of the mission, certain 
observations that were made need to be noted.  In this context, the need for improved harm 
reduction measures remains of significant importance in Poland. . . .There is a significant 
concern that people do not take  seriously the risk of  being infected with HIV, that infections are 
often diagnosed too late, that there is a permanent necessity to enhance the availability of ARVs, 
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and that there are few and limited financial resources allocated to HIV prevention.  As a result, 
there are few voluntary counseling and testing (VCT) centers and severe limits on the ability to 
finance programs implemented by NGOs.”  (Grover, 2010)  
 
The absence of comprehensive HIV prevention efforts for injecting drug users and the structural 
risk related to the punitive drug policies have been detailed in Chapter Four: Drug Treatment and 
Harm Reduction and Chapter Three: Drug Use and Drug Policy.  Here, I intend to discuss the 
evolution of the priorities of the National AIDS Center responsible for coordinating prevention 
activities throughout the country.   
  
Zofia Kuratowska, a physician and member of Solidarity, the opposition party during the 
socialist government, was the first public figure to speak about HIV in Poland. She published the 
first book about it in the mid-1980s and continued her advocacy when she became the Vice-
Marshal of the senate. As described by one of my interviewees, “When talking about AIDS she 
always spoke as a physician, she was very rational about it and lacked any political motives.”   
The first person to be appointed by the Ministry of Health as an advisor on AIDS was a 
physician,  Maria Dziedzic.  She held the post from 1986 until 1988, leaving over a disagreement 
with the Minister on prevention priorities.  In an interview, Dziedzic recalled the discomfort 
caused to various civil servants when gay visitors came to the Ministry and the fact, that this was 
the first community to reach out to the Ministry of Health asking for support; many unanswered 
letters sat in the files until her arrival. During her time at the Ministry, in collaboration with the 
Polish Red Cross, the first brochure about AIDS was published. Ten million copies were meant 
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to be sent to all households.  According to Ms. Dziedzic, less than a quarter reached their 
destinations and it is unclear what happened to the rest.   A researcher and an advocate 
specializing in sexuality and HIV matters recalls: “Maria knew exactly what needed to be done.  
She understood the nature of the problem, but the Ministry was not ready.”   Another advocate 
remarked that  Dziedzic’s affect was profound because she was the first person in the ministry to 
deal with AIDS in a professional, nonjudgmental manner.  She felt that Dziedzic set a standard 
that was later followed; she managed to couch HIV in the domain of biomedical and sociological 
issues, rather than one of pathology.   Marek Kontanski, the founder of MONAR, was another 
proactive figure often evoked in discussions of the early days of the HIV epidemic.  While many 
of the staff at the MONAR centers were afraid of HIV and resigned in haste as their clients 
learned of their HIV status, Mr. Kotanski insisted on accepting people with HIV for drug 
treatment.  “Whatever you might say about Kotanski,” said one of his MONAR colleagues, “he 
was one of the first to understand HIV and drug use and to really want to do something about.  It 
was a bit about publicity and spectacular actions, but it worked to the advantage of the fight 
against AIDS.”   Kotanski’s colleague referred to the frequent criticisms of Kotanski’s 
charismatic style and, in some eyes, self-indulgent public appearances.  His name is still widely 
recognized in Poland, even among the youth, who only learned of the issues after his accidental 
death in 2002.   
 
From the beginning of the epidemic, drug users were subject to stigma and discrimination:  
“Drug users who are suspected of being HIV infected are generally denied treatment by doctors, 
surgeons and dentists, and instead (are) referred to emergency units. In addition, the management 
of emergency units issued an order prohibiting ambulances to be used to transport drug users. In 
131 
 
some emergency departments, routine HIV antibodies testing has been introduced contrary to 
national and international guidelines” (Hendriks, 1991).  In these early years, the director of one 
of Warsaw’s two detoxification centers decided not to admit HIV positive drug dependent 
patients because they presented a “danger” to other patients and staff. The explanations were that 
hospitals did not have enough latex gloves and disposable syringes, patients might use each 
other’s toothbrushes, and patients and staff use the same bathroom and kitchen appliances.  
According to the director, caring for HIV patients required the following additional procedures: 
disinfecting the water after washing the patient, and scrubbing and disinfecting walls, doors, 
floors and windows when the patient leaves (Jedrzejewski, 1989).  As first the HIV infections 
were detected, identifying medical entities that would take responsibility for treatment was 
extremely difficult.  The first ministerial staff in charge of HIV recalled that she attempted to 
interest tropical disease specialists, “I thought, at the time, that since AIDS came from Africa, it 
would make sense.  Well, they hated the idea all together.  What I learned later is that such 
specialization did not really exist in Poland.  For the most part, these were just general physicians 
that were given an additional salary for adding this responsibility.  To be honest, I am not sure if 
they hated me for discovering this or for trying to hand over AIDS treatment to them.”   The few 
people who were infected with HIV through blood transfusion were cared for by the hematology 
departments.   Hematology was not willing to take on HIV care for anyone else.  The first 
infectious disease physician who finally agreed to care for HIV positive patients was Professor 
Lidia Babiuch at Warsaw’s Infectious Diseases Hospital.   
 
Krystyna Sienkiewicz, the Vice Minister of Health from 1989 to 1992, was responsible for the 
Ministry’s HIV portfolio. At this time the first halfway house for people living with HIV and a 
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history of drug use was established.  There was much resistance by the local community, 
including two attempts at arson. The second of these was so severe that the house had to be 
vacated and, for a number of days, its residents found shelter in Minister Sienkiewicz’s office in 
the Ministry.  The halfway house was one of many institutions run by Marek Kotanski who 
invited a young catholic priest, Arkadiusz Nowak, to help him respond to the local community’s 
resistance and who, during these efforts, developed a close collaboration with Minister 
Sienkiewicz.   
 
In the early days of the HIV epidemic, during and immediately after the political transition of 
1989, a number of halfway houses were created for people living with HIV and for drug users. 
Every one of these evoked strong opposition from their local communities.  One interviewee 
suggested that the opposition was not just to people living with HIV, but also due to the 
perception of drug users as irresponsible, dangerous, and malicious.  The conflation of HIV and 
drug use created, in the minds of potential neighbors, an unacceptable level of risk. In 1989, 
having only just emerged from decades of central planning, there was no practice of consulting 
with local residents when institutions, industrial or otherwise, were placed within communities.   
Residents learned of the changes as they were being instituted.  In this manner, the halfway 
houses were established without consultations in their new neighborhoods.  A remarkable post 
factum “educational” campaign took place after protests erupted following the discovery that two 
HIV positive children lived in a local halfway house. The response was to rain HIV information 
pamphlets on the protestors from a helicopter. One of my interviewees was present at one of the 
homes when a protest began.  He remembered the reactions being extremely violent: “They came 
in with sticks and axes.  I really thought that we might die there.”  When another of my 
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interviewees, a psychologist, was recalling these events she was struck by the lack of strategy at 
the time, but also recognized the influence of people such as Zofia Kuratowska who stepped in 
and publicly associated with the cause, with positive effect.  With a few exceptions, despite the 
initial opposition, these homes have managed to survive and are still in existence today.   In 
many instances, the assumption was that HIV positive drug users would live in these 
establishments until they died.  A number of them, in fact, were transformed into hospices.    It is 
important to recognize the political context of this period.  As transformation was gaining speed, 
inflation was dramatic, jobs were lost, services were cut, many felt disoriented, and a climate of 
fear was the norm.  What was perceived as bringing HIV and drugs into often isolated, small 
communities, with no consultation and education, was a dramatic oversight.  Showing people’s 
reaction on national television, ridiculing their ignorance, and making them look like “village 
idiots” further exasperated the difficulties.  
 
In the early 1990s, Minister Sienkiewicz recruited Arkadiusz Nowak to run a new home for HIV 
positive drug users under the purview of the Ministry of Health.  Later, between 1995 and 2002, 
Nowak served in the formal capacity as an advisor on AIDS and Drugs to three separate 
Ministers of Health and oversaw the National Bureau for Drug Prevention and the National 
AIDS Center.  He became a broker between the sphere of public health and the powerful 
institution of the Catholic Church. As the unchallenged moral authority in Poland, since 1989 the 
Catholic Church has vigorously instigated and emerged victorious from the discourse on abortion 
and sexual health in the schools.  Nowak’s influence over the National Bureau for Drug 
Prevention was limited.  Its first director, Olaf Mejer Zachorowski, a charismatic psychologist, 
carved out a large independent space for the activities of his office.  Apart from Mejer 
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Zachorowski’s political skill, it is likely that the church was just not as interested in drug-related 
matters.  That was not the case with the National AIDS Center.  Nowak’s influence over this 
institution was vast and for a number of years, after his post as Advisor to the Minister on AIDS 
and Drugs was terminated, he remained its salaried consultant.  He appointed the current 
Director, Anna Marzec-Boguslawska, as well as her two predecessors.  My interviewees were 
divided over the current role played by Arkadiusz Nowak in the HIV landscape today.  Some felt 
he exerts no influence while others were convinced that he is significantly engaged in decision 
making.  An ethnographer from the University of Kentucky researching HIV prevention in 
Poland who was aware of the importance of the church was surprised by the church’s lack of 
direct engagement in AIDS work.  She was also frustrated at not being able to interview Nowak 
during the fifteen months of her field research. At the same time, as she tried to understand why 
HIV prevention is never explicit, she heard of the importance of not angering the Church or the 
conservative parliamentarians because they had the power to eliminate the National AIDS Center 
(Owczarzak, 2007).   A similar view was presented by a psychologist specializing in drug 
treatment: “When I talk to people at the margins of various meetings, colleagues I work with, it 
is clear to me that everyone understands their role and the church-delineated boundaries.  No one 
is brave enough to go outside of these.  In the area of drugs and alcohol, the tacit objective is 
clear, ‘blessed sobriety.’ That is what we are to work for.  Anything short of sobriety is 
unacceptable. The only reason there has not been a real fight around HIV or harm reduction is 
that no one is willing to test that boundary – certainly not government institutions such as the 
Drug Centers and the National AIDS Center.” Ms. Owczarzak reported that an NGO seeking 
support for educational materials for MSM that reflected a content standard consistent with West 
European publications, was told that they were too graphic for the government to endorse (2007).  
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Another NGO had a similar experience when it sought governmental endorsement of a 
publication for drug users offering guidance on safe injection practices.  As recalled by one of 
my interviewees, use of condoms by heterosexuals, was the only acceptable publication to be 
supported by the National AIDS Center as long as it was couched in the context of advocating 
monogamy and abstinence.   The ABC strategy, Abstain, Be Faithful, use Condoms, was, for 
example, its flagship campaign. Throughout all the prevention discourses taking place in Poland, 
none factor in the social and economic context that makes people vulnerable to HIV infection.  
The limited prevention efforts in Poland align closely with the approach described by Adkins 
where vulnerability to HIV infection is viewed as a matter of individual action and responsibility 
for prevention is located entirely with the individual who is expected to adopt certain lifestyle 
choices (2001).   In the Polish paradigm, no narrative of structural interventions as a matter of 
government responsibility emerges. 
 
 In a 1990 interview in a Catholic weekly Nowak encourages mercy and support for those 
already infected, but at the same time, he clearly emphasizes the primacy of morally appropriate 
behavior.  It also reflects his limited enthusiasm for harm reduction, “You cannot be sympathetic 
towards drug users…. .  You cannot feel bad for them or be friendly towards them. The love you 
offer has to be tough.  . . . You cannot trust them. Drug users are best at manipulating and it is 
my job not to let them.”  As defined by Harm Reduction International, a highly respected, UK-
based international advocacy group: “Harm reduction refers to policies, programs and practices 
that aim to reduce the harms associated with the use of psychoactive drugs in people unable or 
unwilling to stop. The defining features are the focus on the prevention of harm, rather than on 
the prevention of drug use itself, and the focus on people who continue to use drugs.”  The 
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premise of Nowak’s approach is complete abstinence, including sexual. For example, to qualify 
for housing in any of the institutions under his supervision, one must comply with this 
requirement. In the interview, Nowak went on to say: “At the root of AIDS often lies immoral 
behavior, or sin, but it does not mean that we have the right to judge.  I will say, however, that 
once infected they have to deal with the consequences of their immoral behavior. . . . If you do 
bad things, it is very likely that they will end badly.  .  AIDS is not about punishment but it is 
about justice.” (Okonski, 2000)  Five years later, in an interview with a women’s magazine, 
Nowak restated his position that AIDS is not God’s punishment for moral corruption and offered 
his thoughts on prevention of sexual transmission.  He explained, for example, that condoms are 
not the only available HIV prevention since they do not address the change in values needed for 
HIV prevention, and they do not guarantee full protection. According to Nowak, adhering to the 
Christian value of fidelity and abstinence until marriage is the only effective prevention since 
one can never know for sure if a potential sexual partner has HIV and because condoms do not 
guarantee full protection (Domagalik, 2005). These statements are consistent with his interview 
in 2000 when he stated, “God gave us rules, and they certainly do not include acceptance of 
promiscuity.” (Okonski, 2000)  This narrative of acceptance and support for people living with 
HIV was present during the time when Nowak oversaw the National AIDS Center and continues 
to be the case.  Prevention technologies such as needle exchange and condom use, on the other 
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hand, have never been the priority of Father Nowak or the National AIDS Center.   The United 
Nations Development Program
3
 (UNDP)  became active in the area of HIV in Poland in 1995.  
UNDP headquarters approved the appointment of 22 HIV officers to be placed in national field 
offices around the world.  Since Poland was one of the two countries in Central Europe with the 
highest HIV rates (along with Romania where an HIV epidemic among children broke out), one 
of these 22 posts was assigned to Poland.  The UNDP forged an agreement with Nowak to lead 
prevention activities, in a cost-sharing fashion. During this time, and with the support of the 
Open Society Institute (OSI), a number of needle exchange programs as well as methadone 
programs were initiated.  Condoms were also purchased and distributed.  A number of people I 
spoke to referred to the UNDP project as useful for institutionalizing support for an emerging 
and difficult issue. For example, its training project for medical staff engaged HIV positive drug 
users as formal trainers. The first gathering of people living with HIV was also funded at this 
time.  It was hoped that the United Nations would provide a certain level of protection against 
any opposition that might emerge in response to these approaches.  However, this hope was not 
entirely realized. Several years later, in 2005, a heated discussion ensued over a leaflet produced 
in the context of the UNDP project, designed for MSM.  A Lambda representative, who was 
distributing the leaflet at a training about homosexuality organized by the Krakow municipality, 
had her HIV educator certificate revoked following complaints made by the local, conservative 
                                                 
 
3
 Author initiated UNDP’s AIDS program in Poland and was its coordinator from 1995 until 1998   
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party.   Her HIV educator certificate had been awarded and was then revoked by the National 
AIDS Center.   
 
While Nowak’s moral and religious principles helped to reduce some anxiety related to the 
presence of people living with HIV in Polish society, they also fueled the lack of clarity in 
national prevention efforts.  Furthermore, his goal of “normalizing” people living with HIV and 
presenting them as “regular,” rather than portraying them as drug users and homosexuals, may 
have contributed to the highly generalized discourse on the epidemic that omits drug users and 
men who have sex with men from prevention efforts.  Poland has never had a national prevention 
campaign that clearly endorses condom use and/or needle exchange.  By the time that drug 
possession was criminalized in Poland there was already abundant international evidence that 
criminalization drives drug users underground, making access to and use of effective prevention 
technologies difficult (Kerr, 2004 and Room, 2012).  Neither the National AIDS Center nor 
Nowak spoke out against this legislation.  Moreover, Nowak recently opposed liberalizing 
punitive drug laws, arguing that such a change would send the wrong moral message.  When 
discussing his engagement with a number of my interviewees, most had a positive view of his 
overall role.   While some agreed that he had a complicated relationship to the prevention effort, 
they did think that he did all he could in his capacity as both an advisor to the Minister of Health 
and a Catholic priest, to advance an open debate about HIV in Poland.   One interviewee 
reminded me that when Nowak first became engaged, the church was at the peak of its “power 
grabbing” following the political transition from the socialist system: “There was no better 
person than a priest to advocate in support of HIV positive people.  No one else would have been 
able to be effective in this environment.”  Finally, a senior policy official felt that it really did not 
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matter who was installed in Nowak’s role.  At the time, and to this day, the political climate did 
not allow for open, transparent, and explicit messaging related to sexuality and drug use. 
 
The National AIDS Center, a government agency funded by the Ministry of Health and 
established during the time Nowak was an advisor to the Minister, is responsible for coordinating 
the national response to the HIV epidemic in Poland.  The responsibilities of this structure are 
broad and include: preparation of the National Program for Combating AIDS and Preventing 
HIV Infections, and coordination of its implementation and monitoring; initiation and 
implementation of various HIV prevention efforts as well as improvement of the quality of life 
of people living with HIV and AIDS ( including the promotion of social inclusion);  initiation 
and implementation of various trainings and certifications;  oversight and implementation of 
analysis of HIV-related research;  procurement  and  distribution of HIV medication as well as 
the monitoring and coordination of its use in medical centers;  collaboration with national 
consultants on infectious disease,  laboratory  diagnosis  and epidemiology and other national 
institutions; provision of technical assistance to local authorities;  initiation and implementation 
of international cooperation; analysis of various legislation that may impact HIV programing; 
and coordination of the activities of  the Red Ribbon Chapter, an award given to individuals and 
institutions whose actions improve the quality of life of people living with HIV or the  quality of 
prevention programs (Rogalewska, 2007).   While the Center’s mandate is extensive, its 
budgetary allocations do not match the comprehensive scope of responsibility. Figure 11 





Figure 11.  HIV Expenditures 1994-2002 (Prevention and Treatment) 
 
Since 2002, the imbalance between funding for prevention and funding for treatment became 
even more dramatic.  In 2010, 96% of the national HIV budget was spent on purchasing and 
distributing HIV medication for 14 treatment sites.  The remaining 4% was allocated to 
prevention, and this included the support for HIV testing sites (Minister of Health, 2011).  
During 1995, with Nowak’s engagement, some harm reduction activities were supported with 
AIDS funding.  However, this support ended in early 2000.  It is unclear if this was the result of 
a shift in priorities related to the purchase of medication or for the other reasons explored.  A few 
of my interviewees mentioned a serious conflict between Akradiusz Nowak and Marek Kotanski 
and there is suggestion that this conflict might have contributed to the decision.  Others have 
suggested that there has been an overall increasingly conservative trend in the decision making 
of the National AIDS Center.   Over the last ten years, the National AIDS Center has become 
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more bureaucratic and cautious, focusing on the mechanical processes of medication 
procurement and distribution, data collection, and gathering information on the implementation 
of the National AIDS program. This gradual bureaucratization is a reflection of both, ’s notion of 
administering an epidemic (2000a), and Housner’s concept of avoidance of decision making 
among the employees of the Polish government (2007).  One of my interviewees pointed out that 
in 1949, the medical schools in Poland were removed from the universities and established as 
independent entities – Medical Academies.  Graduating high school students were immediately 
immersed in their medical instruction without any exposure to sociology, psychology, and the 
humanities that are typically offered in places of higher education.  He used this analogy to 
explain the transformation of the National AIDS Center in the 1990s, from a socialist-style 
public education organization devoted to counting infections, and producing and distributing 
educational brochures to the medical institution it became in the 2000s, predominantly focused 
on treatment.  With its singular focus on the medical aspects of HIV there is little reflection as to 
who is becoming infected, what puts them at risk, and what are the ways in which effective 
interventions can be inspired and supported.    
 
Even though all the funds for HIV treatment flow through the National AIDS Center, there is 
little information that is gathered by this institution, for the purposes of policy making.  As 
expressed by one of the AIDS physicians:  “The Center knows exactly how many people are 
treated, how many dropped out, how many new clients came in, how many therapy regimens had 
to be changed.  Yet, I have never seen any published analysis of this information, or guidelines to 
assist us with adherence. The reason for this, in my view, is the ongoing conflict between various 
treatment units and the Center itself.  What exists is a transaction of providing and absorbing 
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medicines.  Each treatment center owns its own data and the National Center, even though it has 
access, cannot publish it.”  This illustrates, as do many others, the various conflicts within the 
HIV community and the great resistance to collaboration, which has led to many missed 
opportunities for practice improvement.   
 
When discussing the expenditures of the national AIDS budget my interviewees shared various 
perspectives.  One felt that since Poland is “terrible” on prevention overall, and since public 
health is a nascent field in Poland, the expenditures for implementing the National AIDS 
Program simply reflect a trend in the Polish health system’s overall expenditure and is a 
symptom of a larger “Polish problem.” The majority felt that moving the purchase and 
distribution of HIV medication from the protected area of the National AIDS Center and 
incorporating it into the national health scheme would be a mistake.  Various examples were 
offered with HIV diagnostics, when the National Health Fund limited payments for necessary 
procedures, including cutting the number of methadone patients that a given site was able to 
treat.  Poland was recently ranked 27th, at the bottom of Europe, in the 6th edition of the Euro 
Health Consumer Index and it is continuing to deteriorate (Björnberg, 2012). At the same time, 
some frustration was expressed with the status quo: “It is not normal, really, that the Director of 
the National AIDS Center, with tears in her eyes, thanks the Minister of Health for providing 
money for AIDS medications at the plenary of a National Conference. It is as though he is doing 
this as some kind of favor.  This is the tenor of our discussions about AIDS in Poland.”   Another 
interviewee noted the persistence of the hierarchical bureaucracy inherited from the socialist 
system and its current impact. The way people relate professionally is always perceived through 
rank, and the lower ranking staff are always considered an applicant, never a partner.  Thus it 
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follows that the NGOs are considered applicants of the National AIDS Center and the National 
AIDS Center is considered an applicant of the Ministry of Health.  Two NGO representatives 
shared a distinctly different view on the AIDS Center’s role in the purchase of medicine: “The 
National AIDS Center is huge, I think it has five accountants.  It is hard to understand its 
purpose.  It does not do prevention.  All it does is pay for medicine and its distribution.  Why is 
there such a huge infrastructure for such a basic activity? Yes, in the beginning, it was tough.  
Everyone was worried that there would not be any medicine, and that no one would stand up for 
people with HIV.  Today, years later, HIV medication should be handled by the national health 
system, as with all other illnesses. The National AIDS Center should be about policy, prevention, 
problem solving.”  Another interviewee was even stronger in his view: “It is absurd that the only 
technical agency that should be helping us implement successful programs is spending all of its 
resources on HIV medicine. That should be a part of the regular health care system.”  While 
most of my interviewees felt that safeguarding HIV treatment was important, they also expressed 
frustration over the lack of investment in prevention and strategic initiatives.  Through these 
discussions, a theme emerged that suggested a conscious choice had been made by the staff of 
the National AIDS center.  In a conservative, Catholic country such as Poland, it is easier and far 
more admirable to be a person who saves lives and provides medicines, than to be someone who 
deals with sexuality and drug use.  As one interviewee said, “Why would you want to use words 
such as condoms, semen, vagina, safe injection, and anal sex every day when you can be 
spending your time negotiating lifesaving medication with pharmaceutical agents? Why do you 
think we have the same director for over ten years? She does not use these words.”  Another, a 
provider of drug treatment, agreed with this view and felt that treatment serves as a “shield” 
which protects the senior staff from dealing with issues that would potentially put them in 
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conflict with key contacts in the government.  Another interviewee pointed out: “The AIDS 
Center came up with a way to pay for AIDS meds by maneuvering the system so that moral 
judgments and economic considerations would not interfere with treatment.  Even though I am 
pleased for those who have access to medication, I find this somehow to be wrong.” He went on 
to explain that as more people need treatment, the less sustainable the current model will 
become. So called “protected” systems are costly because they are isolated from the established 
healthcare delivery system and thus require a separate infrastructure and that, as the operations 
continue in their present form, will miss opportunities to evolve and integrate with other areas.  
Ideally, we want HIV treatment to be available to all who need it as the result of a transparent 
decision made by those mandated to make such decisions – the National Health Insurance.  
Otherwise, HIV treatment will remain on the periphery of the larger health system. 
 
HIV Treatment as Prevention 
The public health approach to HIV frames HIV treatment as prevention: the less infectious the 
person is, the less likely they are to pass the virus on to others. After years of intense 
international debate over the value of investing in prevention or treatment, and almost 10 years 
after the establishment of the Global Fund to Fight AIDS, TB and Malaria (the leading funder of 
HIV treatment worldwide), the matter was largely put to rest. During the 2011 AIDS Conference 
in Rome, Anthony Fauci, Director of the United States’ National Institute of Allergy and 
Infectious Disease (NIAIH) pronounced, “The idea of the tension between treatment and 
prevention, we should just forget about it and just put it behind us, because treatment is 
prevention.” Fauci was commenting on the results of the Prevention Trials Network study 
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showing that antiretroviral drugs (ARVs) reduced the risk of heterosexual transmission by 96% 
(Cohen, 2011 and Cairns, 2011).  The head of UNAIDS subsequently stated, “This breakthrough 
is a serious game changer and will drive the prevention revolution forward. It makes HIV 
treatment a new priority prevention option.” (UNAIDS, 2011)  As discussed widely at the 
Conference on Retroviruses and Opportunistic Infections (CROI) 2012, while there are ongoing 
concerns about the practical implications of these findings, such as achieving good adherence, 
maintaining a long term undetectable viral load, and a constant supply of medicines (Fowler 
2012 and The Lancet, 2011), inspiring drug users to test and be treated with antiretrovirals could 
have an additional benefit of HIV prevention.   
 
Though the National AIDS Center is primarily focused on the delivery of HIV treatment, I was 
unable to locate any information about the strategic effect of these new findings on the Polish 
HIV policy.   Furthermore, as stated by one of my interviewees, “On paper, HIV treatment is 
available to people who inject drugs if they meet the clinical criteria, but if there are no supports 
in place, they will not be treated.  We all know that, for the most part, these supports do not exist 
in this country.  So, as with many other things, the papers look great, but the practice is entirely 
different.”    Another person, an advocate of methadone patients had a similar observation, “Most 
of the HIV positive people were told that they will not get ARVs if they do not go on methadone.  
A number of those on methadone were told that they have to be on it for a while, to prove that 
they will be responsible with their medicines.  There are others who were told ’no’ once, and 
would therefore not return.  These are the ones I worry about the most.  What tops the cake is the 
fact that people can only apply for housing available to those who are HIV positive after they 




When discussing the silence on the topic of people going untreated, the most marginalized 
members of society, one of my interviewees responded, “Drug users in Poland have a tradition of 
taking drugs quietly, of occupying dark corners in dark buildings, of getting sick and dying 
quietly.”  This silence on HIV treatment among drug users is present in the statements of the 
National AIDS Center: “Since antiretrovirals became available in Poland in 1996, all persons 
who meet the medical criteria receive these medications without charge. Those who are eligible 
include the uninsured, prison inmates, and the homeless (Redlinska, 2010).   Among the 274 
AIDS cases that were identified within three months of HIV diagnosis between 1999 and 2004, 
IDUs represented 31.8%, suggesting that drug users may have been tested very late in the 
process (ECDC, 2006).   
 
IDUs have successfully started antiretroviral medication in at least 50 countries where they have 
enjoyed significant benefits from HIV therapy.  Furthermore, the studies show that virological 
resistance does not differ between IDUs and other patients (Mathers B, 2010; Wolfe, 2010).  The 
World Health Organization issued clinical protocols detailing regimens for IDUs and stated that 
active injecting drug use should not be a criterion for exclusion from HIV treatment.  As 
described by HIV physicians (Carrieri 2006; Altice 2010; and Cholewinska 2007), a number of 
adherence supports are available to assure that active drug users can be effectively treated with 
HIV medication.  The range of support interventions is diverse and includes cues and reminders, 
adherence counseling, contingency management, supervised therapy, medication-assisted 
therapy, and integrated health services delivery (Altice, 2010).  A physician describing her 
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efforts to begin a discussion of HIV treatment for drug users in Poland related: “My efforts only 
got me in trouble.  My colleagues do not think that our job is to assist our patients with 
adherence.  They told me that our job is to treat patients who want to be treated.”  This approach 
is very similar to the drug free philosophy for drug treatment.  A drug treatment provider 
reported that for a number of years the HIV physician requested that his HIV positive drug using 
patients bring a note stating that they were promising to undergo drug treatment, before being 
enrolled on antiretrovirals.  He fears that the practice ended only because new drug users are no 
longer being enrolled in treatment due to funding limits and swelling numbers.  Another AIDS 
physician stated that her community is divided: there are doctors who do their best to treat HIV 
in active drug users and then there are those who believe it is a waste of funds.  “In my view, this 
is not a discussion that has come to a conclusion.  A number of years ago, it was on the agenda 
and as a result, a few centers initiated methadone provision.  Then it got quiet and no one has 
made an effort to come to a consensus on this.  It is important to acknowledge that active drug 
users in Poland do drop out often, but let’s be honest, what sort of adherence work is done to 
keep them enrolled?  For the most part, the answer is, very little or none.  There is not one person 
who lobbies for HIV treatment on behalf of drug users.”  The two programs mentioned by my 
interviewee are in Katowice and Wroclaw.  Both were established because of the efforts of 
infectious disease doctors who noticed a high number of active drug users at their HIV clinics, 
wanted to provide treatment, and felt that a methadone program will aide in that goal 
(Gasiorowski, 2007 and Beniowski, 2007).  Even earlier, an outpatient AIDS clinic in Warsaw 
made a methadone program available to its patients, as did the infectious disease hospital 
(Cholewinska, 2007).  It did so in a closed ward for HIV positive drug users where until today,   
patients are not allowed to have visitors.  An anonymous, voluntary survey of 95 patients, 
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reported that most are homeless, receive no social services, have no income and have no 
relationship with their families (Piekarska, 2004).  The study offered no explanation for patients 
being locked in or forbidden to receive visitors for the duration of their hospital stay. The closed 
ward was discussed by a number of my interviewees as an inexplicable phenomenon.  Some 
asked if I had ever seen such a set up in other countries.  One NGO representative shared an 
illuminating experience: “We had guests from the Ukraine once and we took this visit very 
seriously – there is a high level of HIV in Ukraine.  We took them to visit NGOs, they travelled 
throughout the country, saw needle exchanges, methadone clinics, and various HIV treatment 
centers.  Then they visited the Helsinki Foundation for Human Rights.  While there they asked 
about the human rights of the HIV positive drug users who were locked-up in the Warsaw 
hospital ward.  We all just looked at each other and did not know what to say.  It’s always been 
there.  I guess we all got used to it and no one really asked questions about its existence.” 
 
A number of countries have used the provision of HIV medications as an opportunity to motivate 
members of various vulnerable communities to come forward for testing.  The availability of 
treatment makes it worthwhile, even if discrimination is still a problem.  Poland is missing this 
opportunity among its drug users.  People whose infection resulted from intravenous drug use 
still constitute more than a half of all those diagnosed with AIDS (45% in 2005, 52% in 2006).  
In 88% of the AIDS cases reported between 2004 and 2005, patients had not received 
antiretrovirals before their AIDS diagnosis (Rosinska, 2007).  Four years later, the percentage of 
late presenters, defined as those with a less than 3 month period between HIV and AIDS 
diagnoses, is still reported to be high and makes up 56.1% of AIDS cases. This suggests that a 
significant proportion of AIDS incidence could be prevented with improved testing rates. The 
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largest group among patients with AIDS are also males aged 30 to 39 years old. Of these, 40.2% 
of were likely to have been infected through unsafe injecting drug use (Wierbinska-Sienkiewicz, 
2011).   
 
As stated by an HIV physician I interviewed who recently participated in a multidisciplinary 
workshop on HIV for non-HIV doctors, it was surprising how limited their knowledge was about 
HIV treatment. They had no idea of the existence of anti-retrovirals, of the fact that people with 
HIV can live for a long time, and that their expertise, for example in cardiology, may be useful 
for patients with HIV who are aging, as is the case with the rest of the population.  Such lack of 
interest and knowledge may help to explain the great delays in HIV diagnosis which continue to 
be a problem in Poland; family physicians unfamiliar with the risks and symptoms may not offer 
HIV testing to their patients.  Examples of dramatically late AIDS diagnosis were shared by a 
number of my interviewees.  Recently, a 23 year old man was hospitalized and bed ridden for 
eight months with multiple AIDS-related symptoms before receiving an HIV test – a day before 
he died.   A scientific body, the Polish AIDS Society, was seen by a number of persons I spoke 
to as a potential solution to the lack of knowledge about HIV and AIDS held by so many 
physicians.   For the most part, however, they concluded that there is little interest in reaching 
out to others and that the members are very focused on issues internal to their group. 
 
An important piece of international advocacy – treatment activism – has not made its way to 
Poland.  Polish treatment discussions contrast strongly with the treatment activism of the 
International Treatment Policy Campaign (ITPC), HealthGap in the United States and the AIDS 
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Treatment Action Campaign in South Africa.  In all of these instances people organized around 
the lack of access to HIV drugs, not only for themselves, but also for those who were invisible 
and powerless.  The ITPC, for example, brings together activists that engage not only in single 
communities and countries, but also across continents.  In Poland, the financial pressure is felt 
and much anxiety is shared when a new budget is approved each year.  This anxiety, as 
expressed by many of my interviewees, is over ensuring that those people who are currently on 
treatment, continue to receive it.  Little concern is expressed over newly identified cases or larger 
groups, such as drug users, who may be consistently excluded.   Securing funds for the purchase 
and distribution of medicine within the policy and decision making bodies may preclude such 
advocacy.  During the last gathering of people living with HIV that I was invited to, I was struck 
by the congratulatory tone of the event towards the Ministry of Health and the National AIDS 






Non-Governmental organizations  
Civil society, as defined by political scientists, is the matrix of institutions and associations that, 
“Fill the space between family and state.”   While Buchowski (2001) states that civil society can 
be defined differently, depending on the political context, he argues that it is inappropriate to try 
to understand post-communist civil society by comparing it to the West. In mature democracies, 
the non-governmental sector frequently fills in where the state ceases to meet the needs of its 
citizens.  NGOs have played a pivotal role in maneuvering HIV and AIDS onto government 
agendas and forcing appropriate action and funding. For this reason, it is hard not to look at 
Poland’s AIDS organizations without some expectation that they adopt the methods that worked 
for others in the West.  The ACT-UP model, a United States based organization of middle-class 
gay men committed to policy change and willing to do civil disobedience when necessary to 
obtain it (Nathanson, 2007), or any of its other advocacy tools, was never adopted in Poland.  In 
fact, the French organization AIDES, following its mission to Poland, reported:  
. . .most of the very limited funding for NGOs comes from the state.  Criticizing the 
institutions responsible for AIDS funding is, therefore, definitely not advised—unless 
you’re willing to risk your organization’s survival. In any case, none of these organizations 
take such risks; any problematic political positions or demands are stifled before rising to 
the level of conscious thought.  Only the occasional request (usually regarding a special 
case) discreetly reaching government ears through well-placed friends is likely to get 
results.  Their precarious situation is made worse by the fact that government funding does 
not cover the organizations’ administrative costs (such as rent, telephone, and electricity).” 
(Wasson, 2006)   
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While there are a number of NGOs that focus on HIV and drug use in Poland, they all provide 
services, are project-based, and rely heavily on funding from the state and the local governments.  
These factors limit their ability to advocate on behalf of their constituency.  A physician with a 
history of working with HIV in both the governmental and NGO sectors stated, “People choose 
to engage where they know there will be profit.  Much of the international funding available to 
the non-profit sector before Poland entered the European Union is no longer available.  In the fall 
of 2011, when Poland held its first Presidency of the Council of the European Union, it placed 
drug-related matters on its presidency agenda.  At a conference held in Warsaw, in support of 
this priority, the head of the National Drug Prevention Bureau delivered a speech in which he 
encouraged other European countries to follow Poland’s example, in which eighty percent of 
drug prevention and treatment is delivered by NGOs.  A number of my interviewees were 
puzzled as to why this heavy reliance on the non-profit sector is considered a measure of success.  
In fact, many felt that most of the NGOs have serious governance issues, poorly trained staff, 
and are severely underfunded. They also felt that these institutions are poor substitutes for the 
role that the government should not abandon.  Over dependence on project-oriented government 
funding transforms potentially powerful civil society advocates into an informal arm of a 
stagnant government.  Tensions between various civil society organizations are high and there is 
little evidence of cooperation.  Since both sectors, drugs and AIDS, are small, everyone knows 
one another and any serious conflicts may result in exclusion.  As one of my interviewees 
pointed out, “No one can afford an open conflict. People know that once you are out, there is no 
way to get back in because everyone knows everyone else.”  As a result, the current atmosphere 




As shared by an NGO representative: “It is difficult to criticize the people who can chose, or not, 
to finance your program.  What we clearly lack in Poland, is a think tank that can do research, 
provide independent recommendations, and to carry out effective advocacy.”  What is striking, 
when assessing the Polish NGO scene, is that there is no leading AIDS organization.  For the 
most part, they are service oriented and, more precisely, they provide various amenities to the 
government as implementers of components of the National AIDS Program. Advocacy is a small 
component of their work, if at all.   When describing the relationship to the government, another 
of the NGO representatives stated: “As I think about all these years of AIDS work in Poland I am 
amazed at how much we have managed to do despite the government.  It is hard to remember 
one instance when the government institutions took the lead on any one of the issues. 
Furthermore, the initiatives that NGOs cannot tackle on their own such as epidemiology, HIV 
treatment for drug users, and scaling up substitution treatment have been inadequately addressed.  
If one wants to discuss any of these issues, our shamefully incomplete data, for example, there is 
really no one to address.”   When government grants are paying for NGO salaries, they do not 
fund posts, but pay per deliverable.  This makes planning very difficult for civil society groups 
and leaves little room for the leaders of organizations to be compensated for overall 
coordination, grant writing, etc.  A staff member of a harm reduction program recounts: “When 
we have visitors from Canada or Western Europe, they are always surprised that I have five jobs.  
They exchange needles and syringes five days a week and can live on their salaries.  I would not 





MONAR, registered in 1981, had to suspend its activities during the period of Martial Law.  It 
started again when Martial Law ended in 1982.  It was the only non-governmental organization 
dealing with drug users in the 1980s and was the first to notice HIV infections in this population 
and to talk about this issue. The first HIV-specific NGO was established in 1989, the same year 
that Poland’s political and economic transition occurred.   Maria Malewska, a psychologist with 
a long history of working with drug dependent persons, founded the non-governmental 
organization, You Are Not Alone, to provide support for HIV positive individuals.  Along with 
delivering psychological assistance, the newly formed group also provided food, holiday 
packages and other necessities.   Malewska operated out of her home and fundraised through TV 
appeals which she had easy access to.  She also travelled throughout Poland conducting HIV 
education sessions that instructed on proper condom use, a novelty in a newly post-communist 
country.  Malewska’s organization, however, has not managed to sustainably establish itself in 
the Polish HIV scene.  The next group to come into existence, also in 1989, was Solidarni 
“PLUS” which was dedicated to supporting the social reintegration of marginalized individuals, 
including drug users living with HIV.  One of their activities is running an eco-farm.  The Social 
AIDS Committee (SKA), registered in 1993 with the support of parliamentary players as well as 
the Helsinki Commission.  Its portfolio has diversified and developed over the years and 
currently includes training services, counseling and testing for HIV, outreach to sex workers and 
advocacy. When the Social AIDS Committee was accepted as a member of the European Civil 
Society Forum in 2005 it subsequently issued to all HIV NGOs in Poland a request for 
information about their work, needs, successes and challenges. Several groups replied. Badz z 
Nami, which came into existence in 1993, is mostly composed of people living with HIV.  They 
run a 24-hour hotline, a program of volunteers who assist people living with HIV, and organize 
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various support activities for people living with HIV.   Most of their activities are centered in 
Warsaw.  Bez Granic, an NGO operating in Southwest Poland where HIV infection rates have 
historically been high, also provides various forms of assistance, including the identification of 
employment opportunities. Międzynarodowego Stowarzyszenia Studentów Medycyny is an 
organization of medical students whose primary activities are pro-bono educational efforts.  
Krakowskie Stowarzyszenie Pomocy Uzaleznionym (KTPU), based in Krakow, provides a wide 
range of services to support people who use drugs.   Lambda is an organization focused on 
supporting men who have sex with men and runs outreach to young sex workers and at dance 
events.  Other HIV NGOs include Siec Plus, a network of people living with HIV that organizes 
annual gatherings for its members, and Res Humane, founded by Arkadiusz Nowak, runs 
trainings, a hotline, and administers the annual AIDS conference of the National AIDS Center.  
Pozytywni w Teczy, is a support group for men who have sex with men.  With one exception, 
none of these Polish organizations have a significant advocacy or campaigning mandate.  The 
exception is SKA, which, for example, attempted to coordinate a Polish NGO report to a review 
by the United Nations General Assembly Special Session on HIV/AIDS (UNGASS).   
 
Recent opportunities for NGOs to talk about the challenges they face in their work revealed 
many serious threats that include the lack of: funding, publications and educational materials in 
Polish, and opportunities for exchange and learning from others in Europe. During my 
interviews, there were several accounts of effective knowledge transfers from organizations in 
other countries.  NGO cooperation with the Dutch, Germans, Austrians, Swedes, and French was 
mentioned. None of these have continued into the present.  The list of difficulties also included 
poor communications with national government entities, local governments, and NGOs 
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themselves. Budgetary planning has been marred by nepotism, difficulties in accessing funding 
networks, the lack of long-term contracts. Additional challenges are the constant manipulation of 
NGOs by making them compete for “pennies,” the poorly defined priorities of key decision 
makers that are not based on evidence, the limited capacity of NGOs and lack of resources to 
increase capacity, and limited access to high-speed internet due to budgetary constraints. The 
lack of inter-organizational cooperation has resulted in the largest NGOs acting as monopolists, 
while all of the smaller organizations, having insufficient funding to specialize and excel, do a 
little of everything, usually poorly. National grant givers treat NGOs like potential thieves and 
make them jump through time consuming hoops. The National Centers (AIDS and Drug 
Prevention) lack interest in making international documents available in Polish and language 
barriers to communicating with groups outside of Poland make it impossible to collaborate. 
Poorly educated medical practitioners are causing harm to people living with HIV and drug 
users.   There is very little information sharing or collaboration among the groups.  Their small 
size and lack of cooperation are a serious obstacle to accessing funding from the European 
Commission which prefers large grants with established and collaborative partners.  No 
assistance in accessing international funding is provided to the NGOs by the National AIDS 
Center or the National Drug Prevention Bureaus for help with proposal writing, identifying 
opportunities, or bringing partners together to discuss potential international collaboration.  
 
When talking to various HIV NGOs about the lack of prevention strategies for drug users in the 
early days of the epidemic one narrative emerges– MONAR was a well funded, highly visible 
organization specializing in drug treatment and the assumption was that it was taking care of all 
drug user needs, and represented all drug user interests.  MONAR began needle and syringe 
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distribution in the mid-1980s and in 1989 passed a bylaw formalizing the procedure.  This 
assumption about MONAR was somewhat flawed since MONAR was a treatment organization 
and was reaching only those drug users seeking treatment assistance. As stated by one of my 
interviewees: “Getting sterile shooting equipment was not easy. Before receiving your needles 
and syringes, which, by the way, were of terrible quality, you had to have an entire conversation 
about why you take drugs, about not wanting treatment, etc.  So as you can imagine, this was not 
an attractive offer to people who wanted to shoot-up immediately.” None of the people I 
interviewed could recall any prevention activities for the community of active drug users until 
much later, in the mid-1990s, and most of these efforts were enabled by the external resources of 
the Open Society Institute. As in the United States, seven years passed in Poland between 
diagnosis of the first HIV positive IDU and the establishment of the first formal needle exchange 
for active drug users.   It took even longer for any government funding to start flowing into this 
area. The two regional leaders in harm reduction efforts were the MONAR offices, first in 
Krakow and then in Warsaw.  As described in an earlier chapter, the leaders of both programs 
were later dismissed from their posts because of conflicts within the larger MONAR network.  
 
In an interview on the twenty-fifth anniversary of HIV in Poland, the director of the National 
Center for HIV Prevention stated: “One of the most important factors that determined the shape 
of the epidemic in Poland was the quick cooperation of the government with people living with 
the virus, that is, with civil society. This cooperation continues to be one of our main pillars.” 
(Kontra, 2010).  At the same time, the NGO representatives I spoke with seemed dissatisfied 
with their relationship the National AIDS Center: “If we want to do something, we just do it.  
Government agencies have little expertise, and provide no information. International sources are 
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the only ones to rely on.”  According to AIDES, most of the NGOs providing direct prevention 
and support services remain vulnerable financially.   “Private funding is extremely limited; an 
appeal for donations sent to 10,000 people by Res Humanae netted a total of 10 replies and only 
three of these contained checks. The primary source of funding, albeit limited, to NGOs is the 
national government” (Wasson, 2006).  My interviewees agreed on one aspect of civil society 
engagement – that there was not only a lack of cooperation, but there existed open hostilities.  
The reasons given for this state of affairs varied.  Some blamed the previous political system; the 
pervasive fear of informers and therefore the need to keep information close to ones chest. 
Others talked about scarce resources.  Some felt that increasingly scarce funding created a 
constant feeling of competition and that the few funders that do exist, for the most part 
governmental, manipulate organizations to prevent them from creating a common front.  A 
physician I spoke with, suggested that I should not perceive this as a problem of civil society: 
“Doctors do not like to share information with other doctors because they want to feel that they 
are the most competent.  They do not even publish, which might be a Polish phenomenon. 
Government agencies have no interest or habit of informing and consulting others they 
collaborate with.  Why should NGOs be different?”  When asked about collaboration between 
NGOs and the medical establishment another physician stated that no such efforts exist and that 
no institution ever tried to forge such partnerships. “Doctors do not really trust NGOs.  I doubt 
they would know how to work together or how to set a common agenda.  There is no institution 
here that ever attempted to facilitate such a discussion.”  Another pointed out: “This is something 
that has to be learned in a classroom, in a community.  No one ever invested in teaching us 
cooperation.”   A number of people I spoke to made the point that Polish culture precludes 
coming together to solve a common problem, especially across various sectors.  The head of a 
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think tank offered the following observation: “During the communist time nothing was safe. The 
government that was shooting at workers was certainly something to stay far away from.  This 
experience remains in the minds of many.  Now, competition is so deadly that we have another 
reason not to come together.”  Another person stated, “Look at our national agencies.  Since we 
began talking about AIDS in the mid-1980s different bureaus were created for AIDS, alcohol 
addiction, and another for drugs, and a separate office for public health education was 
established at the Ministry.  Everyone wants to be the director of their own office with a 
secretary and a computer.  The same is happening with the NGOs.  It’s not about us coming 
together, but rather about everyone getting her or his own cake and being a director.   I do not 
recall even one moment when the worlds of AIDS and drugs came together to discuss HIV 
prevention and treatment for people who use drugs.” Another NGO representative confirmed this 
view: “It seems that the National AIDS Center and the National Bureau for Drug Prevention 
divided the territory.  As a result, the AIDS groups do not talk to the Drugs people and Drugs 
people do not talk to the AIDS NGOs.  There are very few spaces for collaboration in Poland.”  
None of the HIV positive people who collaborate with the National AIDS Center are drug users.  
While drug users in Europe have been organizing around their shared identity since the 1970s, 
with Rotterdam Junkiesbund in Holland, and continue to be active throughout the region, they 
have never done so in Poland.  Unlike in the United States where the critical role of activist 
interventions was confirmed, there has been no advocacy for needle exchange in Poland.  The 
organization of methadone patients, Jump’93, comes the closest.  While methadone patients try 
to advocate for expansion of the very limited availability of substitution treatment, they have not 
managed to organize successfully to voice their concerns over the gradual disappearance of other 
services.   
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A number of people mentioned that working with HIV in the early days of the epidemic was 
easier because it was not a business yet.  Rather, it was a group of “fantastic” people who were 
moved by the issue and really wanted to do something about it.  This is no longer the case.  They 
observe that now it is simply just one of the many ways to make money and that relationships 
within and between organizations are tense and often unpleasant.  A few expressed a concern 
over young people joining civil society organizations: “It is really hard for them now.  There are 
all these old timers that are in place with no opportunities for them, no additional funding 
coming in, so there is no room for all of these young, enthusiastic people.  That is a real shame 
because many are highly competent, speak English fluently, and could make a significant 
contribution.  We are doing ourselves a great disservice by not finding ways to welcome and 
retain the next generation.” 
 
While the global discussion of HIV vulnerability is increasingly understood as a matter of social 
and economic justice, most Polish prevention efforts have focused entirely on personal 
responsibility.  Without acknowledging the structural risks, the inadvertent assumption is that 
every citizen has the knowledge and resources to opt into a drug-fee lifestyle, choose and 
practice sexual abstinence, or always use condoms or clean syringes and needles.  The 
criminalization of personal possession that removed drug users from public view, a phenomenon 
proven throughout the world to hinder the delivery of harm reduction services, was never 
discussed. Strategies were not put in place to ensure that drug users, increasingly receding from 
public spaces, would continue to have access to necessary services. Furthermore, no efforts were 
made to track the levels of HIV infection among injecting drug users since they make up a 
diminishing percentage of those people tested for HIV.  Although, HIV prevalence close to 10% 
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is consistently shown among those drug users who come forward to test, the government has 
effectively removed them from the epidemic’s narrative and focused exclusively on the theme of 
general transmission. In so doing, the Polish government removed drug users from HIV 
prevention and treatment efforts, from safe spaces that confirm their human dignity and protect 




Chapter Six -- Crucial Issues for the Future of HIV in Poland  
 
 
Without effecting long term changes in the structures of society and in relations of power, there 
can be no hope for ending the HIV epidemic (Parker, 2000a).  Based on gathered data, there are 
seven crucial issues that require immediate action if Poland is to manage HIV prevention and 
care for people who use drugs in a manner consistent with the international standards.   The areas 
requiring action are: a change in the drug policy, expansion of needle and syringe programs that 
includes expansion into the  prisons,  improved data collection and an increase in the availability 
of HIV testing, scaled-up substitution treatment, improved quality of other forms of drug 
treatment, greater investment in civil society organizations, improved access to HIV treatment, 
and educational and training efforts that encourage greater attention to HIV related matters 
across disciplines.  
 
Drug Policy Change to Create an Enabling Environment 
As discussed earlier, the current drug legislation is at the very heart of the challenge to mounting 
an effective response to HIV among drug users in Poland. These inadequate and unreliable 
polices greatly undermine public health efforts and encourage continued human rights violations.  
Public appearance trump public health strategies and drive the problem underground. The 
removal of drug users from public spaces, such as the central train stations in Warsaw, Krakow, 
Katowice, and Chorzow, makes it difficult to reach them with public health interventions.  As 
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stated by a methadone advocate, “Users got swept under the rug.  When they come out, they are 
immediately harassed and picked up by the police.  One might think that someone did their job 
really well –drug users are now invisible.”    
 
Furthermore, these actions set the wrong tone – one that clearly suggests that criminal justice, 
along with the quest for total abstinence, are the only appropriate paradigms to follow – a 
message that spread rapidly among the population.  As one of my interviewees pointed out, 
during the 1990s, whatever you did for drug users in one city, was immediately known in 
another.  This was a very communicative and mobile community.  He suggested that even if 
needle exchange programs were not widely available, and not everyone knew about the ones that 
did exist, the discussion about not sharing needles was noticeable as there was much buzz across 
Poland about the existing programs.  Drugs move as fluidly as information, some of which may 
be contaminated and can be very dangerous, as made evident by recent reports of anthrax deaths 
among drug users in the UK (Health Protection, 2012).  In the past, information about a few bad 
experiences in one city quickly made its way across the country.   But with the atomization of the 
drug user community, under police persecution, much of this information sharing has been 
reduced.   Poland’s law enforcement professionals need to understand the detrimental 
consequences their actions cause to public health interventions, as well as the implications of the 
law and order approach for the tone set in drug policy debates in Poland.  Former Minister of 
Justice, Krzysztof Kwiatkowki, when discussing the positive amendments to the existing drug 
law in 2011 at an implementation meeting a few months later, stated that he felt he could only 
shepherd through the Parliament those changes he felt were possible.   
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It needs to be pointed out that the criminal justice representatives are not in agreement, and do 
not speak with one voice about the effectiveness of their anti-drug efforts: 48% of surveyed 
police officers and 60% of prosecutors did not find criminalizing personal possession to be an 
effective tool in apprehending drug traffickers, and 66% of prosecutors, 58% of probation 
officers, 46% of judges, and 51% of police officers did not think that criminalizing personal 
possession deterred potential drugs users (Kuzmicz, 2010).  Now that the debate has begun again 
and includes new allies, such as former President Kwasniewski, rather than continue the process 
of ongoing amendments to poorly designed legislation, a new drug law is needed. This new law 
should consider support to public health efforts and compliance with human rights goals among 
its benchmarks of success.   The discussion of legislative changes and amended engagement of 
criminal justice should be guided by the Office of the High Commissioner for Human Rights 
(OHCHR) and UNAIDS, “States should review and reform criminal laws and correctional 
systems to ensure that they are consistent with international human rights obligations and are not 
misused in the context of HIV or targeted against vulnerable groups. . .”  And, “Criminal law 
should not be an impediment to measures taken by States to reduce the risk of HIV transmission 
among injecting drug users and to provide HIV-related care and treatment for injecting drug 
users.” (2006)    
 
Needle and Syringe Exchange and Changing Patterns of Drug Use  
The patterns of drug use have clearly changed in Poland: the proportion of opiate users as 
compared to users of other substances has declined.  During the 1980s and 1990s injected heroin 
was the predominate substance, today, relative to other drugs, its market and use is greatly 
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reduced.  The risk factors have changed as well.  The display of freedom during the Solidarity 
movement expressed by joining a counter-culture where drugs were injected is not the current 
experience of young Poles. The severe economic crisis of the 80s, and the lack of knowledge 
about HIV transmission, where a needle was used hundreds of times until it dulled, is no longer 
the case.  But it is a mistake to interpret the changing socio-economic environment and patterns 
of drug use as justification to limit or decrease services, especially taking into account an 
established HIV prevalence of 10% among the clients of harm reduction programs.  A harm 
reduction worker from Warsaw, for example, reported recently meeting approximately 40 new 
users who began by smoking heroin and, as their use progressed, switched to injection.  They 
had received information about needle exchange from their heroin dealer.  No public health 
information reached them through formal channels.  Growing interest in cannabis use and the 
problems associated with it, does not absolve the responsible authorities from providing the 
necessary care to drug users who inject opiates and other substances.   Otherwise, as in other 
locations where services are scarce, injectors, while currently constituting a small group, will 
continue to bear the greatest burden of the epidemic in terms of mortality and morbidity.   It 
needs to be considered that Polish data, similar to that of Germany and Switzerland, reports 
opioid use to be low.  However, Germany and Switzerland continue to invest in substitution 
treatment, injection rooms, and other facilities aiming to support people who inject drugs 
(Michels 2012, Csete 2010).   Poland, on the other hand, uses the same low reported rate of 
injecting drug use, to justify its lack of scale.  The dearth of data on the number of injectors in 
Poland is troubling.  Clearly, opiates are not the only drugs administered through injection. For 
example, much anecdotal evidence exists about the injection of amphetamines.  Every effort 
needs to be made to expand and professionalize harm reduction programming so that the 
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programs can respond to the needs of all injectors.   The effort should be broad and address 
multiple problems, per the guidelines of the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA,2011). All Polish cities must make available: robust outreach to drug 
users, needle exchange, HIV testing, condom distribution, STI testing, basic medical care, and 
social and legal assistance.  The trend in declining availability of needle exchange is troubling 
and requires immediate attention.  Efforts need to be made to understand this phenomenon and 
plan for an appropriate response. Innovative approaches to assure that drug users in smaller 
communities have access to services, such as mobile vans, need to be supported by the local and 
national governments.  Finally, the designation of case workers may be considered by providers 
of harm reduction services.  As stated by one outreach worker, “Our services really have to 
respond to people’s needs.  They have so many complications in their lives that a useless service 
is not where they will be spending their time. Needle and syringe exchange is one option, but 
legal services, social services, and medical assistance are also needs we have to respond to all the 
time.” 
 
While arrest and incarceration is now the default response to many drug users, prison based 
services are inadequate to prevent HIV. Needle exchange is not available to prisoners in any 
Polish prisons.  According to the European Commission, “Harm reduction interventions in 
prisons within the European Union are still not in accordance with the principle of equivalence 
adopted by the UN General Assembly, UNAIDS/WHO, and UNODC, which calls for 
equivalence between health services and care (including harm reduction) inside prison and those 
available to society outside prison. Therefore, it is important for the countries to adapt prison-
based harm reduction activities to meet the needs of drug users and staff in prisons and improve 
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access to services (Michels, 2012). Prison services need to consider making needles and syringes 
available. 
 
Data and HIV Testing: Documenting the Problem of HIV 
There is an urgent need to develop and employ confidential HIV testing and reporting – first for 
case finding and secondly to address the significant data gaps in Poland, especially among drug 
users .  Between  15,000 and 25,000 people are currently estimated to be injecting opiates .  In 
addition, 40% (50,000) of the estimated 125,000 problem drug users, as defined by the 
EMCCDA, are diagnosed with poly use (Category F-19).   It is unclear how many of these poly 
users are injectors and require harm reduction services.   The most recent report from the 
National Drug Prevention Bureau states that there  is  no  clear  evidence  that  the  number  of 
injecting  drug  users  is  falling (2010 National Report).   It is equally unclear who is HIV 
infected in Poland.  Evidence points to a decrease in HIV testing among drug users. Measures 
need to be taken to reverse this trend, keeping in mind that the current methods of delivery have 
proven inadequate for this population.  The decision of the ECDC and WHO to remove Poland 
from the European trend analysis, because of its incomplete data  (ECDC, 2011), illustrates the 
scale of this problem.   Necessary procedures, including implementation of clear guidance 
related to legislative decisions on HIV reporting,  must be implemented to assure that complete 
data on new infections is gathered, reported, and analyzed.  Policy making needs to be instigated 




HIV testing urgently needs to be scaled up in order to better understand the incidence rate and to 
know who is HIV infected.  It is also critical to enrolling those who need treatment as early as 
possible.  Currently, in significant number of cases HIV treatment is offered very late, often 
when a person has become visibly ill. Limited data suggests that late diagnosis and treatment is 
especially prevalent among drug users.  Improved testing practices would allow for greater 
access to, and more effective, HIV treatment.   Since it is not possible to effectively prevent and 
treat HIV without sufficient testing and accurate data, these should be given the highest priority.  
 
Recent reports from Romania and Greece show a significant increase in HIV incidence among 
injecting drug users. In Romania, as in Poland, while patterns of drug use appear to be changing, 
access to sterile syringes has been on the decline.  In Greece, access to substitution treatment is 
limited to only a few sites in large cities ( EMCDDA, 2012). The implications of these 
developments in Greece and Romania are very concerning for Poland in light of the fact that 
there is a high undiagnosed prevalence: a substantial proportion of HIV infected injecting drug 
users in Poland, especially recent injectors, are unaware of their infection (Rosinska, 2010); 
reported needle sharing behavior is at 40% among those tested at VCT sites (Walichnowska, 
2012); and all of this is set in the context of an overall lack of enabling environment.   The data 
from Greece and Romania and the parallels to the situation in Poland, point to the fact that HIV 






The difficulty with Polish substitution treatment is not only that it is so scarcely available, with 
exception of Warsaw’s six programs, but it is the spirit in which services are delivered.  Many of 
my interviewees spoke of substitution being offered with the same punitive philosophy and 
contempt for drug users that is present at many abstinence treatment services. ”The only change 
is the service itself.”   Further education of substitution providers is needed, including exposure 
to practices in neighboring countries as well as a roll-out of new programs.   A substitution 
advocate argued that programs should be stratified: “There should be a  low threshold mobile 
point, which would include needle exchange and treatment of abysses; a medium level to offer 
social services and legal assistance; and a high threshold program which would provide 
psychological counseling, job training, along with legal and social services.“   Availability of 
substitution is especially important in the context of adherence to HIV treatment. A number of 
my interviewees reported that HIV care is often linked to substitution and only available to drug 
users enrolled in a methadone program.  The examples of Chorzow and Wroclaw need to be 
followed, where substitution treatment was made available by infectious disease clinics.   Access 
in small towns was on the minds of a number of people I spoke with:  “There is a small group in 
Elk, near Bialystok, maybe 15 of them.  They will just stay there, until they start getting sick and 
dying.  Accessing services is practically impossible and no one is going to open a clinic for 15 
people.”  Each city needs to offer substitution and consideration has to be given as to how to 
serve opiate dependent persons living in smaller communities.  Prescriptions issued by local 
physicians should be implemented along with mobile outreach.  As stated by one of my 
interviewees: “We need to ‘free’ methadone in Poland.” There are a number of doctors who do 
not want to be labeled as addiction specialists, but who do, quietly, assist people who are drug 
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dependent. They usually quietly treat five, may ten patients with ‘underground’ substitution.“   
Poland needs to standardize this practice, rather than relegate these physicians to potential 
conflict with the law.   Substitution programs should also be much more flexible about take 
home doses, and it is important to put measures in place making sure that the lack of substitution 
does not impede access to HIV care.  A model developed and implemented at Yale Medical 
School, where mobile outreach is made available for both purposes, substitution and HIV care 
(Bruce, 2010).  This approach may be considered for smaller communities and more remote 
areas.   As shown by Germany (Michels, 2012), expanding substitution by strictly offering it the 
settings of methadone programs is not possible.  Urgent discussions are needed about registering 
buprenorphine as a substitution drug, and allowing its prescription outside of rigid program 
settings.   “Expanded substitution treatment in Poland should not necessarily mean additional 
rigid methadone programs.”    Buprenorphine, along with methadone, is included on WHO’s list 
of essential medicines. Medicines used in substance dependence programs include methadone 
and buprenorphine, and opioid analgesics, such as morphine (WHO, 2007) and should be 
classified as such in Poland.     
 
When legislation was passed in 2005 expanding the number of entities allowed to provide 
substitution treatment, it was hoped that civil society groups would seize this opportunity. This, 
however, was not the case: only three,  NGO-run programs were opened.   One of my 
interviewees observed: “People who want to expand substitution availability are not interested in 
following the current model.  Instead, they are trying things that are somewhere on the borderline 
of illegal, because, from their point of view, that is more effective, closer to the clients’ needs, 
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respectful of human rights, and they are probably counting on the fact that soon they will be able 
to do so legally.” 
 
While a few jails offer methadone treatment, by and large, availability is limited.  Reports of 
arrests of opiate dependent persons who then suffer in jails without proper medical support make 
their way to the few existing advocates.  According to UNCHR, sick prisoners who require 
specialist treatment shall be transferred to specialized institutions or to civil hospitals (UNCHR, 
1997). Finally, it needs to be formally acknowledged that some patients on substitution treatment 
will continue to inject drugs, at least for an initial period. Methadone programs need to make 
needles and syringes available rather than continue the current policy of expelling drug using 
patients.   Continued use is often evidence of poorly administered treatment that needs to be 
adjusted, i.e. when a patient needs a higher dose (Newman, Raport 20011).  A number of people 
I spoke to with were concerned about the emergence of new HIV infections among clients of 
methadone programs.  Since people are fearful of being recognized at the needle exchange 
programs, and as a result, being denied substitution, they discontinue using this service and HIV 
infection follows.    
 
Other Drug Treatment 
While most of Europe offers outpatient drug treatment as a primary mode of delivery, the 
situation in Poland is reversed.  The most significant budgetary allocations are for long-term, 
inpatient facilities and 70% of state funding goes to organizations that came into existence before 
1989. Several observations were made by the Helsinki Foundation for Human Rights after it 
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visited 18 inpatient drug centers. The stationary treatment centers should admit those who have 
been subject to therapy at outpatient clinics and are clearly motivated to undergo treatment. This 
sort of regulation of access would not allow for a popular practice now – that clients stay at the 
center as a place of temporary residence and a way to temporarily “mend” their health.  While 
not stated explicitly, they are not aiming to complete a full course of treatment.  The 
effectiveness of therapy should be assessed, also in the context of the costs incurred, especially 
since they vary considerably. There is a need to upgrade addiction treatment standards based on 
modern knowledge (Helsinska Fundacja, 2010). 
 
The absence of evaluations of the quality of services is another serious problem.  As stated by the 
Helsinki Foundation: “In our view, there is a need to perform an assessment of the Polish model / 
system of drug addiction treatment. Evaluation and diversification of the inpatient treatment is 
clearly needed. Perhaps the long-term residence facilities, at which clean-up work occupies the 
majority of the residents’ time have a raison d‘etre, possibly as social assistance institutions 
under the Ministry of Social Welfare rather than as drug treatment facilities under the Ministry of 
Health. Undoubtedly, the range of therapeutic offers should be more diversified not only based 
on the duration of the stay.  Finally, it is unclear if such a number of isolated, stationary centers 
is needed in Poland and if emphasis should not be shifted on development of a coherent system 
for outpatient treatment where such an important element as family therapy could be carried 




Since Polish drug treatment developed around long term inpatient facilities, outpatient services 
are low in number, often underfunded, and many require technical assistance. Investment in 
outpatient services is needed.  Much has been said about MONAR as a monopolist.  In order to 
diversify services, other entities must be empowered with special attention paid to short-term 
options.    
   
Post-rehabilitation is another area that requires attention.   As shared by one of my interviewees: 
“ It should be located in places where people can work, learn, where they can rent out a small 
apartment and try real living, with a real goal of re-integration. What we have instead, is a 
lengthened stay in a therapeutic community.   An isolated treatment facility puts up an additional 
signboard, makes a few rooms available, and moves clients who have completed their treatment 
process next door.  Local governments must address this and start supporting real post-rehab 
efforts.” 
 
Non-governmental Organizations and Their Funding 
Given these systemic and governmental obstacles to effective drug policies and programs in 
Poland a strong role of civil society is essential. Globally, civil society’s role in exerting pressure 
on governments and multilateral bodies for appropriate responses to HIV has been monumental.  
From local policy making to the creation of the Global Fund, NGO advocates played a crucial 
role.  Attempts can be observed in Poland where, for example, the Social AIDS Committee 
began advocacy efforts to promote testing, and NGOs have quietly created injection rooms and 
prescribed buprenorphine hoping to inspire a positive policy response. By and large, however, 
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the successes of civil society advocacy in Poland have been limited by the same problems that 
have impeded governmental action. As argued throughout my paper, and consistent with the 
writings of the political scientist, Patricia Siplon, HIV and drug use has largely affected those 
without power. Even when the powerless organize and come together, those who do hold power 
are often able to diffuse their demands.  They can force “non-decisions” by preventing 
grievances from developing into issues requiring decisions and change. The fundamental 
problem of HIV, she argues, is one of the configurations of power relationships among 
individuals, organizations, and nation-states (Siplon, 2007). One way this manifests itself in 
Poland is through the severe and haphazard underfunding of civil society organizations.   None 
of them receive institutional support which would allow them to set an independent agenda.  The 
salaries of staff, for example, are attached to individual deliverables: a project director receives a 
salary for a training, but only if he or she performs the actual role of trainer.  None of the other 
costs, such as preparation, oversight, and office space, for example, are covered by state funds.  
And overhead costs are not allowed.  NGOs, in reality, are the implementers of the national 
programs set forth by the government agencies, at extremely low cost.   As stated by one of my 
interviewees: “There is little effort made to invite us to discussions about how to improve 
national policy.  Rather, there are instructions for us, NGOs, for implementation of various 
pieces that have already been decided upon.”  This approach is evidenced by the Polish proposal 
to the Global Fund to Fight AIDS, TB and Malaria submitted while Poland was still eligible 
before entering the EU.  While the Fund required the establishment of a Country Coordinating 
Mechanism allowing all entities to engage in the process, the Polish proposal had one single 
component – HIV education for the schools of social work.  When I asked NGO representatives 
how many weighed in on the process of identifying this as a priority, the answer was that none 
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had.  A number of NGOs were asked, post factum, to sign the application that was prepared 





Not surprisingly, the advocacy that does occur on the part of civil society, happens on non-paid 
basis as an “add on” to various service delivery. As pointed out by a French delegation that 
visited Polish NGOs, they are very constrained by the funder-grantee relationship that the state 
and local funding institutions have with the civil society groups.    
 
For a number of years, an alternative to state and local funding was offered by private 
foundations and  small grants from the European Commission, as Poland was preparing to join 
the European Union.  After Poland became a member of the EU, most of these financial 
mechanisms ceased to be available.  There was no institution that took responsibility for 
preparing Polish civil society for this massive transition.  The European Union funding 
opportunities available now are on a scale that is simply too large for the nascent and 
inexperienced Polish civil society. The funding requirements call for collaboration among many 
                                                 
 
4
 Author served on the Global Fund’s Technical Review Panel but consistently with Fund’s policy, recused herself 
from review of the Polish proposal.  
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partnering organizations, ideally from at least two countries, proposals need to be submitted in 
English, co-funding is mandatory. All of these requirements make this form of funding nearly 
inaccessible.    
Other obstacles, related to local funding, were identified as well.  As explained by one of my 
interviewees: “Since we are funded by the municipality, we can only work within the boundaries 
of the city.  If we learn of groups of drug users situated immediately outside the boarders of the 
city itself, we are not allowed to assist them.”  Attempts were made to create a Polish Harm 
Reduction Network to support collaboration and advocacy across the country but the project 
failed to secure funding.     
 
Independent funding sources for civil society is urgently needed in Poland.   Also, state and local 
agencies should make every effort to assist NGOs in obtaining European Union and bilateral 
funding.  A service that helps to identify priorities, and assists with proposal writing and 
partnership seeking, could greatly strengthen the civil society sector and improve Poland’s 
response to HIV and drugs.  The organizations themselves need to reach out to other, more 
experienced groups such as human rights and women’s organizations, to create partnerships and 
share resources.  This would also allow them to learn about development experiences from 
others.   
 
International experience sharing is important to the continued development of Polish NGOs.  
Connections with European organizations that, as a whole, have a long history of advocacy and 
service provision, must be established and nurtured.   This may be possible through various small 
177 
 
collaborative initiatives supported by local embassies.   While most embassies focus on 
commercial collaboration, there may be opportunities to explore civil society cooperation.   
 
HIV Treatment: A Continuing Debate 
While elsewhere in the world ARV treatment is now becoming a cornerstone of policy 
(including its use as prevention ), in Poland much anxiety emerges when discussing access to 
HIV medication. First off, the model in which the only technical agency dedicated to HIV 
prevention, the National AIDS Center,  spends 96% of its budget on HIV treatment is highly 
problematic.  The Polish healthcare system, along with its financing, has been under constant 
debate since the political changes of 1989.  However, no discussions are taking place to integrate 
HIV treatment into the national funding scheme rather than have it funded and administer it 
centrally by the National AIDS Center, as it’s the case now.  A thoughtful strategy is needed to 
move HIV treatment into the National Health Fund (NFZ), keeping in mind the need for 
continuous and uninterrupted funding for ARV medicines.  While NFZ can be problematic,   
there are some sign of hope: a recent event where the supply of chemotherapy drugs was 
interrupted, but then immediately responded to by the Ministry of Health, illustrates the 
increasing maturity of the national system.   One option to purse would be to stage the process, 
with a built in mechanism, to assess the capacity of the National Health Fund to absorb the newly 
diagnosed patients.  The “protective” mode, in which HIV medicines are considered by the 
National AIDS Center works to the long-term disadvantage of patients and dramatically limits 
the funding available for prevention efforts .  
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In this context, special attention must be paid to HIV treatment for drug users.  While they make 
up the majority of those infected before 2000 and possibly later, and are most likely to have 
progressed in their HIV illness and require antiretroviral treatment, their numbers, as a 
percentage of enrolled patients, are ambiguous and appear to be small.   In addition, they make 
up 70 percent of those with a late diagnosis, within one year of HIV infection (Rosinska, 2011). 
 
Professional Education and Training  
Currently, HIV knowledge is located only in a few specialized centers across the country. 
Medical educational institutions must expand their academic portfolios in the area of HIV and 
drugs at the level of physician and nurse trainings, and also at the level of continuing education. 
The majority of medical staff trained outside of these centers are therefore not privileged to the 
knowledge that would allow them to consider the possibility of HIV when diagnosing patients.  
As expressed by an AIDS physician:  “If a person arrives at a general practitioners office, or any 
other doctor, with an acute fungal infection, they will spend months being treated without 
considering an HIV test.  There will not be a discussion about lifestyle and risk factors because 
doctors do not talk to their patients.  If drug use is not visible, it is likely that she or he will be 
diagnosed at the very late stages of AIDS.”  This explanation is supported by data with late 
diagnosis of HIV. Polish medical academies and other establishments charged with medical 
education need to expand their curricula to provide fuller knowledge of HIV as well as an 
understanding of drug treatment.   In both instances, special attention must be paid to physician 
supported adherence efforts, and the knowledge must be consistent with international standards 




Since 2002, training efforts have existed to standardize the capacities of those providing drug 
treatment in Poland.  All drug treatment counselors undergo certification trainings by the 
National Drug Prevention Bureau. However, those who had practiced for at least 12 years when 
the process started, were granted certificates without the examination.   This turned out to be 
problematic since, for the most part, counselors with the longest history in therapeutic 
communities are the most entrenched in the abstinence-only approach, and have little formal 
training and education (Raport, 2011) Alternative modes of furthering their competencies should 
be considered.  The Czech Republic introduced a certification process for treatment centers, for 
example, which sets ongoing educational expectations for all staff.   
 
This area of professional education must extend to a broader set of skills – including 
management, advocacy , and development . Polish NGOs have very few personnel that have 
been trained in administration, fundraising, or management.  This presents a significant 
challenge to the effective running of organizations, work plans, budgeting, reporting, creating 
advocacy strategies, etc.  Funding is greatly needed and should be made available by the state to 
strengthen the capacity of Polish AIDS and drugs NGOs in the areas of organizational 
development.  Foreign language classes would also be greatly beneficial, especially in light of its 
membership in the European Union. Polish civil society groups have few partners outside of 




A recurring theme in my interviews was the lack of opportunity to participate in international 
events.   This is highly problematic since a significant number of academics emerged from Polish 
universities before 1989, and their expertise is often not congruent with the current Polish 
realities. Exposure to the practices of other countries would be useful to inspire discussions in 
Poland.  There is no funding however, for civil society groups to take part in international 
meetings and conferences. Those who do travel are government officials with office budgets and 
physicians whose costs are covered by pharmaceutical companies.   
 
Greater educational opportunities need to exist in Poland in the area of HIV.  There is not one 
institution of higher learning where specialization in HIV exists in any of the fields.  As a result, 
there are very few professionals in the area of psychology, sociology, social work, etc, that have 
any academic credentials in the area of HIV.  One of my interviewees pointed out that the 
problem with the limited number of testing sites is that there simply are no competent people to 
provide HIV testing, especially outside of large cities.   There are also no advocacy efforts 
targeting local governments to introduce or expand the availability of HIV testing.   Various 
opportunities to expand the knowledge base in the area of HIV and drugs needs to be supported, 
from concrete skills around motivational counseling and HIV testing, to serious academic 






Chapter Seven  – Conclusions:  Human Rights and Public Health  
 
 
The lessons to be learned from the history and the current state of the HIV epidemic in Poland 
have general significance for specific epidemics of infectious disease globally, and for how 
public health is understood in the modern era.  
 
Human rights violations, when ongoing and severe, are a major determinant of health.  While 
social determinants theory does not specifically identifying human rights, it talks about the 
economic and social factors contributing to poor health outcomes.  When examining HIV 
prevalence globally, the greatest disease burden is closely associated with the most socially 
excluded including the poorest families and communities, who are most often the core of the 
drug user population (Grund, 1992; Rhodes, 2009; Reference Group, 2010).  The inequalities 
reflect the forms of structural violence (Degenhardt, 2010) that lead to increased HIV 
vulnerability and mortality (Farmer 1996, Mann 1999).  As discussed by Parker (2000), the 
spread of HIV infection has tended to uncover the fault lines of social cleavage, as well as 





The Case of Poland 
Poland entered the global HIV crisis in an unfavorable moment. As suggested by Bobak (1996), 
it is likely that the social environment existing in CEE and the fSU had a strong influence on 
psychosocial well-being of the region’s citizens resulting in poor life styles.  Social, political and 
economic factors have been influencing health behaviors.  The problem of HIV among drug 
users in Poland is not a lack of knowledge about effective instruments for HIV prevention and 
treatment, nor a constraint on resources – Poland’s economic development and per capita income 
are well above that of many societies in the region and likely to improve with EU membership.  
It now ranks 41 in the Human Development Index.  When Poland was discovering HIV among 
its drug users in the late eighties, it could have been argued that the response was slow and 
cautious because the country, emerging from decades behind the iron curtain, was simply 
unaware of many new issues and focused on its early stages of modernization and economic 
achievement.  This clearly does not apply today -- the evidence for engaging in HIV prevention 
efforts among people who use drugs is strong and the nation is fully capable of effective action.  
Access to the means of effective interventions are now externally well supported - by the 
International Red Cross; the Institute of Medicine; the UNAIDS, the Joint United Nations 
Programme on HIV/AIDS (UNAIDS); the World Health Organization (WHO); European 
Monitoring Centre on Drugs and Drug Addiction (EMCDDA) the United Nations Office on 
Drugs and Crime and many others.  Yet, the availability of the most fundamental measures to 
prevent HIV among the nation’s drug users is wholly inadequate -- needle exchange efforts are 
declining and the number of substitution treatment programs in Poland remains well below the 





Figure 12. Substitution clients as percentage of estimated need (EMCDDA, 2013)  
 
HIV and drug policy has been more about politics than evidence-informed public health. During 
the 70s, drug users perceived as a nuisance and a challenge to the system were put away in 
psychiatric facilities and remained there often heavily sedated and mismanaged.  Similarly now, 
the quality of services is driven by, and responds to political contexts -- humiliation of clients at 
MONAR treatment centers, high threshold and frequent urine screenings of methadone patients, 
strip searches, serve as powerful examples. Why this is so and what forces continue to restrict 
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Poland’s ability and political will to act effectively on its HIV and drug problems has been the 
subject of this inquiry. 
 
I have argued that the heart of the problem is that drug users most fundamental needs and wants, 
in fact, their human rights have been ignored, rendering them invisible and powerless as 
individuals, communities, and as political actors at the national level.  When MONAR was 
created almost 30 years ago, its intervention method very much aligned with the government’s 
approach – the assumption was that treatment had to hurt.  Mini police squads were established 
at its facilities and humiliation, shaved heads, were the norm. An ongoing process of political 
transition from socialism to democracy and free market economy and the many social tensions 
that emerged as a result, have sustained this state of affairs.  The neoliberal governance based on 
the idea that the state should have a reduced role in the provision of public services is evident as 
one records the Polish state’s response to both HIV and drugs.  As argued by Buse (2008), 
Poland is an example of “Laws and regulations that continue to stand in the way of effective 
policies.”   Various decisions makers, either actively, out of hostile intention, passively or both, 
block potential solutions to the drug problems that are all too evident. 
  
An example from neighboring Germany provides an illustration of how ideology prevails over 
evidence where needle exchange projects in prisons that had been initiated and found to be 
effective were stopped due to political changes following election outcomes in which an anti-
drug position gained power .  “Neither the encouraging findings of scientific supervision, nor 
positive practical experiences played a role in this purely political decision. Out of seven 
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projects, only one in Berlin remains ….One of the lessons learnt is that syringe provision in 
penal institutions must be agreed to and accepted by all participants as well as by politicians.  
This acceptance must constantly be renewed in order for such preventive methods to be 
sustained. Only against a background of this specialized and politically firm rooting can one 
become immune to shortsighted, populist strategy modifications” (Michels, 2012). 
 
While Poland can take comfort in being classified as a low prevalence country for HIV, there is 
no assurance that this will continue to be the case.  And three decades of experience with HIV 
tell us that much needs to change in order to have Polish AIDS policies meet the public health 
needs of people injecting drugs. In 1987, Jonathan Mann wrote about the need to for inclusion, 
of bringing people into structures of social, psychological, and medical support in order to avoid 
driving the epidemic underground (Parker, 2000a).  Two decades later Poland continues to be 
resistant to this call.   Structural interventions are urgently required, including availability of a 
full range of services and a change of the national drug law which would allow drug users to 
access these services without fear and hesitation.  In addition, deeper attitudinal changes are 
essential -- national and local policies must recognize that vulnerability to HIV goes far beyond 
individual choice and behavior, and acknowledge that such behaviors are the result of larger 
environmental factors that sustain high risk.  These structural interventions must involve 
governments through their own policies in various sectors, and by not blocking actions 




There is awareness of this issue among frontline health and social service professionals in 
Poland. When asked for his view on the current situation, a long-time outreach worker, stated: 
“First, it is important to cast doubt on the proclaimed success and ask for real proof and reasons.   
We are probably in ‘a success mode’ at all costs, and are trying to present only the best as we 
constantly compare ourselves to other European countries. . . For many years we felt 
incompetent and now we are going in the opposite direction: we are overstating our success.   As 
a result, we are a little lethargic when it comes to problem solving.  What we lack is a rational 
discussion. We need to ask: what are we doing, here are we headed and are the methods we use 
optimal or do they need improvement? . . . We need space for discussion.  Not a space where we 
will criticize each other, but where we can problem solve.  To date, when we talk, blood gets 
shed.“   While this reflection was offered about a national situation in Poland, it strikingly 
resembles comment that were offered by the UNAIDS Reference Group on Human Rights to the 
UNADS secretariat on its recent report, as a learned in a correspondence with one of its members 
-- Statements about the world being “on the brink of ending one of the worst pandemics of our 
time” and other hyperbole in the beginning of the document falsely raise expectations to believe 
that the HIV epidemic may soon be over.  The Reference Group advised UNAIDS to rethink its 
broader messaging and communications strategy to be much more balanced between 
achievements and the difficult work that remains to be done.   





Improved communication with others societies facing similar problems and within Poland:  
Recently Poland served as Vice-Chair of the Northern Dimension Partnership in Public Health 
and Social Well-being’s (NDPHS) Expert Group on HIV/AIDS and Associated Infections 
(HIV/AIDS&AI EG). With the financial support of the European Commission and various 
governments, Northern Dimension brings together ten Northern European countries, including 
Russia.  Issues of drug use and HIV were often discussed and reported on since parts of Russia 
are heavily affected by drug related problems.  Statements and recommendations related to drug 
policy and harm reduction are often published by the group, “Scientific studies show that harm 
reduction is an essential element in effective HIV prevention among IDUs, the policies should 
combine harm reduction programs with medical and social rehabilitation, implement harm 
reduction strategies in prisons, services should also include harm reduction measures to keep the 
patients attached to the treatment.” (NDPHS, 2008)   A review of the publications of the National 
AIDS Center reveals that none of these discussions and recommendations were taken up in 
Poland.  Even though Poland also held a leadership role in the Program Coordinating Board of 
UNAIDS where drug use and HIV are often discussed, it has not resulted in “nationalizing” these 
conversations at the country level. Instead, government documents offer no specifics on how 
various agencies plan to address any of the complex issues and whatever actions are proposed 
are innocuous and bland. The Parliament-approved work plan lists and describes what various 
ministries and partners should be doing as a matter of routine, is filled with vague references to 
various partnerships and consultations that do not directly address the clear structural risks and 
social exclusion associated with human rights violations, and misses a crucial opportunity to be 
an urgent call for the social, legal and human rights solutions that will address the real barriers.  
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Limited information for transfer of knowledge between government and civil society is also a 
significant problem.  
 
The only two systematic occasions in Poland for a national dialogue to take place are the 
National AIDS Conference occurring annually, in observance of World AIDS Day, and a newly 
organized drug treatment gathering of medical professionals specializing in dependence.  But 
participation at both is highly fragmented.  Outreach to different segments is needed in order for 
a variety of views to be included in these national events, as well as in smaller meetings that deal 
with substantive matters.  One of the drug counselors I spoke with shared: “There is a great 
opportunity lost in Poland – we are denied the possibility to confront each other’s views and to 
dialogue.  At each conference, we are patting ourselves on the back.  No space exists to ask real 
questions, to point out errors.  And then the dominant group,   representatives of the therapeutic 
community, do not even show up.” Civil society’s limited foreign language skills and lack of 
resources for translation make it easy for the state to selectively disseminate information on the 
issues it deems to be a priority.  Government-run newsletters published by the National AIDS 
Center and the National Drug Prevention Bureau, are the only organized source of information.   
In both cases, these are recent and limited initiatives.  While civil society organizations have 
identified the lack of information as a problem, there is no NGO that has taken the responsibility 
to provide this service for others.   There is not one listserv in Poland with the goal of 
information sharing among various AIDS NGOs and across the two communities dealing with 
HIV and drugs.   One explanation that was offered during the interviews was that the constant 
lack of funding and high level of job insecurity makes it impossible for anyone to take on 
additional, long-term projects.   Others worried that this would be seen negatively, as though 
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they are trying to coordinate everyone else.  And finally, there was a real hesitation to share what 
was perceived as a scarce resource – information.   In order to address communications 
difficulties, civil society needs support in the form of technical assistance and funding for roles 
that facilitate dialogue and information sharing.   Other institutions, such as academia, should be 
approached and encouraged to contribute to knowledge dissemination throughout the country. 
 
Leadership in HIV and drugs  
When analyzing the factors that have led to the successful containment of HIV in other countries, 
a critical common denominator is the presence of strong leadership by an individual or a group 
that is clearly focused on the goal of HIV prevention and quality care for those already infected , 
and is not constrained by political or religious boundaries.   In the Czech Republic, for example, 
Pavel Bem, a physician and the Mayor of Prague, spent his early years as a doctor working in the 
first needle exchange in his city. In Switzerland, President Ruth Dreifuss was so concerned and 
touched by the misery of drug users in Zurich injecting parks that she, along with local 
physicians, mobilized an emergency response which was, over time, institutionalized across the 
Swiss cantons. In Portugal, Joao Goulão, President of the Institute of Drugs and Drugs 
Addiction, with the backing of other political leaders, consistently advocated for moving matters 
of personal possession and use out of the realm of criminal justice and into that of public health.  
These are just some of the instances in which stronger leadership led to effective change (Csete 
2010 and 2012, Domoslawski, 2011).   While Poland certainly has had visible and long-lasting 
advocates such as Marek Kotanski and Arkadiusz Nowak, they were greatly limited by other 
personal and professional interests and alliances.  Kotanski’s primary goal was the survival of 
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MONAR’s network of drug treatment centers and perpetuating his great commitment to the 
abstinence-only paradigm.  Nowak’s commitment was to the church’s view on sexuality and 
morality as a prevention tool.  While both were charismatic, media savvy, and dedicated, they 
fell short when it came to advocating for evidence-informed public health interventions.   
Furthermore, by virtue of their status and recognition, the narratives they promoted predominate 
years later and are difficult to alter.    It is possible that Marek Kotanski’s premature death 
deprived Poland of a leader who would have evolved and moved MONAR, and public opinion, 
towards greater appreciation of the efficacy of methadone and other harm reduction practices.     
 
Polish government officials have been absent from all of the difficult and controversial 
discussions.  Consistent with Hausner’s analysis, they are non-inflammatory civil servants who 
oversee administrative processes and who are positioning themselves as Polish representatives in 
the international arenas.   While the state institutions have produced evidence-informed policies 
and action plans, there is a lack of clear leadership.   Much greater public engagement is needed 
to promote harm reduction at the national and local levels.  Since 70% of the funding for 
prevention comes from local authorities,  the national Drugs and AIDS institutions need to give 
guidance and monitor expenditures so that previous allocations, such as building soccer fields, 
does not become the main prevention effort. Bureaucratic processes and National Programs are 
important for framing what needs to be accomplished, but in and of themselves, they offer little 
support in advancing actions that are considered controversial.  Robust advocacy must 
compliment the bureaucratic processes. A journalist who often covers the needs of marginalized 
communities made the following observation:  “A few years ago, when Kaczynski, as a President 
of Warsaw, denied gay men the right to a parade, the number of supporters who came out to 
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protest in Warsaw was enormous. They included many moral authorities, such as people from 
the old opposition movement.  Suddenly, they understood that there is a bigger issue at stake and 
they responded. This is what’s lacking with AIDS and drugs: the inspiration for others to see the 
issue as theirs and to join in. “ 
 
The struggle to build leadership in AIDS work has been crippled by continued discussion in 
Poland about who “owns” the problem, yet to be resolved. Interestingly, this is similar to the 
situation in the United States in the early years of the epidemic (Nathanson, 2007;  Drucker 
2012) and can be linked to the continued high incidence of new HIV infections in America.  The 
two government entities in Poland charged with responsibility for HIV, the National AIDS 
Center and the National Drug Prevention Bureau, must collaborate on assuring adequate services 
and become more  visible in discussions on relevant legislation and other discussions with 
criminal justice officials. Dividing the territory, as it seems to currently be the case is detrimental 
to quality and coverage and the existence of an enabling environment.  Switzerland and the 
Czech Republic, two countries that are upheld as models of public health in the area of HIV and 
drugs, pride themselves on the ongoing and close collaboration between the drugs and AIDS 
agencies, as well as among various other state and civil society bodies.  Monthly meetings of 
various entities are the rule rather than the exception (Csete, 2010).   Consistent with Buse’s 
argument that policy emerges through interactions  among institutions, ideas,  and  interests 
(2008),  Poland’s officials must make immediate efforts to inspire such collaboration in order to 
facilitate an understanding  of these interactions  and to  identify and address the political barriers 
and opportunities that undermine evidence-based policy.  It maybe that the Council for 
Counteracting Drug Addiction, chaired by the deputy Minister of Health, composed of 
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secretaries and undersecretaries of state from various ministries and representatives of local 
governments, with its mandate to shape national drug policy, including substitution treatment, 
and the efficacy of primary prevention, can fill the leadership void that exists in Poland in 
relation to drug use and HIV.  Including civil society groups in this body may also provide the 
necessary inspiration for more active civic and grassroots engagement in public debates and 
policy making.  One community worker interviewed in the course of this research had the 
following idea about what effective leadership would look like: “It should be a small office that 
continuously inspires action.  It does not have to have a lot of money.  If people are competent, 
they can always find money elsewhere.  The point is that there would be a resource for others to 
come to for technical guidance, for support. Individuals and organizations with a problem could 
call and know that there is competence and a willingness to engage. “ 
 
Towards Ending The “ Paradox” of HIV Among Drug Users in Poland  
This thesis began with the 2006, statement by the director of the Polish National AIDS Center 
“that injecting drug use no longer contributed to the HIV and AIDS crisis in Poland” , a 
statement that was re-iterated two years later by the Director of Poland’s National Bureau for 
Drug Prevention.  My research has documented that evidence does not support this claim.  But 
the fact that it is repeatedly expressed is vital to understanding the true nature and great depth of 
Poland’s HIV and drug problems.  The consequences of such a statement by Poland’s drug and 
HIV policy leadership are profound as most of the dominant risks associated with HIV infection 
go unaddressed in policy and practice.  As the accurate focus is removed from injecting drug use, 
the population of drug users themselves are subsequently neglected by HIV prevention efforts, 
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denied access to HIV care, and marginalized as human beings.  On a practical level, various 
international guidelines on drug use related public heath interventions and policy are being 
ignored.  As a consequence many of the required steps for effective HIV prevention among drug 
users are very weak or altogether missing in Poland – including broad availability of needle and 
syringe distribution or exchange; outreach services with condoms and other paraphernalia;  
provision of STI and other disease screening and treatment; referrals to or direct provision of 
housing; substitution treatment; HIV testing and treatment, and overdose prevention – as well as 
a non-punitive policy environment that emphasizes public health rather than criminal justice.  
The interviews I conducted, as well as the review of the literature on drug and HIV policies and 
programs in Poland suggest that services are scattered, often unavailable, and that their number is 
stagnating, at best, and in some cases, even decreasing.   With populist politics and the 
increasingly popular “law and order” paradigm the few services that are available are 
increasingly hostile towards public health goals. As these essential interventions remain 
unavailable or operate at a wholly inadequate scale in practice, it is highly likely that the HIV 
epidemic among drug users will worsen in Poland.  
 
There are two opposing paradigms related to the global drug policy discussion today.  First, 
represented by a call for drug reform by a number of Latin American states where drug- related 
violence gave an impetus for change along with a few Western Europeans invested in public 
health approach to drugs and second, by Asia and Russia standing in support of the international 
drug regime.  Over the next few years Poland, along with a number of others, will need to take 
an important policy decisions as to what drug policy it will pursue. The upcoming UN General 
Assembly Session in 2016, dedicated to review of global drug policies, offers a useful motivation 
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for a long overdue national-level evaluation. In the meantime, Poland’s drug users excluded from 
the discussion of risk, as described by one of my interviewees, “are the voiceless actors – the 





Appendix 1:  Individuals mentioned and engaged in HIV and drugs debates 
 
Babiuch, Lidia -- the first physician to care for HIV positive patients at Warsaw’s  Hospital   
Balicki, Marek – a physician, twice a Minister of Health of the Social Democratic Party  
Dziedzic,  Maria -- first employee of the Ministry of Health dedicated to HIV control 
Housner, Jerzy -- an economist and former Finance Minister 
Jablonski , Piotr – current director of  National Bureau for Drug Prevention in Poland 
Jaruzelski, Wojciech -- the last Communist leader of Poland, a general who imposed martial law 
Jolanta Koczurowska, current head of MONAR 
Kotanski, Marek -- a psychologist who founded MONAR, the network of therapeutic 
communities 
Krajewski, Krzysztof -- professor of law at Jagiellonian University, a drug policy scholar 
Kuratowska, Zofia – a physician, Vice-Marshal of the Senate, one of the first HIV advocates 
Kwasniewski, Alexander -- two term president of Poland, politician from Social Democratic 
Party, currently a member of Global Commission on Drug Policy 
Kwiatkowski, Krzysztof – Minister of Justice who coordinated efforts to pass the 2011 drug law 
amendments 
Marzec-Boguslawska , Anna – current director of  the National AIDS Center in Poland 
Mejer-Zachorowski, Olaf – first director of National Bureau for Drug Prevention in Poland 
Nowak, Arkadiusz – a catholic priest, served as an AIDS and Drugs Advisor to three consecutive 
Ministers of Health, currently advises the National AIDS Center 
Osiatynski, Wiktor  -- professor of constitutional law engaged in public discussions about 
alcohol and drugs 
Staniszkis,  Jadwiga --  prominent sociologist,  professor at Warsaw University, engaged in 
various political debates 




Appendix 2: Timeline of major events:  
 
1978 – first therapeutic community opened by Marek Kotanski in Gloskow 
1980 – massive anti-government protests and emergence of Solidarity 
1981 -- martial law imposed  
1983 – martial law revoked 
1985 -- first HIV case detected in Poland 
1985 -- first modern legislation dedicated to drug related matters  
1988 -- the first HIV positive drug user identified in Poland 
1989 – first modern, free, multi-party elections in Poland, fall of the Berlin Wall  
1991 -- first, high threshold substitution treatment opens at the Institute of Psychiatry and 
Neurology in Warsaw,  one of the first of its kind in the entire post-communist block 
1993 -- the National Bureau for Drug Prevention was created  
1997 --Poland began the process of negotiations for accession to the European Union  
1997 -- Drug Abuse Prevention Act is adopted making possession illegal but suspending 
criminal penalties for personal possession 
1999 -- Poland joined the North Atlantic Treaty Organization (NATO) 
2000 -- Article 62 to the drug law introduces criminal charges for possession of any amount of 
illicit substance 
2004 – Poland joins the European Union 
2010 -- Prime Minister Tusk, overnight, shut down over 1,000 shops selling “smart-drugs” 
2011 – amendment to existing drug law allows prosecutors, in some specific cases,  to drop the 
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